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The overall objective of this work was to probe the fundamental relationship between 
enzyme structure, environment, and activity.  These relationships were in turn exploited as the 
basis for developing effective strategies for stabilizing and thus improving the efficiency of 
biocatalysts.          
Initially, the utility of ionic liquids, which represent an environmentally green alternative 
to conventional solvents, as reaction media for anhydrous enzymatic reactions was explored.   
Solvatochromic and partition coefficient analysis suggest that ionic liquids are considerably 
more polar and hydrophilic than organic solvents.  In model transesterification reactions, the 
enzyme lipase was found to be highly active in 1-butyl-3-methylimidazolium 
hexafluorophosphate, but inactive in more hydrophilic ionic liquids.  Conventional approaches to 
preventing deactivating conformational changes in non-aqueous environments were ineffective 
in improving lipase activity in ionic liquids.  Moreover, stability studies indicated that lipase are 
significantly more stable in ionic liquids compared to in organic solvents. 
To effectively control the pH of essential enzyme-bound water molecules, which is 
critical even in anhydrous enzymology, a novel buffering approach was developed.  This 
approach was based on the hypothesis that simultaneous biocatalytic reactions that produce acid 
and base will create a dynamic pH equilibrium.  The concept of biocatalytic pH control was 
successfully demonstrated by employing urease-catalyzed urea hydrolysis, which forms 
 iv 
ammonia, to neutralize acid produced by the enzymatic degradation of organophosphorous 
toxins.  Based on the pH-dependent activity profiles of the enzymes, the pH of the combined 
enzyme system is predictable and can be controlled by adjusting the relative ratio of enzyme 
activities. 
Lastly, poly(ethylene glycol)-modification was investigated as a method of enhancing the 
stability of therapeutic proteases in in vivo settings.  Matrix metalloproteinase-1 (MMP-1), which 
has considerable therapeutic potential in the treatment of fibrotic conditions, was employed as a 
model protease for these studies.  Comparison of the efficacy of native full-length enzyme, the 
truncated active enzyme, and a poly(ethylene glycol)-modified form of the truncated active 
enzyme in a laceration model in mice showed that the truncated active enzyme produced the 
greatest reduction in interfibrillar collagen.  Structural characterization of the modified enzyme 
suggests that site-specific modification are key to retaining activity and to improving the 
enzyme’s stability.    
 
 
 
 
 
 v 
DESCRIPTORS 
Biocatalytic buffering 
Bioremediation 
Diisopropylfluorophosphatase 
Green chemistry 
Ionic liquids 
Lipase 
Matrix metalloproteinase-1 
Muscle fibrosis 
Nerve agents 
Nonaqueous enzymology 
Organophosphorous hydrolase 
PEGylation 
Transesterification 
Urease 
 
 vi 
TABLE OF CONTENTS 
LIST OF TABLES.......................................................................................................................XII 
LIST OF FIGURES ................................................................................................................... XIII 
NOMENCLATURE ................................................................................................................XVIII 
PREFACE.................................................................................................................................. XIX 
1.0  INTRODUCTION ......................................................................................................... 1 
2.0  BACKGROUND AND LITERATURE REVIEW........................................................ 6 
2.1  ANHYDROUS ENZYMOLOGY......................................................................... 6 
2.1.1  Enzyme Structure in Anhydrous Solvents ...................................................... 7 
2.1.2  Influence of Water on Enzyme Activity ......................................................... 8 
2.1.3  Solvent Types.................................................................................................. 9 
2.2  EFFECT OF pH ON ENZYME ACTIVITY AND STABILITY ....................... 12 
2.3  PROTEASE STABILITY ................................................................................... 15 
2.4  STRATEGIES FOR ENZYME STABILIZATION............................................ 16 
2.4.1  Chemical Additives....................................................................................... 16 
2.4.2  Chemical Modification ................................................................................. 19 
2.4.3  Immobilization.............................................................................................. 23 
2.4.4  Protein Engineering ...................................................................................... 28 
2.4.5  Directed Evolution........................................................................................ 30 
 vii 
3.0  SPECIFIC AIMS.......................................................................................................... 32 
4.0  CHARACTERIZATION OF ENZYME ACTIVITY AND STABILITY IN IONIC 
LIQUIDS .............................................................................................................................. 35 
4.1  INTRODUCTION ............................................................................................... 35 
4.2  MATERIALS AND METHODS ........................................................................ 38 
4.2.1  Materials ....................................................................................................... 38 
4.2.2  Methods......................................................................................................... 39 
4.2.2.1  Determination of Octanol-Water Partition Coefficients ....................... 39 
4.2.2.2  Solvatochromic Characterization.......................................................... 40 
4.2.2.3  Poly(Ethylene Glycol)-Modified Lipase Synthesis .............................. 41 
4.2.2.4  Lipase-Containing Polyurethane Foam Synthesis ................................ 41 
4.2.2.5  Lipase Stability in Ionic Liquids........................................................... 41 
4.2.2.6  Water Activity Measurements in Ionic Liquids Using Humidity Sensor .  
 ............................................................................................................... 42 
4.2.2.7  Water Transfer Measurements in Ionic Liquids ................................... 42 
4.2.2.8  Lipase-Catalyzed Transesterification of Methyl Methacrylate and 2-
Ethylhexanol ......................................................................................... 43 
4.3  RESULTS AND DISCUSSION.......................................................................... 44 
4.3.1  Physical Characterization of Ionic Liquids................................................... 44 
4.3.2  Lipase Activity in Ionic Liquids ................................................................... 48 
4.3.3  Use of Modified and Immobilized Lipases in Ionic Liquids ........................ 51 
4.3.4  Lipase Stability in Ionic Liquids................................................................... 53 
4.3.5  Controlled Water Activity in Ionic Liquids .................................................. 56 
 viii 
4.3.6  Impact of Water Activity on Lipase Activity in Ionic Liquids..................... 61 
4.4  CONCLUSIONS ................................................................................................. 64 
5.0  BIOCATALYTIC pH CONTROL IN ENZYMATIC REACTIONS ......................... 65 
5.1  INTRODUCTION ............................................................................................... 65 
5.2  THEORETICAL MODELING OF DYNAMIC pH EQUILIBRIUM IN OPH-
UREASE COMBINED ENZYME SYSTEM ...................................................... 69 
5.3  MATERIALS AND METHODS ........................................................................ 71 
5.3.1  Materials ....................................................................................................... 71 
5.3.2  Methods......................................................................................................... 72 
5.3.2.1  OPH Activity Assay.............................................................................. 72 
5.3.2.2  Urease Activity Assay........................................................................... 72 
5.3.2.3  Preparation of Helicobacter Pylori Urease........................................... 73 
5.3.2.4  Fluoride Inactivation of Ureases ........................................................... 73 
5.3.2.5  Use of Cationic Scavengers to Prevent Fluoride Inactivation of Urease..  
 ............................................................................................................... 74 
5.3.2.6  ADA Activity Assay ............................................................................. 74 
5.3.2.7  Measurement of Nerve Agent Conversion and pH in Dynamic pH 
Controlled Reactions ............................................................................. 75 
5.4  RESULTS AND DISCUSSION.......................................................................... 76 
5.4.1  Characterization of pH Buffering in OPH-Urease System and Experimental 
Validation of Predictive Model..................................................................... 76 
5.4.2  Effect of Fluoride on Urease Activity........................................................... 83 
5.4.3  Solution to the Fluoride Problem.................................................................. 88 
 ix 
5.4.3.1  Impact of Urease Activity on Fluoride Inactivation of OPH-Urease 
Buffer .................................................................................................... 89 
5.4.3.2  Cationic Fluoride Scavengers ............................................................... 91 
5.4.3.3  Alternative Base-Producing Biocatalytic Reaction............................... 93 
5.5  CONCLUSIONS ................................................................................................. 98 
6.0  REDUCING SCARRING IN LACERATED SKELETAL MUSCLE USING MATRIX 
METALLOPROTEINASE-1 ............................................................................................... 99 
6.1  INTRODUCTION ............................................................................................... 99 
6.2  MATERIALS AND METHODS ...................................................................... 102 
6.2.1  Materials ..................................................................................................... 102 
6.2.2  Methods....................................................................................................... 102 
6.2.2.1  PEGylation of rhMMP-1..................................................................... 102 
6.2.2.2  Muscle Laceration Model ................................................................... 103 
6.2.2.3  Histological Analysis .......................................................................... 105 
6.2.2.4  MMP-1 Activity Assay Using Thioester Substrate............................. 107 
6.2.2.5  Collagen Degradation Assay............................................................... 108 
6.2.2.6  Stability of Native and PEG-Modified rhMMP-1............................... 108 
6.2.2.7  Computation of Solvent Accessibilities of Lysines ............................ 108 
6.2.2.8  Computation of Lysine pKa Values.................................................... 109 
6.2.2.9  SDS-PAGE of Native and PEG-Modified rhMMP-1 ......................... 109 
6.2.2.10  Matrix Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-
TOF) Mass Spectrometry .................................................................. 109 
 x 
6.2.2.11  Analytical Ultracentrifugation Analysis of Native and PEG-Modified 
rhMMP-1........................................................................................... 111 
6.3  RESULTS AND DISCUSSION........................................................................ 111 
6.3.1  Rapid Assessment of Potential Therapuetic Efficacy of proMMP-1, rhMMP-
1, and PEG-rhMMP-1 in Laceration Model ............................................... 111 
6.3.2  Quantitative Comparison of Efficacies of Native and PEG-Modified 
rhMMP-1 in Reducing Muscle Scarring in Laceration Model ................... 114 
6.3.3  Effect of PEGylation on rhMMP-1 In Vitro Activity and Stability............ 118 
6.3.4  Prediction of Reactivity of Modification Sites in rhMMP-1 ...................... 122 
6.4  CONCLUSIONS ............................................................................................... 130 
APPENDIX................................................................................................................................. 132 
BIBLIOGRAPHY....................................................................................................................... 135 
 xi 
LIST OF TABLES 
Table 1.  Log P and Reichardt’s dye (ENT) polarity values for ionic liquids and select organic 
solvents. ........................................................................................................................................ 46 
 
Table 2.  Initial rates of lipase-catalyzed transesterification of methyl methacrylate and 2-
ethylhexanol in ionic liquids and organic solvents.  All initial rates are reported in the units 
μM/hr/mg-enzyme. ....................................................................................................................... 50 
 
Table 3.  Water activities of [bmim][PF6] containing salt hydrates at 25 °C measured using a 
humidity sensor.  The values were compared to the water activity of salt hydrates in organic 
solvents, which were compiled from the literature. ...................................................................... 58 
 
Table 4.  Kinetic parameters for native and PEG-modified rhMMP-1 catalyzed degradation of 
thioester peptide substrate........................................................................................................... 118 
 
Table 5.  Theoretical pKa and solvent accessibility values of the N-terminal α-amino group and 
lysines in rhMMP-1.  The residue number corresponds to that of the residue in the sequence of 
full-length proMMP-1................................................................................................................. 125 
 xii 
LIST OF FIGURES 
Figure 1.  Michaelis-Menten mechanism showing potential ionization steps.44 .......................... 13 
 
Figure 2.  Enzyme stabilization by specific additive.  The ligand binds specifically to the native 
conformation of the enzyme, thereby forcing the equilibrium of enzyme folding to favor the 
catalytically active native state.  In the enzyme structure, the diamond-shaped binding pocket 
represents the active site. .............................................................................................................. 17 
 
Figure 3.  Enzyme immobilization techniques: (A) entrapment, (B) adsorption, (C) conventional 
covalent immobilization, and (D) multipoint covalent immobilization into polymeric network.  
The blue spheres represent enzyme molecules. ............................................................................ 24 
 
Figure 4.  Structure of ionic liquids.  Anions available for X1- were hexafluorophosphate ([PF6]), 
acetate ([CH3CO2]), nitrate ([NO3]) and trifluoroacetate ([CF3CO2]).  Anions available for X2- 
were hexafluorophosphate ([PF6]), acetate ([CH3CO2]), nitrate ([NO3]), trifluoroacetate 
([CF3CO2]), trifluoromethylsulfonate ([CF3SO3]) and methanesulfonate ([CH3SO3]). ............... 37 
 
Figure 5.  Lipase-catalyzed transesterification of methyl methacrylate and 2-ethylhexanol to 2-
ethylhexyl methacrylate. ............................................................................................................... 38 
 
Figure 6.  Reichardt’s dye (2,6-diphenyl-4-(2,4,6-triphenylpyridinio)phenolate)........................ 40 
 
Figure 7.  Solvatochromic probing of organic solvents (from left: tetrahydrofuran, acetonitrile, 
methanol, t-amyl alcohol and acetone) with Reichardt’s dye.  Differences in solvent polarity alter 
the absorption energy of the dye.  These differences are reflected by the visible color of the dye-
containing solutions. ..................................................................................................................... 47 
 
Figure 8.  Stability of Novozym 435 in ionic liquids ([bmim][PF6] (?), [bmim][NO3] (□), 
[bmim][CH3CO2] (∆), [mmep][NO3] (?), [mmep][CH3CO2] (▲) and [mmep][CH3SO3] (●)).  
Error bars represent the standard deviation for two separate experiments. .................................. 55 
 
 xiii 
Figure 9.  Stability of Novozym 435 in organic solvents (butanol (?), tetrahydrofuran (□), 
acetonitrile (▲), dimethyl sulfoxide (?) and hexane (?)).  Error bars represent the standard 
deviation for two separate experiments. ....................................................................................... 56 
 
Figure 10.  Progress curves for the transfer of water from salt hydrate pairs (Na2HPO4 12/7 (▲), 
Na2HPO4 7/2 (?), NaAc 3/0 (●), Na2HPO4 2/0 (∆), Na4P2O7 10/0 (○), CuSO4 5/3 (□)) to 
[bmim][PF6]. ................................................................................................................................. 60 
 
Figure 11.  Solubility of water at 25 °C in [bmim][PF6] that contained salt hydrates (▲) and that 
was pre-equilibrated with saturated salt solutions in presence of substrates (methyl methacrylate 
(∆), 2-ethylhexanol (?)).  Experimentally measured water solubilities were compared to data 
from the literature (●). .................................................................................................................. 61 
 
Figure 12.  Initial rates of lipase-catalyzed transesterification of methyl methacrylate and 2-
ethylhexanol in [bmim][PF6] (○) and hexane (●) at fixed aw.  In dry* incubations, crushed 
molecular sieves were employed in place of salt hydrates in order to remove residual water from 
the solvent. .................................................................................................................................... 63 
 
Figure 13.  The pH dependence curves of two enzyme-catalyzed reactions depicting the concept 
of biocatlaytic pH control.  The base-producing enzyme (black line) has a lower optimal pH than 
the acid-producing enzyme (gray line).  When both enzymes are present, the pH should stabilize 
at the intersection point, which is termed the pH set-point........................................................... 67 
 
Figure 14.  (A) OPH-catalyzed hydrolysis of paraoxon and (B) urease-catalyzed hydrolysis of 
urea at neutral pH.......................................................................................................................... 69 
 
Figure 15.  pH-Dependence of (A) urease (jack bean) activity and (B) the kinetic parameters kcat 
(?) and KM (?) for paraoxon hydrolysis by OPH.  Error bars are representative of standard 
deviations from the mean.............................................................................................................. 77 
 
Figure 16.  Dynamic pH buffer created by the simultaneous biocatalytic hydrolysis of paraoxon 
and urea.  The solid line and closed circles represent the measured pH and paraoxon conversion 
profile respectively in the presence of urease (jack bean) and urea.  The dotted and dash-dotted 
lines correspond to the model predicted pH and paraoxon conversion profile also in the presence 
of urease and urea.  The dashed line and closed diamonds refer to the measured pH and paraoxon 
conversion profile in the absence of urease.  The pH set-point remained constant as long as the 
ratio of activities of the enzymes was unchanged (A) [urease] = 0.081 units/mL and [OPH] = 
0.0026 units/mL ([urease]/[OPH] = 31) (B) [urease] = 0.49 units/mL and [OPH] = 0.016 
units/mL ([urease]/[OPH] = 31). .................................................................................................. 79 
 xiv 
Figure 17.  pH Buffering of paraoxon hydrolysis by OPH employing a ratio of jack bean urease-
to-OPH activities of 0.54.  The actual activities of urease and OPH were 0.0025 U/mL and 
0.0047 U/mL respectively, resulting in a pH set-point of 7.20.  The solid line and closed circles 
represent the measured pH and paraoxon conversion profile respectively in the presence of 
urease and urea.............................................................................................................................. 81 
 
Figure 18.  pH Buffering of paraoxon hydrolysis by OPH employing a ratio of jack bean urease-
to-OPH activities of 0.30.  The actual activities of urease and OPH were 0.0014 U/mL and 
0.0048 U/mL respectively, resulting in a pH set-point of 6.71.  The solid line and closed circles 
represent the measured pH and paraoxon conversion profile respectively in the presence of 
urease and urea.............................................................................................................................. 82 
 
Figure 19.  The impact of the ratio of jack bean urease-to-OPH activities on the pH set-point in 
the combined enzyme system. ...................................................................................................... 83 
 
Figure 20.  Chemical structures of organophosphate compounds that are degraded by hydrolysis 
of a P-F bond................................................................................................................................. 84 
 
Figure 21.  Mechanism of fluoride inhibition of urease.  E and E* represent enzyme and a form 
of the enzyme that is missing a critical active site water molecule.  Only E* can bind fluoride. 85 
Figure 22.  Fluoride inhibition of (A) jack bean urease, (B) H. pylori urease, (C) Roche liquid 
stable, industrial jack bean urease, and (D) K. aerogenes 9-1 mutant urease.  The activity of the 
ureases in the presence of various concentrations of fluoride (denoted by the numbers in 
millimolar) was monitored by progress curves............................................................................. 87 
 
Figure 23.  Simultaneous biocatalytic hydrolysis of DFP (0.5 mM) and urea by OPH and urease 
(K. aerogenes urease 9-1 mutant).  The actual activities of urease and OPH were (A) [urease] = 
0.15 units/mL and [OPH] = 0.1 μg/mL and (B) [urease] = 0.5 units/mL and [OPH] = 0.1 μg/mL.  
The solid line and closed circles represent the measured pH and conversion of DFP as a function 
of relative butyrlcholinesterase inhibition respectively. ............................................................... 90 
 
Figure 24.  Protection of K. aerogenes urease mutant (9-1) from fluoride inactivation by the 
addition of (A) calcium chloride, (B) lanthanum nitrate, and (C) nickel chloride.  Urease activity 
was monitored by progress curves in the presence of various concentrations of the cationic 
fluoride scavengers.  For each assay, the concentrations of fluoride and cationic scavenger are 
inidicated as the top and bottom concentrations respectively....................................................... 93 
 
Figure 25.  ADA-catalyzed hydrolysis of adenosine. ................................................................... 94 
 
 xv 
Figure 26.  (A) pH-Dependence of ADA activity.  (B) The effect of fluoride ions on ADA 
activity........................................................................................................................................... 95 
 
Figure 27.  Simultaneous biocatalytic hydrolysis of DFP (5mM) and adenosine by OPH and 
ADA.  The actual activities of adenosine deaminase and OPH were 0.2 units/mL and 0.4 
units/mL respectively.  The solid line and closed circles represent the measured pH and DFP 
conversion profile respectively. .................................................................................................... 97 
 
Figure 28.  Specific activity of proMMP-1 upon activation of the full-length enzyme with 
varying mass ratios of trypsin-to-enzyme.  When fully activated, proMMP-1 had a specific 
activity of 0.0047 units/μg-enzyme when assayed with a thioester substrate. ........................... 104 
 
Figure 29.  Histological analysis of muscle adjacent to the laceration site 14 d after treatment.  
(A) Images of tissue stained with picrosirius red acquired with a 4x objective.  (B) Comparison 
of interfibrillar collagen in control and treatment groups (∗ p < 0.05).  The boxed areas represent 
the fields in which the amount of connective collagen was quantified.  Error bars represent the 
standard deviation from the mean for each treatment group. ..................................................... 113 
 
Figure 30.  (A) Brightfield image of blue tissue marking dye at laceration site acquired with 100x 
objective.  The arrows indicate the presence of hemosiderin, the brown pigment, at the site of 
injury.  (B) Fluorescent image of the equivalent field showing co-localization of green 
fluorescent microspheres with the tissue marking dye at the laceration site.  The arrows point to 
examples of individual microspheres in the captured field.  (C) Control image showing the size 
of the green fluorescent microspheres prepared on a blank glass slide at the same magnification.
..................................................................................................................................................... 115 
 
Figure 31.  Results of histological analysis from follow-up in vivo study at 11 d post-treatment of 
lacerated GMs with rhMMP-1 (0.8 mU) or PEG-rhMMP-1 (0.8 mU).  (A) Images of unstained 
sections showing tissue marking dye at site of laceration and matching area in Masson’s 
trichrome stained specimens (10x objective).  (B) Selected fields from Masson’s trichrome 
stained specimens used for quantification of interfibrillar collagen and below, corresponding 
thresholded areas.  (C)  Comparison of interfibrillar collagen in the left and right GMs of mice 
within the same treatment group (∗ p < 0.05).  The level of fibrosis in the GMs of mice treated 
with buffer only and in the GM of uninjured mice are also shown.  Error bars represent the 
standard deviation from the mean for each treatment group. ..................................................... 117 
 
Figure 32.  Degradation of lyophilized type I collagen scaffolds by native rhMMP-1 (▲), PEG-
rhMMP-1 (?), and buffer (?).  Error bars represent the standard deviation from the mean for 
three separate experiments.......................................................................................................... 119 
 
 xvi 
Figure 33.  Thermostability of native (●) and PEGylated rhMMP-1 (?) at 65 °C.  The stability 
of rhMMP-1 in the presence of 10 % (w/v) fully hydrolyzed PEG-SPA (Mw 5000) was also 
measured (○).  Error bars represent the standard deviation from the mean for two separate 
experiments. ................................................................................................................................ 121 
 
Figure 34.  (A) Stability of native and PEGylated rhMMP-1 in the presence of trypsin at 50 °C.  
Native rhMMP-1 (closed symbols) and PEG-rhMMP-1 (open symbols) were incubated with 
varying amounts of trypsin (0.0 mg/mL (squares), 0.1 mg/mL (diamonds), 0.5 mg/mL 
(triangles), 1.0 mg/mL (circles)).  (B) Stability of native and PEGylated rhMMP-1 in the 
presence of subtilisin Carlsberg at 37 °C.  Native rhMMP-1 (closed symbols) and PEG-rhMMP-
1 (open symbols) were incubated with varying amounts of substilisin (0.0 mg/mL (squares), 
0.001 mg/mL (diamonds), 0.1 mg/mL (circles)). ..................................................................... 122 
 
Figure 35.  Schematic of rhMMP-1 PEGylation with PEG-SPA. .............................................. 123 
 
Figure 36.  Ribbon diagram of rhMMP-1 showing the most likely sites of PEG-attachment (red).  
The active site residues H218ALGHSLGLSH (purple) and the enzyme-associated zinc (green) 
and calcium (black) ions are also highlighted............................................................................. 126 
 
Figure 37.  SDS-PAGE of native and PEGylated rhMMP-1.  Lanes: (1) protein molecular weight 
markers, (2) native rhMMP-1 (0.5 μg), (3) PEG-rhMMP-1 (Mw 5000; 1 μg), and (4) PEG-
rhMMP-1 (Mw 5000; 2 μg). ........................................................................................................ 128 
 
 xvii 
NOMENCLATURE 
1-butyl-3-methylimidazolium hexafluorophosphate 
1-butyl-3-methylimidazolium acetate 
1-butyl-3-methylimidazolium nitrate 
1-butyl-3-methylimidazolium trifluoroacetate 
1-methyl-1-(-2-methoxyethyl)pyrrolidinium hexafluorophosphate 
1-methyl-1-(-2-methoxyethyl)pyrrolidinium acetate 
1-methyl-1-(-2-methoxyethyl)pyrrolidinium nitrate 
1-methyl-1-(-2-methoxyethyl)pyrrolidinium trifluoroacetate 
1-methyl-1-(-2-methoxyethyl)pyrrolidinium trifluoromethylsulfonate 
1-methyl-1-(-2-methoxyethyl)pyrrolidinium methanesulfonate 
adenosine deaminase 
diisopropylfluorophosphate 
gastrocnemius muscle 
organophosphorous hydrolase 
poly(ethylene glycol) 
recombinant full-length matrix metalloproteinase-1 
recombinant human active matrix metalloproteinase-1 
water activity 
[bmim][PF6] 
[bmim][CH3CO2] 
[bmim][NO3] 
[bmim][CF3CO2] 
[mmep][PF6] 
[mmep][CH3CO2] 
[mmep][NO3] 
[mmep][CF3CO2] 
[mmep][CF3SO3] 
[mmep][CH3SO3] 
ADA 
DFP 
GM 
OPH 
PEG 
proMMP-1 
rhMMP-1 
aw 
 xviii 
PREFACE 
 There are many individuals to whom I am indebted for their guidance and support in 
completing this thesis.  It is to them that I dedicate this thesis and any future success in my 
research endeavors. 
 First and foremost, I am especially grateful to my advisor Dr. Alan Russell, who has 
provided me with every possible opportunity to succeed as a graduate student and beyond.  His 
creativity and enthusiasm for great science made working under him an exciting and motivating 
experience.  Among other things, he has taught me to be confident in my work and to not be 
timid in the face of opposition (even if it means arguing against your advisor in lab meetings!).  
Over the last six years, he has become as much a friend as a mentor.  
 I would like to thank Drs. Géraldine Drevon, Jason Berberich, and Rick Koepsel for their 
technical assistance, helpful discussions, and proofreading of this and numerous other 
documents.  Throughout my time in the lab, they have made themselves available as day-to-day 
mentors and, as a result, are largely responsible for my growth and development as a researcher.  
Their mentoring was particular vital in the early stages of my research when I was still learning 
basic laboratory skills, including enzyme assays, bioconjugation techniques, molecular biology 
protocols, and how to function independently in the lab.  They too have been great friends along 
the way with whom I’ve shared many laughs and countless cups of coffee. 
 I wish to express my gratitude to my committee members, Drs. Mohammad Ataai, Eric 
Beckman, Harry Blair, and Johnny Huard, for their insightful comments and constructive 
 xix 
critisms, which helped to improve the overall quality of my thesis.  Special thanks to Dr. Blair 
for his assistance with the histology component of this work and to Dr. Yong Li, although not 
officially part of my committee, for help with animal surgeries.  Additionally, I would like to 
acknowledge Dr. William Federspiel as being an influential instructor, mentor, collaborator, and 
friend.   
 I am also thankful to the members of the Russell lab, past and present, for having made 
the lab an enjoyable place to work.  In particular, I would like to thank Dr. Hiro Murata who, in 
addition to being a tremendous help with chemistry related problems, always managed to keep 
me sane through his friendship and hilarious sense of humor.  Special thanks also to Dr. Marina 
Kameneva, whose lab was adjacent to ours.  By making sure I had my fill of chocolates, she 
made the days, and weekends, manageable. 
 Lastly, I am eternally grateful for the unconditional support and encouragment of my 
caring parents, Gary and Fran (who hopefully after reading this finally realize I do not work with 
stem cells!), brother, Scott, and amazing girlfriend, Jill Landsbaugh.  Jill, while going through 
the rigoros of graduate school herself, has been perhaps my biggest source of support.  She has 
always been willing to do everything and anything to help me through the hardsphips and 
frustrations in the lab.  And she did so, having to put up with my often unpleasant moods, with 
nothing but a smile and the utmost loyalty when anyone else would have quickly grown 
impatient with my ways. 
 xx 
1.0  INTRODUCTION 
Enzymes are highly efficient biological catalysts that are responsible for accelerating the 
reactions inside of living systems (i.e. cells).  On appropriate substrates, they can enhance 
reaction rates in excess of one million times over the corresponding uncatalyzed reaction.  
Perhaps the most remarkable attribute of enzymes is the striking selectivity with which they bind 
to target substrates.  Enzymes can differentiate substrate molecules on the basis of chemical 
functionality (chemoselectivity), positioning of target functional groups (regioselectivity), and 
chirality (stereoselectivity).  The selectivity of enzymes, which is conferred by their unique 
amino acid sequence and three-dimension structure, virtually eliminates the formation of waste 
products due to side reactions, permitting reaction efficiencies to approach 100 %. 
Due to the extraordinary catalytic efficiency of nature’s catalysts, their use in asymmetric 
chemical synthesis and biotechnology has immense implications1-4.  The combination of high 
turnover rates and specificity offered by enzymes is unmatched by conventional chemical 
catalysts.  Moreover, with the ability to convert nearly any substrate, including many synthetic 
and non-naturally occurring compounds, enzymes can in certain cases catalyze reactions that 
cannot be achieved through classic chemistry.  Biocatalysis also offers the potential to greatly 
reduce the environmental impact of existing chemical processes.  Enzymes are completely 
biodegradable and typically most active under mild reaction conditions including near neutral pH 
and ambient temperatures and pressures, thus decreasing energy costs and increasing safety.  
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Because biocatalytic reactions produce practically no waste products, product purification is in 
general simple and such reactions are less polluting than parallel chemical synthesis routes.    
The breadth of feasible biotransformation has been further broadened by advances in the 
ability to rationally manipulate biocatalyst function.  One can now alter, and even expand, an 
enzyme’s reaction specificity by introducing site-directed (by protein engineering)5 or random 
(by directed evolution)6 mutations into the primary structure of the enzyme.  The properties of 
biocatalysts may also be tailored by changing their environment.  In non-aqueous media, 
including organic solvents7-9, supercritical fluids10, and more recently ionic liquids11, biocatalysts 
were shown to accept different substrates and accelerate reactions that otherwise do not occur in 
water as a result of being thermodynamically or kinetically unfavorable.  The practice of altering 
biocatalyst function in this way, which was pioneered by Alexander M. Klibanov in the 1980s, 
has been appropriately termed “solvent engineering”.12                
Cells must constantly modulate their internal environment and, therefore, must be able to 
tightly control the concentration and activity of enzymes.  Consequently, enzymes, and proteins 
in general, have evolved to be highly unstable molecules.  Most enzymes remain active for only 
minutes or hours under ambient conditions even when in water.  Their inactivation can be 
induced by variations in pH, temperature, and pressure as well as exposure to chemical 
denaturants such as surfactants, organic chemicals, and chelators.13  Enzyme activity may also be 
largely affected by oxidation, freezing, thawing, and radiation.  The root cause of inactivation 
can be either global unfolding of the enzyme molecule, loss of active site structure, or chemical 
modification of one or more peptide bonds or critical residues with respect to enzyme 
mechanism.  The loss of activity may or may not be reversible depending on the properties of the 
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enzyme as well as its concentration in solution.  This inherent instability represents a key 
shortcoming in most biocatalytic processes. 
 Because the preparation and purification of enzymes can be costly, enzymes must be 
effectively stabilized to improve their overall utility.  The primary goal of any stabilization 
strategy is to minimize the physiochemical reactions that can occur, which evoke the loss of 
enzyme activity.  Understanding the fundamental relationship between enzyme, structure, 
function, and molecular microenvironment is a prerequisite for developing rational strategies for 
enzyme stabilization.  Conventional strategies for enzyme stabilization include the use of 
chemical additives, which can interact with the enzyme directly or with the milieu of the 
enzyme, chemical modification, and immobilization, which may be covalent or non-covalent in 
nature.13  Stabilization may also be achieved through “re-designing” enzymes using protein 
engineering and natural evolution techniques.6, 14   
Herein, enzyme structure-environment-activity relationships were utilized as the basis for 
developing effective means of stabilizing enzymes, and thus improving biocatalyst efficiency.  
Initially, this rational approach to stabilization was applied the use of enzymes in non-aqueous 
reaction media.  Ionic liquids, organic salts that are liquids over ambient temperatures, were 
explored as an alternative to conventional solvents, many of which inherently denature enzymes 
(Specific aim 1).  The impact of ionic liquid physical properties on enzyme activity and stability 
was probed using lipase as a model enzyme.  Several approaches to preventing deactivating 
conformational changes in harsh non-aqueous environments as well as methods of controlling 
the degree of enzyme hydration were investigated as means of improving lipase activity in ionic 
liquids. 
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 Even in anhydrous enzymology, enzyme structure and function is largely dependent upon 
the presence of water.  Water molecules associated with the enzyme act as a “molecular 
lubricant”, allowing for conformational flexibility, which is required for catalytic activity.15-18  
On a molecular level, the water shields charged and polar groups on an enzyme’s surface, 
thereby preventing electrostatic interactions that may trap the enzyme in a rigid state.  The 
degree to which an enzyme must be hydrated in order to be catalytically active can vary greatly 
depending on the enzyme.15, 16   
In enzymatic hydrolysis reactions, the essential enzyme-bound water is acidified, thereby 
reducing the pH of the enzyme’s microenvironment.  Because variations in pH alter the structure 
and function of enzymes, tight control of pH is required during such reactions.  To this end, the 
second section of this thesis addresses the development of a novel approach to controlling the pH 
within the aqueous layer surrounding an enzyme (Specific aim 2).  The basis for this approach is 
that acid generated by a hydrolysis reaction can be balanced by the simultanesous biocatalytic 
formation of base, essentially mimicking how a cell controls its internal pH.  The ability to 
control pH in this way represents a means of overcoming the shortcomings of conventional 
buffers in many reaction systems, particularly those that are low-water environments. 
Proteases, such as α-chymotrypsin and subtilisin Carlsberg, are among the most well 
characterized enzymes in anhydrous media.  These enzymes naturally catalyze the hydrolysis of 
peptide bonds.  However, in anhydrous environments, they are capable of accelerating a number 
of industrially relevant reactions including esterifications, the synthesis of sugar acrylates, and 
peptide synthesis.3, 19  The use of proteases in anhydrous media effectively stabilizes them since 
removing water suppresses their hydrolytic activity, thereby preventing autolysis as well as their 
inactivation by other digestive enzymes.  Consequently, due to enhanced stability, proteases are 
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of much greater utility in anhydrous media despite still being important catalysts in many 
aqueous processes. 
To enhance the overall utility of proteases, methods to stabilize proteases when the 
aqueous content of the reaction medium is increased must be developed.  Covalent modification 
of enzymes with synthetic polymers represents a promising technique for improving the stability 
of enzymes in aqueous environments.  The last section of this thesis examines the impact of 
poly(ethylene glycol) (PEG)-modification on the aqueous stability of the protease matrix 
metalloproteinase-1 (MMP-1) (Specific aim 3).  Because MMP-1 is of potential therapeutic use, 
changes in the stability of MMP-1 as a result of PEG-modification were correlated to the 
therapeutic effectiveness of the protease. 
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2.0  BACKGROUND AND LITERATURE REVIEW 
2.1 ANHYDROUS ENZYMOLOGY 
Despite the fundamental role of water in enzyme folding and mechanisms, enzymes are 
not constrained to use only in aqueous reactions.  In fact, the longstanding belief that enzymes 
only function in water is a gross misconception.  The reality is that enzymes do not need much 
water at all.  They are surprisingly active in essentially anhydrous environments as long as there 
is enough water to hydrate the enzyme molecule.  This activity has enabled the portfolio of 
feasible biotransformations to be greatly expanded as well as enhanced the industrial utility of 
enzymes.    
The properties of enzymes may be markedly altered by the absence of water in ways that 
improve their catalytic efficiency and permit them to catalyze very different reactions.  Among 
the properties of enzymes that are unique to their use in anhydrous solvents are enhanced 
thermostability, altered substrate and enantiomeric specificities, and molecular memory.9, 15, 16, 19, 
20  Replacement of water with anhydrous solvents can also shift the thermodynamic equilibrium 
of biocatalytic reactions, thereby facilitating the catalysis of reactions that otherwise would not 
occur in water as a result of being thermodynamically or kinetically limited.12, 21  Moreover, the 
use of enzymes in anhydrous reaction media may enhance the solubility of hydrophobic 
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substrates, eliminate undesirable side reactions involving water, increase the ease of product 
recovery, and prevent microbial contamination.9, 15, 19     
2.1.1 Enzyme Structure in Anhydrous Solvents 
To understand how enzymes function in anhydrous solvents, it is critical to first examine 
how the solvent environment affects the structure of enzymes.  Interestingly, in anhydrous 
solvents, it is the conformational mobility of an enzyme that is altered rather than its structure 
per se.  Enzymes become highly rigid molecules that are seemingly locked in their native-like 
conformation.9, 15, 17, 18  This is presumably a result of electrostatic interactions between charged 
and polar groups in the enzyme, which can only occur in the absence of water.  In the presence 
of water, water molecules accumulate around these groups effectively shielding them from each 
other.15, 16  Thus, the propensity for an enzyme molecule to denature is in essence suppressed due 
to the loss of flexibility.  However, the complete loss of conformational mobility may negatively 
impact enzyme activity, since small structural changes are typically essential for catalysis.15, 17 
Enzyme structure and dynamics in anhydrous solvents has been exhaustively studied.  
Such studies have involved the use of structural determination techniques such as nuclear 
magnetic resonance and X-ray crystallography.  For instance, using X-ray crystallography, the 
three-dimensional structures of the proteases subtilisin Carlsberg and γ-chymotrypsin were 
shown to be virtually the same in acetonitrile and hexane respectively as in water.22, 23  
Information regarding the conformational mobility and structure of enzymes in the dry state has 
also been obtained by spectroscopic techniques and enzyme activity assays.15  The results of 
these studies confirm that enzymes lose the necessary flexibility to unfold and consequently are 
structurally trapped in anhydrous solvents.  
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2.1.2 Influence of Water on Enzyme Activity 
Enzyme hydration, which refers to the number of water molecules associated with an 
enzyme rather than the total amount of water in the reaction medium, is critical even in 
essentially anhydrous biocatalysis.24  Water acts as a “molecular lubricant” to enhance the 
conformational mobility of enzymes.9, 15  In order for catalysis to be possible, an enzyme must be 
able to undergo structural rearrangement such that its binding pocket is properly oriented to 
accept a substrate molecule.  The mobility of an enzyme is particularly important in conversions 
involving bulky substrate molecules.15  When an enzyme is completely dry, representing the 
most extreme case, it lacks the necessary flexibility to accommodate substrate binding and thus 
is inactive. 
The addition of only a small number of water molecules per molecule of enzyme may be 
sufficient to activate enzymes in anhydrous solvents.15, 16  Such is the case with lipases, for 
example.  Other enzymes may require up to as much as a monolayer of water surrounding the 
enzyme molecule to be catalytically active.15, 16  Although enzyme activity increases with 
hydration, there is, for a given enzyme, an optimal degree of hydration for which its catalytic 
activity in anhydrous solvents is greatest.  Deactivation of enzymes above a critical hydration 
level can be attributed to the aggregation of enzyme molecules.15   
The degree of enzyme hydration in anhydrous solvents can best be described by 
thermodynamic property water activity.15, 18, 24  Under equilibrium conditions, it is by definition 
equal in the various components of a reaction system, namely the enzyme, substrates, products, 
solvents, and headspace above the reaction solution and thus accounts for the uneven distribution 
of water between the components.  Water activity is a particularly useful measure of enzyme 
hydration when comparing the effects of different solvents on the activity of an enzyme.  This is 
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because the amount of water adsorbed to the surface of an enzyme will differ depending on the 
hydrophibicity of the solvent (i.e. hydrophilic solvents tend to strip water from an enzyme more 
so than hydrophobic solvents).  Because water activity is related to the relative humidity of the 
vapor headspace, it can easily be measured using a humidity probe.    
Water activity in anhydrous solvents can be fixed by the direct addition of water, pre-
equilibration of the various reaction components including the enzyme and substrates with 
saturated salt solutions, and the use of salt hydrates.24-29  The use of salt hydrates provides a 
particularly effective means of controlling water activity since water activity equilibrium is 
established rapidly and is not subject to changes resulting from the adsorption or evaporation of 
water from the environment.  Briefly, the principle behind water activity control using salt 
hydrates is the formation of dynamic water equilibrium by the interconversion of the salt 
between higher and lower hydration states.  Water activity is controlled as long as residual 
amounts both of the solid salts are present.  Different salt hydrate pairs have different intrinsic 
fixed water activity equilibrium.26       
2.1.3 Solvent Types 
The catalytic properties of enzymes in anhydrous enzymology are highly solvent-
dependent.  This is the result of the ability of a solvent to dramatically influence the nature of the 
aqueous microenvironment of an enzyme.  One way a solvent may influence an enzyme’s 
aqueous microenvironment is through interacting directly with the enzyme-bound water.  This 
type of interaction is generally discussed in terms of the ability of a solvent to inactivate an 
enzyme by means of stripping the essential water from the enzyme’s surface.15, 30  The tendency 
of a solvent to compete for water from an enzyme increases with increasing solvent 
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hydrophilicity.  Another way in which a solvent can alter the microenvironment of an enzyme is 
by influencing the local concentration of substrates and products.15  Differences in substrate 
solvation in particular can have a significant impact on the apparent activity of an enzyme.       
Solvent properties such as Hildebrandt solubility parameters (δ), dielectric constants (ε), 
and dipole moments (μ) may all be used as predictors of enzyme activity in anhydrous solvents.  
Octanol-water partition coefficients (log P), which indicate the solvent hydrophilicity, also 
correlate strongly with enzyme activity and are routinely used to assess the likelihood of solvents 
to support enzyme activity.31  Enzymes generally are most active in solvents that have a log P of 
greater than four since such solvents are highly hydrophobic and thus tend not to strip an enzyme 
of its essential bound water.  Solvatochromic parameters provide a measure of solvent polarity, 
which can be useful for solvent selection.32 
Anhydrous biocatalysis has traditionally involved the use of organic solvents.  Indeed, 
much of what we know about how enzymes behave in essentially anhydrous environments is 
from the study of enzymes in organic solvents.  However, because organic solvents are 
detrimental to the environment, there has been a strong drive in recent years to find alternative 
cleaner reaction media.  
An alternative class of solvents that have attracted considerable attention are supercritical 
fluids, which are substances with temperatures and pressures that exceed their critical points.  
Enzyme activity, stability, and even specificity in supercritical fluids is dependent upon the 
solvent’s physical properties, which can be rationally modulated by altering temperature and 
pressure.10  Additionally, the rates of enzymatic reactions may be greater in supercritical fluids 
that in organic solvents due to relatively lower mass transfer limitations.  Supercritical carbon 
dioxide has received the most attention because it offers several environmental advantages over 
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conventional organic solvents.  Such advantages include being environmentally benign, 
nontoxic, nonflammable, and highly available.    
Ionic liquids have also emerged as an environmentally friendly solution to the threat 
posed by organic solvents.  These are organic salts that exists as liquids over unusually large 
temperature ranges, which span ambient temperatures, and which are thermally stable and have 
practically no vapor pressure.33, 34  Moreover, ionic liquids have exceptional solvent properties, 
including the ability to dissolve virtually any chemical compound.  By substituting the cation, 
anion, or attached substituents, the solvent properties may be manipulated, allowing ionic liquids 
to be tailored for specific reaction systems.34  Although it is still not yet fully understood how 
ionic liquids influence the catalytic properties of enzyme, enzymes are active and remarkably 
stable in select ionic liquids such as 1-butyl-3-methylimidazolium hexafluorophosphate.11, 35-37 
 Enzyme reactions may also be carried out in the absence of bulk solvent by using gas-
phase substrates.38-41  Such reactions generally involve flowing gaseous substrates through a 
fixed-bed reactor containing dry enzyme in either free or immobilized form.  A major benefit of 
using gas-phase substrates is that mass transfer limitations are significantly lower in the gas-
phase compared to the solution phase.42  Thus, such as the case with supercritical fluids, 
reactions that are diffusionally controlled can proceed at higher rates in the gas-phase than in 
conventional organic solvents.  Reaction products may also be more easily recovered in the gas-
phase compared to in solution-phase reactions.42, 43 
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2.2 EFFECT OF pH ON ENZYME ACTIVITY AND STABILITY 
A key determinant of enzyme structure and function is pH.  The pH of the essential water 
layer surrounding an enzyme molecule influences the ionization state of residues with acidic and 
basic side chain groups.  When the ionization state of a residue that is critical to the enzyme’s 
catalytic mechanism is perturbed, such as, for example, an active site residue that participates in 
the binding of substrate, the enzyme will be inactivated.44  Although enzymes can contain many 
ionizable residues, within an enzyme there are usually only one or two such residues that must be 
in the correct ionization state for catalysis.  The dependency of enzyme activity on pH is thus 
defined by the pKa values of the side chain groups of these residues.  An enzyme that has only 
one critical pKa will have sigmoidal-shaped pH-activity curve whereas the activity versus pH of 
an enzyme with two critical pKa values will follow a bell-shaped curve. 
Catalytically essential residues are almost always in the active site of an enzyme.  
However, charged groups on an enzyme’s surface may indirectly alter the apparent pKa of an 
enzyme.  This can occur when surface charges stabilize a particular ionization state of a critical 
active site residue, which may be several angstroms away, through long range electrostatic 
interactions.44  The pKa of a critical residue is increased by the stabilization of its positively 
charged state by interactions with negatively charged surface groups.  Conversely, the pKa of a 
critical residues is decreased by the stabilization of its negatively charged state by interactions 
with positively charged surface groups.  Long range electrostatic interactions that affect the pKa 
of ionizable groups in an enzyme may be introduced through chemical modification and protein 
engineering as a means of shifting the enzyme’s pH-activity profile.5  Furthermore, variations in 
pH can disrupt electrostatic interactions between residues far from the active site, which leads to 
the destabilization, and thus inactivation, of an enzyme.44 
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The influence of pH on enzyme activity can described through classical Michaelis-
Menten kinetics by accounting for the potential protonation of the enzyme and enzyme-substrate 
complex (Figure 1).  According to the expanded kinetic model, the enzyme (E) and enzyme-
substrate complex (ES) may be protonated yielding HE and HES respectively.  However, 
product (P) can only be formed from the ES complex.  The Michaelis constant KM represents the 
association constant of ES, and thus is a measure of substrate affinity, while the rate constant of 
the conversion of ES to free E and P is kcat, which practically represents the rate of substrate 
turnover per unit mass of enzyme.  Ka,E and Ka,ES are the ionization constants of E and ES 
respectively while K’M is the dissociation constant of HES.  In this model, it is assumed that the 
substrate molecule is not ionizable.       
 
E + S ES E + P
HESHE + S
KM kcat
Ka,ES
K'M
Ka,E
 
Figure 1.  Michaelis-Menten mechanism showing potential ionization steps.44         
 
Derivation of the steady-state rate expression (i.e. d[ES]/dt = 0) based on the proposed 
model yields (Equation 1):  
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or 
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where v is the velocity of the reaction, [E]total is the total enzyme concentration.  From the model 
of the Michaelis-Menten mechanism, it is clear that protonation of ES, and thus pH, will affect 
the apparent kcat of an enzyme.44  Solving for kcat, which is equal to the maximum theoretical 
velocity (i.e. when [S] >>> KM) of the enzyme reaction divided by [E]total, indicates the apparent 
kcat will vary with pH as (Equation 2): 
pH
ESa,
ESa,cat
pHcat 10K
K
)( −+=
k
k        (Eq. 2) 
Similarly, the apparent KM of an enzyme will inherently be affected by the protonation of E and 
ES.44  The dependency of the apparent KM on pH can be described by (Equation 3):  
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In the case that the substrate can also be protonated, the apparent KM would be further affected 
by this ionization process.  Given the relations of kcat and KM to pH, the dependence of the 
catalytic efficiency (kcat/KM) of an enzyme on pH is given by (Equation 4): 
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2.3 PROTEASE STABILITY 
Enzymes are readily inactivated through a variety of processes and as a result have 
extremely short catatlytic lifetimes, ranging typically from just a few minutes to hours.  
Inactivation of enzymes can largely be attributed to their intrinsic instability.  The free energy 
barrier that prevents an enzyme molecule from unfolding is on the order of only 5 – 15 
kcal/mol.45  The drive to denature is even greater at elevated temperatures and pressures, extreme 
pH, and in the presence of denaturing agents.  Depending on the size and concentration of the 
enzyme, the unfolding process, and thus inactivation, may be reversible or irreversible.45  
Inactivation can also result from irreversible covalent changes in the enzyme molecule, which 
may be caused by process such as oxidation, proteolysis, and radiation.13 
Proteases, which are enzymes that catalyze the hydrolytic cleavage of proteins at specific 
sites, in particular, are inactivated rapidly even compared to most enzymes.  In addition to other 
causes of inactivation, these enzymes can also autolytically degrade into inactive peptide 
fragments.  The activities of proteases are greatest when the target peptide is denatured at the site 
of hydrolysis so as to make the cleavage site more accessible to the protease.13  As a result, most 
proteases retain activity over the course of only minutes in aqueous solutions. 
The stability of proteases may be markedly improved by engineering the reaction 
medium in which they are used.  Proteases are generally stable in anhydrous solvents since they 
have very different activities in such media.  Specifically, these enzymes, when in the dry state, 
catalyze synthesis reactions rather than digestive reactions, which cannot occur because water is 
not available to participate as a substrate.  For instance, proteases are capable of catalyzing 
esterification reactions, peptide synthesis, and the synthesis of sugar acrylates in anhydrous 
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solvents.3, 19  A prominent example of the use of proteases for industrial chemical synthesis is the 
production of aspartame catalyzed by the metalloendopeptidase thermolysin.4 
One way in which the stability of proteases can be enhanced in aqueous and biphasic 
solutions is by covalent modification with PEG.  PEG-attachment generally reduces the 
thermoinactivation of proteases in such environments by increasing the enzyme rigidity and by 
altering the enzyme’s surface hydrophobicity.40, 46-48  Moreover, proteases modified with PEG 
are more resistant to autolysis due to steric hinderance created by the PEG at cleavage sites in the 
protease molecule.49  These same steric effects are also responsible for protecting PEG-protease 
conjugates from interaction with biomacromolecules, including proteins, other digestive 
enzymes, and antibodies.50-53  Accordingly, PEGylation can reduce the in vivo clearance of 
proteases and thus increase the therapeutic effect of proteases, which are employed to treat many 
disease states.54 
2.4 STRATEGIES FOR ENZYME STABILIZATION 
2.4.1 Chemical Additives 
Enzymes, and other proteins for that matter, can be effectively stabilized with a wide 
array of chemical additives.13, 55  Such additives are generally soluble and can impact an 
enzyme’s operational and storage stability.  Furthermore, additives can increase the stability of 
enzymes against thermoinactivation (i.e. increase the melting temperature Tm of an enzyme) as 
well as chemical-induced denaturation.  The enhancement in enzyme stability may result from 
interactions between the additive and the enzyme or the additive and medium of the enzyme.  
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Additives that interact directly with the enzyme are more generally referred to as specific 
additives, whereas those that induce solvent effects are referred to as non-specific additives.  A 
third type of chemical additive that affords stability enhancements is those that compete with the 
enzyme for inactivating agents in the enzyme solution. 
Stabilization by specific additives is a rather straightforward approach that is predicated 
on thermodynamic changes of enzyme folding upon ligand binding (Figure 2).  Specific 
additives non-covalently bind to the enzyme in such a manner that is reversible and shifts the 
thermodynamics of folding of the enzyme to strongly favor the native conformation.13, 55  In 
practice, specific additives may be substrate analogues, products, cofactors, salts, or ligands that 
bind to functional groups on the enzyme’s surface.  Because the stabilized enzyme should retain 
activity, it is critical that the additive not block substrate docking, which presumably may occur 
if substrate analogues or products are used as additives, or alter a site that is pertinent to the 
mechanism of catalysis. 
          
Denatured state Native conformation Stabilized native 
conformation  
Figure 2.  Enzyme stabilization by specific additive.  The ligand binds specifically to the native 
conformation of the enzyme, thereby forcing the equilibrium of enzyme folding to favor the 
catalytically active native state.  In the enzyme structure, the diamond-shaped binding pocket 
represents the active site. 
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Unlike specific additives, non-specifics additives do not interact with the enzyme 
directly, but rather stabilize the natively folded state of an enzyme through additive-medium 
interactions.  Non-specific additives may be sugars, polyols, ionic and non-ionic surfactants, and 
synthetic polymers.  The principal cause of stabilization is the result of either increases in surface 
tension of the enzyme solution or by solvophobic effects, both of which are associated with the 
preferentially hydration of the enzyme and thus preferential exclusion of the additive from the 
enzyme’s aqueous microenvironment.55-60  As the surface tension of an enzyme solution 
increases, the energetic cost associated with expanding the volume occupied by the enzyme also 
increases.60  This ultimately makes unfolding thermodynamically unfavorable.  Solvophobic 
effects arise from thermodynamically unfavorable interactions between the enzyme and 
additive.55, 59, 60  In order to prevent for such interactions, an enzyme will adopt a state that 
minimizes its solvent accessible area.  It is plausible that conformational changes due to 
solvophobic effects may instead lead to a loss of activity, thereby destabilizing the enzyme rather 
than stabilizing it.  Steric exclusion, which also leads to preferential hydration, may also play a 
role in enzyme stabilization when large polymers such as PEG are used as non-specific 
additives.60, 61  The principal of steric exclusion has to do with relative differences in the radii of 
water and that of the additive molecule.  Assuming that the radius of the additive molecule is in 
fact larger that that of a water molecule, the volume surrounding the enzyme that is inaccessible 
to the additive (i.e. exclusion volume) will be larger than that which is inaccessible to water.  
Salts can also alter the solvation of enzymes, and thus may induce stabilization, through “salting 
out”, which refers to the process of reducing the solubility of an enzyme.55  The addition of salt 
in effect draws solvent away from the enzyme molecule.  This in turn minimizes solvation of the 
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enzyme, particularly its hydrophobic pockets.  Generally, kosmotropic salts, those to the left of 
the Hofmeister series, have a tendency to stabilize enzymes. 
Chemical additives that serve to sequester inactivating agents represent a broad class of 
soluble stabilizers.  Indeed, any chemical that inhibits the interaction between an enzyme and a 
molecule that inactivates it classifies as this type of stabilizing additives.  Additives of this type 
may be used to scavenge oxidizing agents, metal ions, free radicals, and other various enzyme 
inhibitors.13, 55       
2.4.2 Chemical Modification 
Chemical modification is a technique whereby the structure of an enzyme is covalently 
altered either by the attachment of monofunctional reagents or chemical cross-linking.  Enzymes 
are modified via the reaction between a modification reagent and accessible functional groups in 
the enzyme.  The sulfhydryl group of cysteines and primary amines on the surface of an enzyme 
(i.e. ε-amine of lysines and the N-terminal α-amine) are ideal sites for modification since they 
are highly reactive under conditions that do not perturb enzyme structure, including near neutral 
pH.62  Modification chemistries may, however, also be targeted to hydroxyl, carboxylic acid, 
guanidine, imidazole, and indole groups present in an enzyme.62, 63   
In reality, when reacted with monofunctional or crosslinking reagents, only a fraction of 
the target functional groups in an enzyme are typically modified.47  This stems from differences 
in the relative reactivity, which may arise from electrostatic interactions with neighboring 
residues, and accessibility of each potential modification site.  For example, it is possible for a 
functional group to be buried in the inner core of an enzyme, and thus inaccessible, or be non-
reactive due to electron withdrawing effects from other functional groups within close proximity.  
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Incomplete modification may also be due to the modification reaction becoming sterically 
hindered.  Furthermore, chemical modification generally yields a heterogeneous mixture of 
enzyme with differing number of modifications.  The properties of the modified enzyme may 
differ significantly depending on the number of modifications per enzyme molecule.47  Thus, in 
order to discern the effects of modification, it is critical to separate the mixture of modified 
enzyme into populations with equal extents of modification.  This is rarely done in practice 
though, as the effects of modification on enzyme properties are in most cases determined as an 
ensemble effect.   
 Enzyme stability may be significantly enhanced by covalent chemical modification.  
Although there are reports of the use of modification to minimize inactivation by pH64, 
solvents65, and even photooxidation66, enzymes are, by far, most commonly modified for the 
purposes of thermostabilization and the prevention of proteolysis.  Consequently, this section 
will focus solely on the impact of modification on the thermal denaturation of enzymes and their 
susceptibility to proteolytic digestion.  It is important to note, however, that, with few 
exceptions, the basic principles involved in the stabilization of enzymes against heat and 
proteases by chemical modification also apply to the stabilization of enzymes from other modes 
of inactivation. 
 The effect of modification on the thermostability of enzymes may result from changes in 
an enzyme’s surface properties and conformational rigidity.47  In the case of monofunctional 
regents, thermostabilization may be increased by altering surface hydrophobicity, although there 
does not appear to be a consistent relationship between stability and the hydrophobicity (or 
hydrophilicity) of enzymes. The attachment of hydrophobic and hydrophilic acylating and 
alkylating reagents has been reported to increase thermostability.47  Moreover, conjugation of 
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enzymes with PEG, which is amphiphilic in nature, also has been shown to improve the 
thermostability of enzymes.46, 48  Therefore, the selection of modification reagent on the basis of 
hydrophobicity must be considered depending on the enzyme of interest, with every enzyme 
having a different degree of surface hydrophobicity for which its thermostability is maximal.47  
Altering the amino acid makeup of an enzyme’s surface may also impart thermostability.  
Specifically, resistance to thermal denaturation has been shown to be markedly improved by the 
conjugation of guanidine groups to an enzyme’s surface.47, 67  This effect can be explained by 
relating the surface of guanidine-modified enzymes to that of thermophilic enzymes.  
Interestingly, the ratio of arginines-to-lysines is generally greater on the surface of thermophilic 
enzymes than on that of mesophilic enzymes.68  Thus, it is likely that the attachment of guanidine 
groups may enhance thermostability by making the surface of mesophilic enzymes more 
thermophilic-like.  In the case of enzyme intra- and intermolecular crosslinking, 
thermostabilization is due to increases in conformational rigidity.13, 47, 59  The attachment of 
monofunctional reagents may also increase slightly the rigidity of an enzyme molecule, however, 
as might be expected, to a much lesser degree than crosslinking.48    
   Modification of enzyme structure may prevent interactions with biomacromolecules and 
thus afford stability against proteolysis.  One way modification may prevent proteolysis is 
through steric effects.  The attachment of large molecules, such as soluble polymers, to the 
surface of an enzyme may sterically block proteases from attacking it.13  This is the rationale for 
enzyme PEGylation.  The PEG chains form a cage-like structure around the enzyme molecule, 
thereby sterically inhibiting enzyme-proteins interactions.69  PEGylated enzymes are hence less 
immunogenic and less susceptible to clearance by plasma proteins than free enzymes.51-53, 70, 71  
Another way modification can prevent proteolysis and even autolysis when the target enzyme is 
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itself a protease by altering positively charged residues.13, 72  This is because many proteases 
cleave polypeptides following positively charged residues and eliminating positive charges in the 
polypeptide makes potential cleavage sites unrecognizable.  If a positively charged residue is 
modified with a negatively charged reagent such as a dicarboxylic acid anhydride, additional 
electrostatic effects may be introduced.13, 72  For instance, the accumulation of negative charge 
on the surface of the enzyme can cause the enzyme to repel proteases that also have a net 
negative charge.  Since enzymes are more accessible to proteolytic digestion when unfolded, 
increases in enzyme rigidity, which can be achieved through crosslinking, may also minimize 
proteolysis under denaturing conditions.13   
Increased stability as a result of chemical modification is usually accompanied by 
changes in the catalytic properties of an enzyme.  The activity of an enzyme is almost always 
altered by modification.  Such changes are dependent upon the extent and site(s) of modification.  
Modification of a residue that is critical to the catalytic mechanism of an enzyme will result in at 
least partial inactivation.  Complete loss of activity is most often associated with the 
modification of residues in or near the active site.  The modification of active site residues, 
which is likely to block substrate binding, can be prevented by adding a competitive inhibitor, 
substrate, or substrate-analogue to the modification reaction.47, 73  By and large, modification to 
the surface of an enzyme will have minimal impact on activity.  However, the greater the number 
of modifications per enzyme molecule, the more drastic the activity loss one can expect.  
Although far less common, there have been reported instances in which modification has led to 
enzyme activation.65  Changes in enzyme activity are reflected in the Michaelis-Menten kinetic 
parameters kcat and KM.  The kcat and KM of an enzyme generally decrease and increase 
respectively upon modification, resulting in an overall reduction in catalytic efficiency (kcat/KM). 
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Apparent inactivation may not necessarily be due to a reduction in catalytic efficiency but 
rather to changes in the pH-dependent activity of the enzyme.47  The addition or removal of 
charge groups on the surface of an enzyme by chemical modification can influence the pKa of 
residues in the enzyme’s active site, which are involved in catalysis.74  Enzyme specificity may 
also change upon chemical modification.75  
2.4.3 Immobilization 
Immobilization, in its broadest sense, involves the fixation of an enzyme to an insoluble 
support.  This fixation may be covalent or non-covalent in nature or neither, as the enzyme may 
instead be confined within a permeable support.  Generally, enzymes are remarkably more stable 
in an immobilized state versus in a free state.13, 76-78  There are many techniques for immobilizing 
enzymes including entrapment, physical adsorption, ionic adsorption, and single or multipoint 
covalent attachment, each of which stabilize enzymes in a different manner. 
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Figure 3.  Enzyme immobilization techniques: (A) entrapment, (B) adsorption, (C) conventional 
covalent immobilization, and (D) multipoint covalent immobilization into polymeric network.  
The blue spheres represent enzyme molecules. 
 
Enzyme immobilization by entrapment refers to the retention of an enzyme by a porous 
matrix, membrane or gel-like material based on differences between the size of the enzyme 
molecule and that of the pores.77, 79  Entrapment occurs when the enzyme cannot leach from the 
framework of the support, as a result of having an effective radius greater than that of the pores, 
whereas reaction substrates and products can diffuse freely in and out (Figure 3A).  Because the 
enzyme does not interact with the support directly, enzymes immobilized in this way are 
typically not subjected to conformational changes that may alter their activity.  The 
encapsulation of enzymes within the lumen of a hollow membrane such as lipsomes, micelles, or 
rigid microspheres is a form of entrapment.76  An entrapped enzyme may be stabilized as a result 
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of restricted conformation motion, which has the same effect as increasing enzyme rigidity.  As 
such, entrapment may prevent thermal, pH, or chemical denaturation.  Entrapment may also lead 
to stability enhancements as a result of influencing the microenvironment of an enzyme.13  The 
intrinsic properties of the support, such as charge and hydrophobicity, may cause partitioning of 
denaturants or even ions between the microenvironment of the enzyme and bulk reaction media.  
It is thus feasible that, depending on the support, entrapment could result in the exclusion of an 
inactivating agent from the immediate vicinity of an enzyme.  Similarly, the concentration of 
substrate in the microenvironment of an enzyme may be less than that in the bulk media due to 
partitioning.  The observed activity of the entrapped enzyme will as a result be less than that of 
the free enzyme.  Furthermore, the entrapment of an enzyme may prevent proteolysis as well as 
interactions with large macromolecules, which cannot diffuse into the framework of the support.  
Enzymes that are immobilized by adsorption are bound to a support by non-covalent, 
ionic, or affinity interactions (Figure 3B).77  In the case of physical adsorption, an enzyme may 
be immobilized through any one or combination of hydrogen bonding, hydrophobic interactions, 
or Van der Waals forces.  Adsorption by affinity interactions provides a greater degree of 
specificity between the enzyme and support than other means of adsorption.  Thus, there is 
generally less non-specific binding of reaction substrates, products, or additives to the support, 
which may displace the enzyme.  The strongest interactions are formed through electrostatic 
interactions between an enzyme and charged support.77  Compared to other immobilization 
techniques, adsorption is relatively simple in practice and does not require sophisticated 
chemistries.  Adsorption, like entrapment, may increase the conformational rigidity, particularly 
when there are multiple interactions between an enzyme molecule and the support, and alter the 
properties of an enzyme’s microenvironment.76, 77  However, relative to other immobilization 
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techniques, the strength of interactions between an enzyme and support by adsorption are 
relatively weak.  Changes in pH and ionic strength can disrupt such interactions, making the 
enzyme prone to leaching.  Moreover, adsorption can lead to inactivation of an enzyme if a 
buried region or motif interacts with the support in a manner that induces unfolding.  Inactivation 
may also occur as a result of adsorption interactions involving active site residues. 
The covalent immobilization of an enzyme is achieved by the reaction of functional 
groups on the enzyme’s surface with a solid support (Figure 3C).76, 77, 79  As is the case in 
chemical modification, chemistries that are specific for the reactive groups on the side chains of 
lysine, cysteine, arginine, aspartic acid, glutamic acid, histidine, tyrosine, methionine, and 
tryptophan residues may be used.62  In certain cases, it may be necessary to initially introduce 
functional groups onto the support using surface modification techniques such as radio frequency 
glow discharge.  Depending on the number of accessible reactive groups on the enzyme surface, 
an enzyme may be bound to the support at more than one site.  The formation of covalent 
linkages from the enzyme increases its conformational rigidity in a manner that is similar to 
chemical crosslinking.76, 77  The greater the number of covalent linkages between the enzyme and 
surface, the greater the extent to which the enzyme’s rigidity is increased.  Comparatively, 
covalent immobilization can lead to much greater thermostability enhancements than entrapment 
or adsorption.77  As is to be expected anytime the structure of an enzyme is modified, covalent 
immobilization may have deleterious effects on enzyme activity.  The basis for this effect is 
analogous to that described for the loss of activity by chemical modification.        
 Combining the power of biology and the sophistication of polymers presents considerable 
opportunities.  Enzyme-containing polymers are prepared by reacting a prepolymer with an 
enzyme, resulting in multipoint covalent attachment of the enzyme directly into the polymer 
 26 
network (Figure 3D).77, 80, 81  In this way, the enzyme plays the role of a monomer in the 
polymerization reaction.  Multipoint covalent attachment ensures retention of the enzyme in the 
polymeric material and typically results in exceptional stability enhancements.  Polyurethanes 
are ideal matrices for enzymes due to their ease of preparation and the tunability of their 
properties.  While studying the effects of multipoint covalent immobilization on the stability of 
organophosphrous hydrolase, LeJeune and co-workers80 described the first successful 
irreversible incorporation of an enzyme into a polyurethane polymer.  
 The characterization of immobilized enzymes is usually complicated by the existence of 
diffusional limitations.13, 76  Diffusional limitations, which affect the apparent activity of an 
immobilized enzyme, may be external or internal with respect to the surface of the immobilized 
enzyme.  The activity of an immobilized enzyme is limited by external diffusion when the rate of 
substrate diffusion from the bulk solution to the immobilized enzyme’s surface is limiting (or 
when the rate of product diffusion from the immobilized enzyme’s surface to the bulk solution is 
limiting).  Conversely, the activity of an immobilized enzyme is limited by internal diffusion 
when the rate of substrate (or product) diffusion within the porous immobilized enzyme particle 
is limiting.  Generally, the immobilization of enzymes by entrapment and multipoint covalent 
incorporation into a polymer matrix leads to both external and internal diffusional limitations 
whereas enzymes that are adsorbed or covalently attached to the surface of a support are only 
affected by external diffusional limitations.  The existence of diffusional limitations can be 
confirmed experimentally by assaying enzyme activity as a function of the amount of 
immobilized enzyme.  If the activity of the immobilized enzyme is diffusionally controlled, the 
relationship between activity and enzyme loading will be nonlinear.  As a result of limited 
substrate diffusion, the apparent stability of an immobilized enzyme can significantly differ from 
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that of its true stability.13  An immobilized enzyme may even have a greater apparent than 
intrinsic stability.  The effects of diffusional limitations on the activity and stability of an 
immobilized enzyme may be reduced by decreasing the size, and thus increasing the net surface 
area, of the support-bound enzyme.  
2.4.4 Protein Engineering 
Advances in recombinant protein technology have dramatically increased the ease with 
which proteins may be produced at sizeable quantities and of high purities.  This, combined with 
the advent of site-directed mutagenesis, a technique that allows one to alter the amino acid code 
of proteins, has provided the necessary tools to rationally engineer proteins.  Protein engineering 
has emerged as a particularly useful technique for the study of enzyme mechanisms.  By 
selectively mutating specific residues in an enzyme and correlating the mutations to activity and 
specificity, the precise role of these residues in catalysis can be elucidated.14, 82, 83  Moreover, 
through protein engineering, it is now possible to re-design enzymes to have radically different 
catalytic properties.  One of the early uses of protein engineering in this way was reported by 
Russell and Fersht5, who demonstrated that the pH-activity profile and specificity of subtilisin 
could be altered via introducing mutations that change the enzyme’s surface charge. 
The three-dimensional arrangement of a polypeptide is stabilized by non-covalent 
interactions between amino acid residues, as well as between amino acid residues and water, and 
occasional disulfide bridges.  Thus, it is logical that rationally introducing interactions of these 
types into an enzyme molecule by means of engineering its structure will have stabilizing effects.  
This approach has been successfully applied to the stabilization of enzymes against thermal and 
chemical denaturation by engineering sites for disulfide bridge formation.59, 84, 85  In some cases, 
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only a single amino acid in the enzyme was converted to a cysteine, thereby introducing a site 
that could potentially form a disulfide linkage with a cysteine that is naturally found in the 
enzyme.  In other cases, cysteines were substituted at two positions in the enzyme, enabling the 
potential for a disulfide bridge to be formed between the engineered sites.  The thermal and 
chemical denaturation of enzymes has also been prevented by amino acid substitutions that 
provide sites for hydrophobic, electrostatic and Van der Waals interactions.59, 78, 84, 85 
Inactivation as a result of covalent modifications of enzyme structure may further be 
prevented through protein engineering.  For example, an enzyme may be engineered to be 
resistant to oxidation by mutating the one or more residues that are prone to being oxidized.59, 86  
In much the same way, proteolysis may be prevented by mutating the primary cleavage site or 
sites.  This rationale is also effective in minimizing autolysis of proteases.86 
The stabilization of enzymes through protein engineering has several distinct 
disadvantages relative to other stabilization techniques.  The primary disadvantage associated 
with protein engineering is that a detailed structural understanding of the enzyme of interest is a 
prerequisite.  Molecular modeling may assist in the identification of possible mutation sites.  
However, in many cases, detailed structural data is unavailable, thus making it practically 
impossible to rationally alter the enzyme’s structure.  The process of producing and purifying a 
recombinant enzyme can also be time consuming.  For comparison, most chemical reactions that 
involve altering the surface of enzymes can be done in a matter of just minutes to at most hours 
whereas the time required to obtain a single purified mutant is on the order of days or weeks.  
Additionally, altering the structure of an enzyme may have a wide range of consequences with 
respect to its catalytic properties including many of which are unexpected.  Thus, it may take 
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several rounds of introducing a mutation and analyzing its effects before obtaining an enzyme 
with the desired properties.  
2.4.5 Directed Evolution 
Directed evolution provides another pathway for developing enzymes with desired 
catalytic properties and stabilities.  Although there may be many subtle variations, the general 
strategy of directed evolution is to construct a library of variants of the same enzyme and to 
subsequently selectively screen the library for variants that have the target functionality.59, 87-91  
To construct the library of variants, random mutations are typically introduced into the DNA 
coding sequence of the enzyme by means of chemical mutagenesis, error-prone polymerase 
chain reaction, and DNA shuffling.  The process of introducing random mutations and screening 
for improved function is generally carried out several times, each time using the mutants that 
have the most improved function as the parental genes (i.e. the starting point) for the next cycle.  
Since the identification of improved mutant enzymes is based on the screening step, it is of 
critical importance that the assay used to measure the target function is both sensitive and not 
easily interfered with.  Interferences, if not detected, can result in the selection of “junk”, which 
are mutant enzymes that are of little or no use. 
The use of directed evolution has proved to be an effective technique for generating 
robust enzymes.  Enzymes have been evolved to have improved thermostability as well as 
increased pH stability and stability against oxidation, organic solvents, and surfactants.59, 89, 91  
Directed evolution may even be employed in conjunction with rational protein engineering to 
yield enzymes with improved stabilities.92  In such cases, the enzyme is typically mutated first by 
site-directed mutagenesis and then by directed evolution. 
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Processes like evolution afford the opportunity to drastically alter enzyme stability 
without knowing anything about the enzyme’s structure.  This represents a considerable 
advantage over rational protein engineering, to which directed evolution is commonly compared 
to, which is based on the ability to predict a priori the effect of structural changes on enzyme 
function.  However, directed evolution has its pitfalls as well.  For example, in order for directed 
evolution to yield improvements of any kind, these improvements must be evolutionarily feasible 
in the first place.  When this is not the case, it can lead one down a fruitless path.  Additionally, 
while directed evolution may lead to stability enhancements, it may at the same time result in a 
dramatic loss of activity.  The loss of activity in many cases may outweigh the benefit of 
stabilization.  It is also possible for directed evolution to produce to a series of neutral mutations, 
which are those that do not improve or worsen enzyme stability.  Furthermore, like rational 
protein engineering, the improvement of enzyme stability by directed evolution is a very long 
process, which can take upwards of weeks or months. 
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3.0  SPECIFIC AIMS 
The overall objective of this research was to utilize fundamental relationship between 
enzyme structure, function, and environment to improve biocatalyst efficiency.  The first aim of 
this thesis was to mediate solvent-enzyme interactions in anhydrous enzymology by engineering 
the physical properties of the reaction solvent.  Because water is required for enzyme catalysis, 
even in anhydrous media, the properties of this essential water, such as pH, represent a key 
determinant of enzyme activity and stability.  Thus, as a natural extension to the first aim, a 
novel approach to controlling pH within the aqueous microenvironment of an enzyme, for which 
purposes conventional buffers have limited utility, was investigated.  Lastly, covalent 
modification with PEG was explored as method of enhancing the stability of proteases as the 
aqueous content of the reaction medium was increased.  The purpose of this last section is to 
enhance the overall utility of proteases by making them more amenable to aqueous reactions.  
 
Specific Aim 1:  Determine the Impact of Ionic Liquid Physical Properties on Lipase 
Activity and Stability. 
 Ionic liquids are molten organic salts that have remarkable solvent properties and non-
existent vapor pressures.  Recently, their potential use as a “green” alternative to conventional 
solvents in non-aqueous biocatalysis has been met with great enthusiasm.  To fully understand 
their utility in biocatalytic reactions, we have: 1) investigated how the physical properties of 
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ionic liquids vary with structure through solvatochromic probing and determination of partition 
coefficients, 2) measured lipase activity and stability in ionic liquids, 3) employed common 
methods of enzyme stabilization including adsorption, PEG-modification and multipoint 
covalent immobilization to enhance lipase activity in ionic liquids and 4) determined the degree 
to which lipase was irreversible inactivated in the ionic liquids.  Additionally, we have examined 
the control of water activity in ionic liquids using salt hydrates and compared the effect of salt 
hydrates on lipase activity in ionic liquids and organic solvents. 
    
Specific Aim 2:   Demonstrate Dynamic pH Control in Nerve Agent Detoxification Using 
Competing Acid-Base Enzyme Reactions.  
 Hydrolytic reactions such as the enzymatic detoxification of nerve agents, if allowed to 
approach completion, can generate large amounts of acidic products, requiring effective pH 
buffering.  To overcome buffering limitations of standard biological buffers in such reactions, we 
proposed a novel method of pH control based on the hypothesis that opposing acid and base 
forming enzyme reactions would create a dynamic pH equilibrium, essentially mimicking how 
cells manipulate their internal pH.  This hypothesis was tested by employing urease-catalyzed 
hydrolysis of urea to buffer the degradation of the nerve agent mimic paraoxon by 
organophosphorous anhydrolase.  The pH and conversion of paraoxon in the OPH-urease system 
was modeled using enzyme kinetic rate equations and experimentally verified.  The extent to 
which ureases are inhibited by fluoride, a hydrolysis product of several G-type nerve agents, was 
also assessed.  In order to improve the resistance of ureases, and thus biocatalytic pH control, to 
fluoride, the use of fluoride scavengers were explored. Alternative base-producing biocatalytic 
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reactions to be used in place of or in addition to urease to circumvent fluoride inactivation of the 
buffer were also identified. 
 
Specific Aim 3:  PEGylate Matrix Metalloproteinase-1 (MMP-1) and Characterize the 
Impact of PEG-Attachment on the Therapeutic Benefit Towards Reversing Scarring. 
 The effectiveness of enzyme therapies is limited by rapid clearance of the enzyme via 
proteolytic digestion, non-specific binding and immunogenic responses.  Therapeutic enzymes 
that are digestive enzymes may have even shorter active lifetimes due to autolytic degradation.  
In this section, we investigated the use of PEGylation as a means of regulating biological 
interactions in vivo that impact the active lifetime of MMP-1, a zinc-containing endopeptidase 
that has considerable therapeutic potential in reversing the effects of scarring.  PEG-MMP-1 was 
synthesized and characterized by protein electrophoresis and mass spectrometry analysis of the 
peptide fingerprint of tryptic digests of the modified protein.  Additionally, residual MMP-1 
activity after PEGylation was measured and thermal stability and resistance of the modified 
enzyme to proteolytic digestion were determined.  The impact of PEGylation on the ability of 
MMP-1 to degrade pre-existing scar tissue was assessed in a muscle laceration model in mice. 
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4.0  CHARACTERIZATION OF ENZYME ACTIVITY AND STABILITY IN IONIC 
LIQUIDS 
4.1 INTRODUCTION 
Thermal stability and the non-existence of vapor pressure, which eliminates volatile 
organic compound (VOC) emissions, make ionic liquids an environmentally attractive 
alternative to conventional organic solvents.  Recoverability and recyclability also render ionic 
liquids a practical solution to industrial environmental concerns.33, 93  That said, little is known 
about the biological consequences of increased concentrations of ionic liquids in the 
environment. 
As solvents for chemical processing, ionic liquids exhibit excellent properties including 
extremely high boiling points and the capacity to dissolve polar and non-polar, inorganic, and 
polymeric compounds.33, 34  The chemical and physical nature of ionic liquids may be modified 
by exchanging the cation, anion, and attached substituents.  This feature plays a key role in 
manipulating the solvent properties of an ionic liquid, thus enabling ionic liquids to be rationally 
designed for specific reaction systems.34 
Replacement of organic solvents with ionic liquids in biocatalytic processes has recently 
gained much attention.  Cull et al.35 employed the ionic liquid 1-butyl-3-methylimidazolium 
hexafluorophosphate ([bmim][PF6]) for the two-phase biotransformation of 1,3-dicyanobenzene 
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to 3-cyanobenzamide and 3-cyanobenzoic acid using the nitrile hydratase from Rhodococcus 
R312.  This work estabilished ionic liquids as a potential alternative to organic solvents for 
multiphase biotransformations.  The first reported enzymatic reaction in an ionic liquid, 
performed in our laboratory, involved the thermolysin-catalyzed synthesis of Z-aspartame in 
[bmim][PF6].11  In this report, it was shown that enzyme activity approached that observed in 
conventional organic solvents and that the enzyme was highly stabile in the ionic liquid.  Since 
this work, there have been many reports of enzymatic catalysis in ionic liquids including the 
anhydrous transesterification of ethyl butanoate and butanol catalyzed by Candida antarctica 
lipase type B (CALB) in 1-butyl-3-methylimidazolium paired with hexafluorophosphate and 
tetrafluoroborate anions36 and the α-chymotrypsin-catalyzed transesterification of N-acetyl-L-
phenylalanine ethyl ester with 1-propanol in 1-butyl-3-methylimidazolium and 1-octyl-3-
methylimidazolium hexafluorophosphate.37   
Almost all enzymatic reactions performed to date have been in ionic liquids comprised of 
dialkylimidazolium cations and the hexafluorophosphate and tetrafluoroborate anions.  Only 
recently have other cations and anions begun to be studied.94-96  In this chapter, the viability of 
replacing conventional biocatalytic solvents with ionic liquids consisting of combinations of 
dialkylimidazolium and N-methyl-N-(-2-methoxyethyl) pyrolidinium cations with a broad range 
of anions including hexafluorophosphate, acetate, nitrate, methanesulfonate, trifluoroacetate and 
trifluoromethylsulfonate was investigated, with the interest of expanding the portfolio of 
potential solvent systems (Figure 4). 
Herein, the first attempt of enzyme catalysis with pyrolidinium cations is described.  The 
lipase-catalyzed transesterificataion of methyl methacrylate and 2-ethylhexanol was used as a 
model reaction for determining enzyme activity as a function of ionic liquid physical properties 
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(Figure 5).  The polarity and hydrophobicity of ionic liquids as determined via solvatochromic 
and octanol-water partition coefficient analysis respectively is also compared to those of organic 
solvents commonly employed in biocatalytic reactions.  Additionally, the use of salt hydrates to 
control the thermodynamic water activity (aw), which may impact enzyme activity, specificity 
and hydrolytic equilibria, in ionic liquids and their effect on lipase catalysis in ionic liquids was 
explored. 
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+
1-Butyl-3-methylimidazolium 1-methyl-1-(-2-methoxyethyl)pyrrolidinium
[bmim] [mmep]  
Figure 4.  Structure of ionic liquids.  Anions available for X1- were hexafluorophosphate ([PF6]), 
acetate ([CH3CO2]), nitrate ([NO3]) and trifluoroacetate ([CF3CO2]).  Anions available for X2- 
were hexafluorophosphate ([PF6]), acetate ([CH3CO2]), nitrate ([NO3]), trifluoroacetate 
([CF3CO2]), trifluoromethylsulfonate ([CF3SO3]) and methanesulfonate ([CH3SO3]). 
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Figure 5.  Lipase-catalyzed transesterification of methyl methacrylate and 2-ethylhexanol to 2-
ethylhexyl methacrylate. 
4.2 MATERIALS AND METHODS 
4.2.1 Materials 
Lipase L-1754 (Candida rugosa) and Chirazyme L-2, carrier-fixed, C2, lyophilizate 
(Candida antarctica type B) were purchased from Sigma (St. Louis, MO) and BioCatalytics 
(Pasadena, CA) respectively.  Novozym 435 was obtained as a gift from Novo Nordisk 
(Bagsvaerd, Denmark).  All enzymes were used without further purification.  Hypol 3000 was 
purchased from Hampshire Chemical (Lexington, MA).  L-62 Pluronic was generously supplied 
by BASF (Parsippany, NJ).  The 1-butyl-3-methylimidazolium hexafluorophosphate 
([bmim][PF6]) employed in water activity and water transfer experiments as well as in 
transesterification reactions with salt hydrates was purchased from Solvent Innovations GmbH 
(Cologne, Germany).  Ionic liquids employed in all other experiments, including [bmim][PF6], 
were synthesized and purified by SACHEM Inc. (Austin, TX) and used as supplied.  All other 
reagents were purchased from Aldrich (St. Louis, MO) and were of the highest purity available. 
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4.2.2 Methods 
4.2.2.1 Determination of Octanol-Water Partition Coefficients 
Partition coefficients for ionic liquids were determined as a ratio of ionic liquid 
concentration in the octanol phase to that in the aqueous phase (Equation 5).  The logarithm of 
the partition coefficient is referred to as the log P value. 
Phase Aqueous
Phase Octanol
[solute]
[solute]
  )(t CoefficienPartition =P      (Eq. 5) 
The “shake flask” method was employed for the determination of all log P values.97  The 
imidazolium ring present in the dialkylimidazolium-containing ionic liquids absorbs strongly at 
approximately 211 nm and can be quantified by UV spectrometry.98  Water-saturated octanol and 
octanol-saturated water were used in all experiments.  For each ionic liquid, the maximum 
wavelength (λmax) due to absorbance of the imidazolium ring was verified in both phases.  The 
volume ratio of the octanol to aqueous phases was varied in an attempt to determine the 
necessary ratio to force the solute into the hydrophobic octanol phase to a detectable level.  A 
100:1 volume ratio was employed for the portioning of all ionic liquids.     
 In a 200-mL separatory funnel, ionic liquid was added to the saturated phases such that 
its final concentration did not exceed 10 mM in either phase.  Inversion of the separatory funnel 
was carrier out at room temperature for 5 min at an approximate rate of 20 inversions/min.  The 
phases were subsequently recovered and centrifuged to eliminate emulsions formed during 
partitioning.  The absorbance at λmax was measured in both phases using a Perkin-Elmer 
(Wellesley, MA) Lambda 45 UV/VIS spectrophotometer.  Standard curves of concentration in 
both phases were prepared for all ionic liquids.   
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4.2.2.2 Solvatochromic Characterization 
Polarity values (ENT) of ionic liquids and organic solvents were measured as described 
previously by Fletcher and co-workers.99  Reichardt’s dye was dissolved in the solvent and 
centrifuged to remove any residual dye particulates (Figure 6).  The visible spectrum of the dye-
containing solvents was scanned to determine the absorption band, which was subsequently 
correlated to an ENT value (Equations 6 and 7).   
[nm]
28591  kcal/mol](solvent)[
max
T λ=E       (Eq. 6) 
32.4
30.7-(solvent)T
T
N EE =        (Eq. 7) 
The normalized polarity scale ranges from water being the most polar (λmax = 453 nm, ENT = 1.0) 
to tetramethylsilane being the least polar (λmax = 925 nm, ENT = 0.0).  All ionic liquids were 
dried in a vacuum oven (26 in Hg) at 70 °C for several days prior to analysis. 
 
N+
O-  
Figure 6.  Reichardt’s dye (2,6-diphenyl-4-(2,4,6-triphenylpyridinio)phenolate). 
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4.2.2.3 Poly(Ethylene Glycol)-Modified Lipase Synthesis 
Free lipase (Candida rugosa) was dissolved in aqueous buffer (10 mM Tris, 5 mM 
calcium chloride, pH 7.5) at a concentration of 1 mg/mL.  Poly(ethylene glycol)-monoisocyanate 
(PEG-NCO) was added in excess to the lipase solution at a 100:1 molar ratio of PEG-to-lipase.  
The reaction mixture was vigorously mixed at room temperature of 30 min and subsequently 
lyophilized.100  No further purification such as the removal of unreacted PEG was attempted.  
The freeze-dried enzyme was employed in all experiments its crude form.  
4.2.2.4  Lipase-Containing Polyurethane Foam Synthesis 
The synthesis of lipase (Candida rugosa)-containing polyurethane foam was carried out 
using the procedure described by LeJeune and Russell.80  Briefly, lipase (1 g) was added to 
aqueous buffer (2.5 mL; 50 mM Bis-Tris propane, 5 mM calcium chloride, pH 7.5) containing 1 
%(w/w) L-62 Pluronic surfactant.  Hypol 3000 (2.5 g), a toluene diisocyanate based pre-
polymer, was added to the aqueous lipase solution and vigorously mixed for 30 s and 2500 rpm 
using a hand drill.  The lipase-immobilized polyurethane foam was cured overnight at ambient 
temperature and pressure and subsequently stored at 4 °C.  In preparation for use in 
transesterification reactions, the foam was ground into small particles using a drill fitted with a 
handmade bit wrapped in sandpaper (grit no. 180).  The drill was set at a low rpm setting and the 
drill speed was kept constant to obtain a constant particle size.  
4.2.2.5 Lipase Stability in Ionic Liquids 
Lipase was incubated in organic solvent or ionic liquid (1 mL) at a specified temperature 
(30 or 50 °C) for various lengths of time.  The enzyme solution was agitated at 300 rpm in a 
constant temperature shaker.  The solvent then extracted and lipase activity was assayed using 
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the Sigma (St. Louis, MO) lipase diagnostic kit, which measures the rate in which the lipase 
catalyzes the conversion of olive oil triglycerides to fatty acids in buffer.  The amount of fatty 
acids generated was measured via titration with sodium hydroxide (0.5 N).  
4.2.2.6 Water Activity Measurements in Ionic Liquids Using Humidity Sensor 
Salt hydrate (0.2 g/mL) and the ionic liquid [bmim][PF6] were added to a glass test tube 
to which a HY-CAL Engineering (Elmonte, CA) Ultra-HTM humidity sensor was tightly sealed.  
The test tube and sensor were housed in a 25 °C constant temperature air bath in which all 
relative humidity measurements were recorded.  Prior to all experiments, the sensor was 
calibrated with dry nitrogen, deionized water, and saturated salt solutions of lithium chloride, 
potassium carbonate, and sodium chloride.  The sensor was allowed to equilibrate to in the 
sample to obtain a stable reading, which typically required less then 12 hr.  In all experiments, 
only the higher hydrate of a salt hydrate pair was added to the test tube.  Water is released by the 
salt to the sample resulting in the formation of the lower salt hydrate, thus creating an 
equilibrium state between the higher and lower hydrates.  Salt hydrate pairs are referred in 
shorthand notation by stating the salt followed by the number of associated water molecules in 
the higher and lower hydrate.  For example, NaI 2/0 refers to a mixture of NaI•2H2O and 
NaI•0H2O. 
4.2.2.7  Water Transfer Measurements in Ionic Liquids 
The ionic liquid [bmim][PF6] (10 g), which contained less than 0.1 % (w/w) water, was 
added to a 20-mL glass vial containing salt hydrate (0.2 g/mL).  In all cases, only the higher 
hydrate of a salt hydrate pair was added.  The salt hydrate-containing ionic liquid solutions were 
incubated at 25 °C while agitated at 300 rpm in a constant temperature shaker.  Samples were 
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withdrawn periodically, filtered and assayed for water content using a Mettler Toledo 
(Columbus, OH) DL31 Karl Fischer (KF) titrator.  In KF titration, the amount of water in a 
solvent is determined by consumption of the water when reacted with methanol, an alkyl 
imidazole reagent and iodine in the presence of excess sulfur dioxide.  Because the water and 
iodine react in a 1:1 stoichiometry, the water content is directly proportional to the amount of 
iodine consumed, which is measured potentiometrically.101     
4.2.2.8 Lipase-Catalyzed Transesterification of Methyl Methacrylate and 2-Ethylhexanol 
The substrates methyl methacrylate and 2-ethylhexanol were dissolved separately in 
solvent at a concentration of 200 mM.  Reactions were initiated by the addition of substrate stock 
solutions (1 mL) to lipase in a 5-mL glass vial.  The enzyme suspension was sonicated for 
approximately 15 s to achieve a homogeneous distribution of the enzyme.  The reaction vials 
where then immediately placed in a constant temperature shaker set at 30 °C and 300 rpm.  
Samples were withdrawn periodically and assayed for 2-ethylhexyl methacrylate formation via 
gas chromatography.25, 102  When performing reactions in organic solvents, aliquots (1.0 μL) 
were removed from the reaction using a 1-μL Hamilton (Reno, NV) syringe.  When performing 
reactions in ionic liquids, 2-ethylhexyl methacrylate was recovered via liquid extraction into 
hexane.  All GC measurements were made with a Perkin-Elmer (Wellesley, MA) Autosystem 
GC fitted with an Alltech (Deerfield, IL) EC-1000 capillary column (30 m × 0.53 mm × 1.0 μm).  
A 1:4 split ratio using helium as the carrier gas was employed and the injector and detector 
temperatures were set to 300 °C.  The oven program consisted of an initial temperature of 100 
°C, which was maintained for 2 min.  The temperature was then ramped to 160 °C at a rate of 25 
°C /min and held for 3 min.  Using these conditions, the retention time of 2-ethylhexyl 
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methacrylate was 5.1 min.  A calibration curve of peak area versus concentration of 2-ethylhexyl 
methacrylate in the presence of the substrates was prepared for each organic solvent and ionic 
liquid.  No internal standard was used; however, the GC was calibrated daily.      
In transesterification reactions at controlled water activities, all components were pre-
equilibrated with the salt hydrates for 1 h at 30 °C and 300 rpm prior to initiating the reaction.  
Typically, lipase and salt hydrate (0.4 g) were added to 2-ethyhexanol (200 mM) in a 5-mL glass 
vial.  The same salt hydrate was added to methyl methacrylate (200 mM) in a separate vial.  
After equilibration, reactions were started by the addition of methyl methacrylate (1 mL) to the 
solution of 2-ethylhexanol (1 mL) containing enzyme and salt hydrate at a 1:1 (v/v) ratio.  
Crushed molecular sieves were substituted for salt hydrate in “dry” reactions. 
4.3 RESULTS AND DISCUSSION 
4.3.1 Physical Characterization of Ionic Liquids 
Solvent selection for enzymatic reactions can be severely constrained due to the inherent 
deactivating effects of many solvents, which is particularly problematic with hydrophilic 
solvents.  This ultimately limits the scope of biocatalytic reactions that can be performed in non-
aqueous media.  Hildebrandt solubility parameters (δ), dielectric constants (ε), and dipole 
moments (μ) may be employed to predict enzyme activity in solvent systems.  However, the 
most common method of predicting enzyme activity is through the use of octanol-water partition 
coefficients.31, 103  Solvatochromic parameters provide a simple and rapid means of assessing 
solvent polarity.31 
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A partition coefficient, which is often reported as a logarithmic value (log P), measures 
how a solvent distributes between an aqueous (water) and organic (1-octanol) phase, thus 
indicating solvent hydrophobicity.  Laane et al.31 reported that solvents with a log P less than two 
are considered hydrophilic in nature and tend to be unfavorable for enzymatic reactions.  In 
contrast, solvents with a log P of greater than four generally support enzyme activity.  Although 
log P analysis is a frequently employed method for gauging biocompatibility, it is important to 
note that this method is not always an accurate predictor of enzyme activity.31, 103 
To our knowledge, these results are the first determinations of log P values for ionic 
liquids.  Huddleston and colleagues104 recently reported the existence of a distinct correlation 
between the partitioning of several substituted-benzene derivatives in a [bmim][PF6]/water 
system.  However, the authors do not explicitly measure, calculate, or approximate the log P of 
[bmim][PF6] in an 1-octanol-water or any other biphasic system. 
The experimentally measured log P for the ionic liquids investigated ranged from -2.39 to 
-2.90 (Table 1).  For comparison, the reported log P for hexane, acetonitrile and tetrahydrofuran 
are 3.5, -0.33 and 0.49 respectively.31  Based on the guidelines detailed by Laane and co-
workers, this would indicate that the ionic liquids are highly hydrophobic and would likely 
inactivate enzymes.  Because UV spectra of the pyrrolidinium-containing ionic liquids did not 
yield any characteristic absorption peaks, the log P for these ionic liquids could not be 
determined.Because the pyrrolidinium-containing ionic liquids did not absorb light in the UV 
region, their respective log P values could not be determined. 
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Table 1.  Log P and Reichardt’s dye (ENT) polarity values for ionic liquids and select organic 
solvents. 
Solvent ENT log P 
   
1-Butyl-3-methylimidazolium acetate 0.57 -2.77 ± 0.11 
1-Butyl-3-methylimidazolium nitrate 0.65 -2.90 ± 0.01 
1-Butyl-3-methylimidazolium trifluoroacetate 0.63 - 
1-Butyl-3-methylimidazolium hexafluorophosphate 0.67 -2.39 ± 0.27 
1-Methyl-1-(-2-methoxyethyl)pyrrolidinium acetate 0.52 - 
1-Methyl-1-(-2-methoxyethyl)pyrrolidinium nitrate 0.84 - 
1-Methyl-1-(-2-methoxyethyl)pyrrolidinium trifluoroacetate 0.37 - 
1-Methyl-1-(-2-methoxyethyl)pyrrolidinium trifluoromethylsulfonate 0.91 - 
1-Methyl-1-(-2-methoxyethyl)pyrrolidinium methanesulfonate 0.78 - 
Hexane 0.009 3.5 
Tetrahydrofuran 0.207 0.49 
Acetonitrile 0.47 -0.33 
   
 
The polar nature of ionic liquids was determined via measuring the solvatochromic 
parameter ENT, which is a normalized dimensionless value obtained from the shift of the charge-
transfer absorption band of the solvatochromic probe Reichardt’s dye in a solvent.  Changes in 
the position of the charge-transfer absorption band within the visible spectrum result from 
hydrogen bonding between the solvent and the phenoxide oxygen atom present in the dye.  An 
ENT value is determined spectroscopically as a function of the band shift (Figure 7).32, 105 
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 Figure 7.  Solvatochromic probing of organic solvents (from left: tetrahydrofuran, acetonitrile, 
methanol, t-amyl alcohol and acetone) with Reichardt’s dye.  Differences in solvent polarity alter 
the absorption energy of the dye.  These differences are reflected by the visible color of the dye-
containing solutions.  
 
There are only a few reported cases of the solvatochromic characterization of ionic 
liquids.99, 105-109  Results of the solvatochromic probing of [bmim][PF6] with Reichardt’s dye 
reported in the literature indicate that the dry ionic liquid has an ENT value very similar to that of 
ethanol (ENT = 0.67) and other short chain primary alcohols.95, 99, 105, 106, 109  This value is 
sensitive to the water content of the ionic liquid.106, 107  Muldoon and colleagues105 suggest ENT’s 
for ionic liquids are dependent upon the strength of hydrogen bonding between the cation of the 
ionic liquid and the phenoxide group in Reichardt’s dye.  A high ENT indicates that strong 
hydrogen bonding forces are present within the ionic liquid-dye complex.  Hydrogen bonding 
with solvent molecules may perturb enzyme structure, leading to lose of function. 
Results of solvatochromic analysis of [bmim][PF6] in this study closely match the 
reported ENT (Table 1).  Replacement of the [PF6] anion with [CH3CO2], [NO3] and [CF3CO2] 
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yielded ENT’s of 0.57, 0.65 and 0.63 respectively.  This small change in the polarity series is 
consistent with previous work.105  The ionic liquids [mmep][CH3CO2], [mmep][NO3], 
[mmep][CF3CO2], [mmep][CF3SO3] and [mmep][CH3SO3] have ENT’s of 0.52, 0.84, 0.37, 0.91 
and 0.78 respectively.  Based on these results, the polarity of pyrrolidinium-containing ionic 
liquids appears to be strongly dependent on the anion.  With the exception of [mmep][CF3CO2], 
the ENT’s for all ionic liquids studied were greater than those of acetonitrile and other organic 
solvents commonly employed in non-aqueous biocatalysis.32  Nonetheless, the polar nature of 
ionic liquids constitutes an ideal reaction media for biotransformations involving highly polar 
substrates such as carbohydrates, which contain multiple hydroxyl functionalitites and are not 
miscible in conventional solvents such as hexane. 
4.3.2 Lipase Activity in Ionic Liquids 
To determine impact of ionic liquids on enzyme activity, initial reaction rates of the 
lipase-catalyzed transesterification of methyl methacrylate and 2-ethylhexanol were measured in 
several ionic liquids and compared to rates observed in organic solvents.  Our experience with 
this reaction system, combined with an extensive data set, made this an ideal model enzymatic 
reaction.  The selection of lipase for these experiments was based on prior work in which several 
lipases including Amano lipases G (Penicillium camembertii), AY (Candida rugosa), AK 
(Pseudomonas fluorescens), MAP (Mucor javanicus), FAP (Rhizopus oryzae), PS (Pseudomonas 
cepacia) and Sigma lipases L1754 (Candida rugosa), L0763 (Chromobacterium viscosum), 
L3001 (wheat germ) were screened for activity in hexane using the same reaction.25, 102  Reaction 
conditions of the transesterifications, 30 ºC and 300 rpm, were equivalent to those employed in 
this study, eliminating any potential temperature or mixing effects on lipase activity.  Results of 
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the lipase screen indicated that Candida rugosa lipase was the most active and thus was selected 
as the model enzyme for this study. 
In [bmim][PF6], free lipase catalyzed the transesterification at an initial rate of 6.75 
μM/hr/mg-enzyme, 1.5 times faster than the reaction in hexane (3.90 μM/hr/mg-enzyme; Table 
2).  Although [bmim][PF6] showed promise as an effective solvent for the transesterification, the 
enzyme was inactive in all other ionic liquids investigated ([bmim][CH3CO2], [bmim][NO3], 
[bmim][CF3CO2], [mmep][CH3CO2], [mmep][NO3], [mmep][CH3SO3], [mmep][CF3CO2] and 
[mmep][CF3SO3]).  No lipase activity was observed in the more polar organic solvents 
tetrahydrofuran or acetonitrile. 
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Table 2.  Initial rates of lipase-catalyzed transesterification of methyl methacrylate and 2-
ethylhexanol in ionic liquids and organic solvents.  All initial rates are reported in the units 
μM/hr/mg-enzyme. 
Solvent 
Free Lipase 
(Candida 
Rugosa) 
Novozym 435 
(Candida 
antarctica) 
Lipase-Immobilized 
Polyurethane Foam 
(Candida rugosa) 
PEG-Lipase 
(Candida 
rugosa) 
     
[bmim][CH3CO2] 0 0 0 - 
[bmim][NO3] 0 0 0 0 
[bmim][PF6] 6.75 15.8 0.93 0 
[bmim][CF3CO2] 0 - - - 
[mmep][CH3CO2] 0 0 0 0 
[mmep][NO3] 0 0 - - 
[mmep][CH3SO3] 0 0 0 - 
[mmep][CF3CO2] 0 - - - 
[mmep][CF3SO3] 0 - - - 
Hexane 3.90 3.68 - 0.75 
Tetrahydrofuran 0 0 - - 
Acetonitrile 0 8.85 - - 
     
 
Water was added to ionic liquids, 25 to 100 μL H20/mL-ionic liquid, in attempt to 
activate free lipase in [bmim][NO3] and [mmep][CH3CO2].  However, hydration of the enzyme 
failed to improve activity in either of the ionic liquids, making stripping of essential water 
molecules from the enzyme by the ionic liquids an unlikely mechanism of deactivation.  
Moreover, addition of the hydrophilic ionic liquids [bmim][NO3] and [bmim][CH3CO2] as co-
solvents to [bmim][PF6] was also investigated as a means of supporting enzyme activity while 
increasing the overall polarity of the reaction media.  The amount of the hydrophilic ionic liquids 
was varied such that the final concentration of [bmim][PF6] in the bmim][NO3]/[bmim][PF6] and 
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[bmim][CH3CO2]/[bmim][PF6] mixtures was 25, 50, or 75 % (v/v).  Despite the use of 
[bmim][PF6] as a co-solvent, no lipase activity was observed in any of the mixed ionic liquid 
mixtures, indicating [bmim][PF6] did not prevent inactivation of the enzyme.   
     Our results suggest enzyme activity in ionic liquids is anion dependent.  Anions such 
as [NO3], [CH3CO2] and [CF3CO2] are more nucleophilic than [PF6] and may coordinate more 
strongly to positively charged sites in lipase’s structure causing conformation changes.110  
Similar results observed with [mmep][NO3], [mmep][CH3CO2], [mmep][CF3CO2], 
[mmep][CF3SO3] and [mmep][CH3SO3] in which all anions are strong nucleophiles further 
supports the notion that nucleophilicity is critical to enzyme activity.  However, due to little 
work with pyrrolidinium-containing ionic liquids, the possibility that the pyrrolidinium cation 
inhibits enzyme activity must not be ruled out.  This new data calls into question the broad utility 
of ionic liquids as solvents for biocatalysis unless the deactivating mechanism can be understood 
and reversed.  
4.3.3 Use of Modified and Immobilized Lipases in Ionic Liquids 
Having shown free lipase to be inactive in all ionic liquids with the exception of 
[bmim][PF6], several methods of enzyme stabilization were investigated in attempt to improve 
lipase activity in the ionic liquids.  Adsorption, PEG-modification, and multipoint covalent 
immobilization in polyurethane foam are techniques that prevent deactivating conformational 
changes in harsh environments and enhance enzyme activity.80, 111, 112  The effectiveness of these 
stabilization methods on lipase activity in ionic liquids was determined by employing the various 
lipase forms to catalyze the transesterification reaction.   
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Using Candida antarctica lipase, type B adsorbed onto a macroporous acrylic support 
(Novozym 435), initial rates of 3.68 and 8.85 μM/hr/mg-enzyme were observed in hexane and 
acetonitrile respectively while no activity was detected in tetrahydrofuran (Table 2).  In all of the 
ionic liquids screened ([bmim][PF6], [bmim][CH3CO2], [bmim][NO3], [mmep][CH3CO2], 
[mmep][NO3] and [mmep][CH3SO3]), Novozym 435 was only activity in [bmim][PF6] (15.8 
μM/hr/mg-enzyme). 
Modification with PEG, in addition to its stabilizing effects, greatly enhances the 
solubility of enzymes in non-aqueous media and in turn, as a result of reduced mass transfer 
limitations, may have activating effects.112  Although PEG-modified Candida rugosa lipase 
catalyzed the transesterification reaction in hexane (0.75 μM/hr/mg-enzyme), no improvement in 
lipase activity relative to that of free lipase was detected in [bmim][PF6], [bmim][NO3] or 
[mmep][CH3CO2] as a result of PEGylation (Table 2). 
Multipoint covalent immobilization was considered by incorporating lipase (Candida 
rugosa) into the preparation of waterborne polyurethane foam.  Reactive residues on the surface 
of the enzyme are conjugated to the polymer backbone during synthesis, thus making the enzyme 
a monomer in the polymerization step.  Drevon and Russell113 reported the irreversible 
immobilization of the nerve-agent degrading enzyme diisofluorophosphatase in polyurethane 
foam.  Upon thorough rinsing with water, less than 1 % (w/w) enzyme leached from the enzyme-
containing polyurethane.  Additionally, the immobilized enzyme retained 67 % activity relative 
to the native enzyme.  The transesterification catalyzed by polyurethane-immobilized lipase 
yielded an initial rate of 0.93 μM/hr/mg-enzyme (Table 2).  However, no detectable activity was 
observed [bmim][CH3CO2], [bmim][NO3], [mmep][CH3CO2] or [mmep][CH3SO3] thereby 
indicating immobilization was ineffective in activating lipase in the ionic liquids. 
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Sheldon and co-workers110 reported similar results using immobilized forms of Candida 
antarctica lipase type B.  Conversions of less than 5 % in a 24 hr period were measured in the 
transesterification of phenylglycine methyl ester using cross-linked enzyme crystals and cross-
linked enzyme aggregates.  The lack of immobilized lipase activity when employing a different 
lipase than that used in this work supports our conclusion that the described activating techniques 
would most likely prove ineffective in enhancing the activity of lipases from other sources in the 
ionic liquids as well.  Clearly, for the broad range of ionic liquids tested, ionic liquids are not the 
panacea for non-aqueous biocatalysis that we had hoped.   
4.3.4 Lipase Stability in Ionic Liquids 
The stability of Novozym 435 in ionic liquids was explored to determine if lipase 
inactivation in the ionic liquids was permanent (i.e. irreversible).  Novozym 435 was incubated 
in the ionic liquid for a specific period of time after which the enzyme was recovered via 
extraction of the ionic liquid, diluted with water, assayed for hydrolytic activity.  The ionic liquid 
was extracted using pipette with care taken to minimize enzyme loss.  The relative activity 
results indicate the fraction of lipase irreversibly inactivated as a result of incubation in the ionic 
liquid.  However, these experiments as performed do not represent the stability of lipase in 
catalyzing a reaction.    
Upon incubation in [bmim][PF6] for 24 hr at 30 ºC, Novozym 435 retained 96 % of its 
initial activity (Figure 8).  Unlike in [bmim][PF6], the enzyme was considerably less stable in 
the other ionic liquids [mmep][NO3] and [bmim][NO3] at the same temperature and over the 
same time period.  However, incubation in [mmep][CH3SO3], [bmim][CH3CO2] and 
[mmep][CH3CO2] resulted in marked increases in enzyme activity once re-suspended in water.  
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Relative activities after removal from [mmep][CH3CO2], [bmim][CH3CO2] and 
[mmep][CH3SO3] were 297, 202 and 176 % respectively.  For comparison, at the same 
conditions, no activity loss was observed when incubated in hexane, whereas Novozym 435 was 
completely inactivated after incubation in butanol (Figure 9).  Relative activity retentions of 73, 
68 and 55 % respectively were measured after incubation in tetrahydrofuran, acetonitrile and 
dimethyl sulfoxide. 
Interestingly, although the ionic liquids [mmep][CH3SO3], [bmim][CH3CO2] and 
[mmep][CH3CO2] do not support lipase activity, they cause irreversible activation of the 
adsorbed enzyme.  One plausible explanation for the activation effect is that these ionic liquids 
swell the acrylic resin on which the enzyme is adsorbed, causing previously inaccessible enzyme 
to be accessed once returned to water.  While seemingly less likely, it also cannot be ruled out 
that the ionic liquid exposed enzyme has a modified tertiary structure with increased activity in 
water.   Further elucidation of enzyme structure in these ionic liquids via spectroscopic 
techniques such as circular dichroism is required to fully explain this data set. 
Sheldon et al.110 recently studied the stability of free lipase (Candida antarctica), 
Novozym 435, cross-linked lipase crystals and cross-linked lipase aggregates in several ionic 
liquids.  The authors reported that after 100 hr of incubation in [bmim][PF6] at 80 °C, an increase 
(120 %) in free lipase activity was observed.  Similarly, results indicated an increase (350 %) in 
Novozym 435 activity after 40 hr incubation in [bmim][PF6] at the same temperature.  It is 
suggested that the ionic liquid coated and thus protected the layer of essential water surrounding 
the free and adsorbed lipases, but it is hard to explain the increases in activity through a merely 
protective mechanism.  We believe that one must invoke a permanent activating conformational 
change or an increase in active site concentration to explain this unusual data. 
 54 
 Incubation time (hr)
0 5 10 15 20 25
R
el
at
iv
e 
ac
tiv
ity
 (%
)
0
50
100
150
200
250
300
 
Figure 8.  Stability of Novozym 435 in ionic liquids ([bmim][PF6] (?), [bmim][NO3] (□), 
[bmim][CH3CO2] (∆), [mmep][NO3] (?), [mmep][CH3CO2] (▲) and [mmep][CH3SO3] (●)).  
Error bars represent the standard deviation for two separate experiments. 
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Figure 9.  Stability of Novozym 435 in organic solvents (butanol (?), tetrahydrofuran (□), 
acetonitrile (▲), dimethyl sulfoxide (?) and hexane (?)).  Error bars represent the standard 
deviation for two separate experiments. 
 
4.3.5 Controlled Water Activity in Ionic Liquids 
The degree of enzyme hydration is a critical parameter in non-aqueous or gas phase 
biocatalytic reactions.24, 38, 39, 96, 114  In addition to its effects on enzyme activity, thermodynamic 
water activity (aw), which describes the amount of water available to the enzyme, may also 
impact enzyme specificity and shift the reaction equilibrium thereby defining the efficiency of 
the desired reaction.24  Because solvent properties influence enzyme activity, true comparison of 
enzyme reaction rates in different mediums can only be obtained at controlled aw.  In the case of 
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ionic liquids, aw control is particularly critical since ionic liquids are hygroscopic and can absorb 
considerable amounts of water.  Hence, in order to realize the absolute effect of ionic liquids on 
enzyme activity and stability, methods of controlling aw in ionic liquids must be explored. 
Common methods for controlling aw in organic solvents include pre-equilibration with 
saturated salt solutions and the addition of various amounts of water to the reaction system.24  
These methods, although simple and effective, are subject to adsorption or evaporation of water 
to or from the environment and thus are only applicable for initial rate measurements and are not 
practical for large scale reactions.  Furthermore, pre-equilibration typically requires lengthy time 
periods on the order of days to weeks.  Salt hydrates may also be employed to control aw in 
solvent systems.24-29  Through the inter-conversion of the salt between higher and lower 
hydration states, a dynamic water equilibrium is established that tightly controls aw in the 
reaction medium.  Each salt hydrate pair has an intrinsic fixed aw equilibrium and as long as 
residual amounts of the solid salts are present, aw remains constant.26   
To date, there have been only a few reports on the control of aw in ionic liquids, all of 
which have involved pre-equilibration of the ionic liquid with a saturated salt solution.96, 114  In 
this study, salt hydrate control of aw in the ionic liquid [bmim][PF6] is investigated. 
Initially, the aw of [bmim][PF6] with several salt hydrates was determined by measuring 
the humidity, which is equal to aw at equilibrium, of the gas headspace above the ionic liquid.  
Eckstein et al.114 recently reported that ionic liquids have high salt hydrate solubilities, indicating 
aw control using salt hydrates in ionic liquids was not feasible.  However, our results indicate 
otherwise as of the seven salt hydrates investigated, aw was controlled in the ionic liquid with all 
but one (NaI).  All measured aw values for the salt hydrates closely match reported literature 
values with the exception of NaI, which partially dissolved in the ionic liquid (Table 3).  
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Although partial dissolution of a salt hydrate should not prevent aw control, the salt ions may, in 
the case of a biocatalytic reaction, adversely impact enzyme activity.  For example, the salt may 
bind to the enzyme surface thereby inducing conformational changes.  The solubility of the salt 
hydrate CuSO4•5H2O in other ionic liquids was also screened.  The salt hydrate did not dissolve 
in [mmep][CH3SO3] or [mmep][CF3SO3], whereas it was soluble in [bmim][NO3], 
[bmim][CH3CO2], [mmep][CF3CO2] and [mmep][CH3CO2]. 
 
Table 3.  Water activities of [bmim][PF6] containing salt hydrates at 25 °C measured using a 
humidity sensor.  The values were compared to the water activity of salt hydrates in organic 
solvents, which were compiled from the literature. 
 aw 
Salt Hydrate Pairs Halling27 Zacharis et al.29 [bmim][PF6] 
    
NaI 2/0 0.12 0.07 0.17 
Na2HPO4 2/0 0.16 - 0.17 
NaAc 3/0 0.28 0.34 0.28 
CuSO4 5/3 0.32 0.42 0.42 
Na4P2O7 10/0 0.49 0.47 0.47 
Na2HPO4 7/2 0.61 0.61 0.63 
Na2HPO4 12/7 0.80 0.79 0.78 
    
  
Controlled aw in [bmim][PF6] was also verified by assaying the water content of the salt 
hydrate containing ionic liquids over time via KF titration.  The salt hydrates were categorized as 
quick or slow based on the length of time required to approach the equilibrium aw (Figure 10).  
Equilibrium aw was obtained rapidly in the ionic liquid containing Na2HPO4 2/0, Na2HPO4 7/2, 
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Na2HPO4 12/7 and NaAc 3/0.  Slow salt hydrates included Na4P2O7 10/0 and CuSO4 5/3.  
Similar results were reported by Zacharis et al.29 in which the rate of water transfer to isopropyl 
ether was rapid with Na2HPO4 12/7, Na2HPO4 7/2 and NaAc 3/0 and slow with Na4P2O7 10/0.  
The similar trends in water transfer rates in [bmim][PF6] and isopropyl ether suggest that salt 
hydrate properties are comparable in ionic liquids and conventional organic solvents.  
The correlation between equilibrium water content and aw in [bmim][PF6] containing salt 
hydrates and in [bmim][PF6] subjected to vapor-phase pre-equilibration with saturated salt 
solutions was compared (Figure 11).  Results indicate the methods of aw control yield identical 
trends and closely match the data reported by Anthony et al.98, who measured the water content 
in [bmim][PF6] using a gravimetric microbalance over a range of water vapor pressures. 
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Figure 10.  Progress curves for the transfer of water from salt hydrate pairs (Na2HPO4 12/7 (▲), 
Na2HPO4 7/2 (?), NaAc 3/0 (●), Na2HPO4 2/0 (∆), Na4P2O7 10/0 (○), CuSO4 5/3 (□)) to 
[bmim][PF6]. 
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Figure 11.  Solubility of water at 25 °C in [bmim][PF6] that contained salt hydrates (▲) and that 
was pre-equilibrated with saturated salt solutions in presence of substrates (methyl methacrylate 
(∆), 2-ethylhexanol (?)).  Experimentally measured water solubilities were compared to data 
from the literature (●).   
 
4.3.6 Impact of Water Activity on Lipase Activity in Ionic Liquids 
Using salt hydrates to control aw in [bmim][PF6], the activity of Candida antarctica 
lipase type B adsorbed to an acrylic support (Chirazyme L-2, carrier-fixed, C2) in the ionic 
liquid as a function of aw was determined.  The lipase-catalyzed transesterification of methyl 
methyacrylate and 2-ethylhexanol was employed as a model reaction for measuring initial rates 
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over a range of fixed aw.  Prior to initiating the reaction, the substrates and enzyme were pre-
equilibrated with the salt hydrates in the ionic liquid for 1 hr. 
The initial rate activity of the lipase increased non-linearly with decreasing aw in 
[bmim][PF6] and hexane (Figure 12).  In both solvents, the enzyme is inactive at high aw (aw = 
1).  Chamouleau et al.115 reported a similar trend in initial rate activity as a function of aw for the 
esterification of fructose in 2-methyl-2-butanol catalyzed by immobilized Candida antarctica 
lipase type B.  At high aw, the hydrolytic reaction was preferred over ester synthesis.  
Furthermore, it is suggested that the decrease in initial rate at high aw may be a result of limited 
transport of the hydrophobic substrates from the solvent through the water layer surrounding the 
enzyme.  
In “dry” conditions, in which case molecular sieves were substituted for salt hydrate, the 
initial rate in hexane (523 mM/hr/g-enzyme) was considerably larger than that in [bmim][PF6] 
(41 mM/hr/g-enzyme).  This is most likely due to more efficient drying in hexane than in the 
ionic liquid, which resulted in a substantial difference in the actual aw’s in the two mediums.  
The high viscosity of the ionic liquid prohibited the complete removal of the crushed molecular 
sieves, which is necessary to measure and directly compare the water content in the two solvents. 
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Figure 12.  Initial rates of lipase-catalyzed transesterification of methyl methacrylate and 2-
ethylhexanol in [bmim][PF6] (○) and hexane (●) at fixed aw.  In dry* incubations, crushed 
molecular sieves were employed in place of salt hydrates in order to remove residual water from 
the solvent. 
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4.4 CONCLUSIONS 
The objective of this work was to investigate the impact of ionic liquid physical 
properties on enzyme activity and stability.  Solvatochromic studies and partition coefficient 
determinations suggest ionic liquids are highly polar and hydrophilic in nature in comparison to 
organic solvents such as hexane, acetonitrile and tetrahydrofuran.  In the lipase-catalyzed 
transesterification of methyl methacrylate and 2-ethylhexanol, the initial rate activity of free 
lipase (Candida rugosa) in [bmim][PF6] was greater than that in hexane.  However, no enzyme 
activity was observed when the reaction was carried out in the other ionic liquids.  Conventional 
methods of enzyme stabilization including adsorption, PEG-modification and multipoint 
covalent immobilization in polyurethane foams proved ineffective in improving enzyme activity 
in the all hydrophilic ionic liquids.  Stability studies indicated that reversible inactivation of 
lipase is observed when the enzyme was suspended in [bmim][CH3CO2], [mmep] [CH3CO2] and 
[mmep][CH3SO3], whereas incubation in [bmim][NO3] and [mmep][NO3] irreversibly 
inactivated the enzyme.  To use hydrophilic ionic liquids as solvents for biocatalytic 
transformations, the mechanism of inactivation must be more clearly understood. 
Salt hydrate pairs were also employed to facilitate aw control in the ionic liquid 
[bmim][PF6].  The salt hydrates, with the exception of NaI, had low solubilities in the ionic 
liquid and behave similarly in the ionic liquid as in organic solvents.  Initial rates of the Candida 
antarctica lipase-catalyzed transesterification of methyl methacrylate and 2-ethylhexanol over a 
range of aw’s showed comparable profiles in [bmim][PF6] and hexane containing salt hydrate 
pairs, indicating the salts do not associate with the ionic liquid in such a way that might alter 
enzyme activity.  These findings will enable direct comparison of enzyme activity and specificity 
within ionic liquids as well as between ionic liquids and various organic solvents. 
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5.0  BIOCATALYTIC pH CONTROL IN ENZYMATIC REACTIONS 
5.1 INTRODUCTION 
Biocatalysis represents a highly efficient method for neutralizing the threat of 
organophosphorous (OP) nerve agents and pesticides.  Enzymes are capable of catalyzing the 
hydrolysis of a broad range of OP substrates at striking rates, which approach the diffusion-
controlled limit in certain reactions.116-119  Moreover, the activities of OP hydrolyzing enzymes 
are not dependent on cofactors and are stable in mild reaction conditions including near neutral 
pH and ambient temperatures.120  Accordingly, biocatalytic decontamination can minimize the 
environmental impact of existing decontamination methods, including incineration and the use of 
materials that are corrosive, toxic, and persistent pollutants in the environment.42, 120-122 
Despite the potential utility of enzymes in our defensive arsenal, there remains many 
barriers that limit their use.  One of the major challenges in using OP hydrolyzing enzymes is 
controlling the environmental conditions of the enzyme, namely the reaction pH.  The hydrolysis 
of OP substrates yields as many as two moles of acid per mole of substrate degraded.  Thus, the 
reaction pH must be effectively buffered to prevent inactivation of the OP hydrolyzing enzyme 
prior to complete conversion of the agent.  This challenge becomes exceedingly difficult in 
large-scale decontamination and is further amplified in low-water environments, such as foams 
and emulsions, where the concentration of agent can reach 0.5 M based on the chemical agent 
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challenge issued by the U.S. National Research Council Division of Military Science and 
Technology (10 g nerve agent per m2).123  At this agent concentration, the level of conventional 
buffer required to reach complete hydrolysis would be greater than 28 % (w/v), which exceeds 
the solubility of many buffer salts (the solubility of HEPES is 26 % (w/v)).  Furthermore, at this 
concentration of buffer, the ionic strength of the reaction solution will be significantly altered, 
which can inhbit the OP hydrolyzing enzyme.  Consequently, the buffering requirement of 
biocatalytic decontamination is such that more efficient means of controlling pH must be 
developed before the full promise of enzymes can be realized.   
An alternative approach to pH control in hydrolysis reactions is to balance the production 
of acid with the biocatalytic generation of base, or vice versa.  In this way, a dynamic pH 
equilibrium is created between the opposing reactions, essentially mimicking how cells 
manipulate their intracelluar pH (Figure 13).  This approach can be conceptually described by 
considering an unbuffered aqueous solution containing an OP degrading enzyme and its 
substrate.  The generation of acid as a result of enzymatic hydrolysis will cause a rapid drop in 
the solution pH, which ultimately will reach a point at which the enzyme is no longer active.  By 
supplementing the reaction solution with a second hydrolytic enzyme and its substrate that is 
converted to a base, the acid may be neutralized.  The solution pH will in theory settle at the 
point (pH set-point) at which the rates of acid and base formation are equivalent.  Because the 
generation of base is catalytic, and the base-producing enzyme presumably has a pH-optimum 
lower than that of the acid-producing enzyme, base would be produced only in response to a 
decrease in pH.  One would predict that the pH set-point would remain unchanged as long as the 
concentration of each substrate remained above the KM of its respective enzymes.  Furthermore, 
the pH set-point should be controllable by altering the ratio of activities of the two enzymes. 
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Gestrelius et al.124 previously reported the pH optima for the coupled enzyme reaction 
involving amyloglucosidase and glucose oxidase is within the range bound by the optimal pH of 
each enzyme.  It was demonstrated that the pH optima is a function of the ratio of the enzyme 
concentrations.  However, the enzymes in this case were not catalyzing opposing acid-base 
reactions and the authors make no mention of biocatalytic buffering. 
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Figure 13.  The pH dependence curves of two enzyme-catalyzed reactions depicting the concept 
of biocatlaytic pH control.  The base-producing enzyme (black line) has a lower optimal pH than 
the acid-producing enzyme (gray line).  When both enzymes are present, the pH should stabilize 
at the intersection point, which is termed the pH set-point. 
 
Urea hydrolysis catalyzed by the enzyme urease is an ideal biocatalytic pH buffering 
agent.  Hydrolysis yields two ammonia molecules and a single carbonic acid.125-128  At neutral 
pH, dissociation of the carbonic acid and protonation of the ammonia cause the reaction pH to 
increase.  Urea is highly soluble (up to 16.65 M) and environmentally safe.  The molecular mass 
of urea is also considerably less than that of conventional buffer salts.  Therefore, substantially 
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less urea is required to neutralize a given amount of acid, which equates to a higher buffering 
capacity per unit mass.  This is of particular importance in considering the logistics associated 
with transporting decontaminant materials.  
In this chapter, we investigated the feasibility of controlling pH during the hydrolysis of 
the model OP compound paraoxon, catalyzed by the enzyme organophosphorous hydrolase 
(OPH), with only the biocatalytic conversion of urea (Figure 14).  The products of paraoxon 
conversion are p-nitrophenol and diethylphosphoric acid, which are partially and fully 
dissociated respectively at neutral pH.  Initially, the impact on pH resulting from the addition of 
urease and urea to a solution containing OPH and paraoxon was determined.  The predictability 
of the system was then ascertained by modeling the pH and conversion of paraoxon as a function 
of enzyme activities and substrate concentrations using Michaelis-Menten rate equations.  The 
theoretical results were validated against experimental data.  After exploring the fundamental 
theory of biocatalytic buffer, the key question of to what extent product inhibition impacts 
biocatalytic pH control was addressed.  Fluoride, which is a common product in the hydrolysis of 
many nerve agents, is a strong inhibitor of ureases.  The extent to which fluoride impacts the pH 
equilibrium in the OPH-urease combined enzyme system was determined.  Moreover, the use of 
cationic fluoride scavengers and alternative base-producing biocatalytic reactions, including the 
adenosine deaminase (ADA)-catalyzed hydrolysis of adenosine, were investigated as potential 
strategies for improving the resistance of such systems to fluoride. 
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Figure 14.  (A) OPH-catalyzed hydrolysis of paraoxon and (B) urease-catalyzed hydrolysis of 
urea at neutral pH. 
 
5.2 THEORETICAL MODELING OF DYNAMIC pH EQUILIBRIUM IN OPH-
UREASE COMBINED ENZYME SYSTEM 
The pH in the OPH-urease system was described as a function of reaction time by a 
proton concentration balance (Equation 8), where VH+ and VOH- represent the rate of formation 
of acid and base respectively.  Using the correlation between proton concentration and pH, the 
rate of change in proton concentration can be expressed in terms of pH (Equation 9).  
−+ −=
+
OHH
VV
dt
]d[H         (Eq. 8) 
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 The rates at which protons and hydroxide ions are formed in the combined enzyme 
system are described by the rates of paraoxon and urea hydrolysis and the dissociation constants 
of the hydrolysis products.  The pH-dependence on the dissociation of p-nitrophenol (pKa, 
PNP129) and diethylphosphoric acid (pKa, DPA130) formed during paraoxon hydrolysis was 
related by the proportionality factor PH+ (Equation 10).  Similarly, the proportionality factor 
POH- relates the overall release of hydroxide ions from the conversion of urea to the dissociation 
of ammonia and carbonic acid, which is in equilibrium with bicarbonate and carbonate, as a 
function of pH (Equation 11).  
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 Substitution of OPH (VOPH) and urease (Vurease) activity and PH+ and POH- into the 
proton balance yields (Equation 12): 
( ureaseOHOPHHpH VPVP)ln(10))(10( 1dtdpH −+ −−= − )     (Eq. 12) 
[paraoxon]K
oxon][OPH][parak
dt
]d[paraoxonV
M
cat
OPH +=
−=     (Eq. 13) 
where the kinetics of OPH activity were computed using the Michaelis-Menten rate equation 
(Equation 13).  Because the concentration of urea is such that urease is substrate-saturated 
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([urea] >>> KM) for the full duration of the reaction, urease activity is assumed to be maximum 
(Vmax) at all times.  The pH and extent of paraoxon conversion at any given time in the reaction 
system can be simulated by simultaneously solving the final proton balance (Equation 12) and 
OPH rate equation (Equation 13). 
5.3 MATERIALS AND METHODS 
5.3.1 Materials 
Urease from Canavalia ensiformis (jack bean) was purchased from Sigma (St. Louis, 
MO).  Jack bean urease S, Lyo. SQ, a liquid stable industrial enzyme, was obtained as a gift from 
Roche Diagnostics GmbH (Basel, Switzerland).  The Klebsiella aerogenes urease 9-1 mutant 
was expressed in Escherichia coli and purified by Drs. Ilona J. Fry and Joseph J. DeFrank at the 
US Army Edgewood Chemical Biological Center (Aberdeen Proving Ground, MD).  OPH from 
Pseudomonas diminuta was kindly supplied by Dr. James R. Wild from the Department of 
Biochemistry and Biophysics at Texas A&M University.  ADA from calf intestinal mucosa was 
purchased from Roche Diagnostics (Indianapolis, IN).  All enzymes were used as received 
without further purification.  The Helicobacter pylori urease gene cluster carried by the plasmid 
pHP8080 in Escherichia coli was generously provided by Dr. Harry L.T. Mobley from the 
University of Maryland School of Medicine.  Fluoride standard solution (0.1 M) was purchased 
from Thermo Orion (Beverly, MA).  Paraoxon employed in OPH activity assays and 
detoxification experiments was synthesized following the procedure described by Steurbaut et al. 
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(1975).  All other reagents were purchased from Sigma or Aldrich (St. Louis, MO) and were of 
the highest purity available. 
5.3.2 Methods 
5.3.2.1 OPH Activity Assay 
The initial rate of OPH-catalyzed hydrolysis of paraoxon was assayed 
spectrophotometrically using a Perkin-Elmer (Wellesley, MA) Lambda 2 UV/VIS 
spectrophotometer by continuously monitoring the release of p-nitrophenol over a range of pH’s 
(6.5, 7.0, 7.5, 8.0 and 8.5) at 412 nm at room temperature.  Briefly, enzyme was added to a 
solution of paraoxon (0.0 – 2.5 mM) in pH-adjusted buffer (50 mM Bis-Tris propane, 0.15 mM 
cobalt chloride).  The extinction coefficient of p-nitrophenol at each pH was measured.  
Michaelis-Menten kinetic parameters (kcat and KM) were determined by non-linear regression 
while assuming a molecular weight of OPH of 39 kDa (Dumas et al., 1989).  One unit of OPH 
was defined as the amount of enzyme that catalyzed the hydrolysis of 1 μmol of substrate per 
min at pH 8.0 when assayed with 0.8 mM paraoxon.     
5.3.2.2 Urease Activity Assay 
A pH-stat assay was employed to measure urease activity in the hydrolysis of urea as a 
function of pH (6.5, 7.0, 7.5, 8.0, 8.2).  The generation of ammonia, a product of urea 
conversion, was titrated with hydrochloric acid (10 mM) using a Radiometer (Lyon, France) 
ABU901 autoburette and PHM290 pH-stat controller.  At a set pH, the amount of acid required 
to neutralize the base formed was recorded and is proportional to enzyme activity.  Reactions 
were initiated by the addition of enzyme to a non-buffered aqueous solution containing sodium 
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chloride (50 mM), cobalt chloride (0.15 mM) and urea (10 mM) and were carried out at room 
temperature.  The pH electrode was pre-equilibrated at room temperature in the solution prior to 
adding the enzyme to obtain a stable baseline.  Addition of titrant and pH were followed 
continuously for at least 15 min within the initial rate period, during which the reaction rate was 
linear.  One unit of urease activity was defined as the amount of enzyme that catalyzed the 
hydrolysis of 1 μmol of substrate per min at pH 6.5 at the specified conditions.        
5.3.2.3 Preparation of Helicobacter Pylori Urease 
An overnight culture (200 mL) of Escherichia coli containing the plasmid pHP8080, 
which encodes the entire H. pylori gene cluster, was grown overnight at 37 °C in Luria broth 
supplemented with nickel chloride (100 μM).  The bacteria were then centrifuged at 5000 rpm 
and 4 °C for 10 min in a Fisher Scientific (Pittsburgh, PA) Marathon 21000R centrifuge.  The 
resulting pellet was washed and re-suspended in 5 mL of buffer (50 mM HEPES, pH 7.4) after 
which the bacteria were lysed via 4 passes through an AMINCO (Urbana, IL) French pressure 
cell equipped with a Carver (Wabash, IN) model C laboratory press.  The cell lysate was 
centrifuged at 15,000 g for 30 mins at 4 °C and the resulting supernatant was stored frozen (-20 
°C).  In attempt to remove intracellular proteins or ions that may bind fluoride, the enzyme 
preparation was dialyzed against buffer (50 mM HEPES, pH 7.4) at 4 °C using a 5,000 MWCO 
membrane.        
5.3.2.4 Fluoride Inactivation of Ureases 
To determine the effect of fluoride on urease activity, progress curves of urea conversion 
were generated using the pH-stat titration assay.  Enzyme was added to the unbuffered salt 
solution containing substrate (10 mM) and sodium fluoride (0 – 5 mM) to initiate the hydrolysis 
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reaction, which was titrated at pH 6.5 and room temperature.  The reaction was monitored 
continuously until the rate of ammonia formation was linear, indicating a steady-state rate had 
been reached. 
5.3.2.5 Use of Cationic Scavengers to Prevent Fluoride Inactivation of Urease 
Progress curve analysis was employed to measure urease activity in the presence of 
sodium fluoride (0.2 mM) and either calcium chloride (0 – 750 mM), nickel chloride (0 – 1 mM), 
or lanthanum nitrate (0 – 0.15 mM) at pH 6.5 and room temperature.  The cationic fluoride 
scavenger was added to the standard assay solution containing substrate (10 mM) and sodium 
fluoride immediately prior to initiation of the reaction with enzyme.  In this method, the enzyme 
was not pre-incubated with fluoride or the scavenger.   
5.3.2.6 ADA Activity Assay 
The activity of ADA was assayed as a function of pH (6.0, 6.5, 7.0, 7.5, 8.0, 8.5) using a 
pH-stat titration method.  To initiate the enzyme reaction, enzyme was added to a solution of 
sodium chloride (50 mM) and cobalt chloride (0.15 mM) containing adenosine (0.8 mM).  The 
conversion of adenosine was monitored continuously for at lease 15 mins by recording the 
addition of titrant (10 mM hydrochloric acid) required to maintain the reaction pH at a set point.  
The rate at which titrant is added to the reaction is proportional to enzyme activity.  All reactions 
were carried out at room temperature.  The pH-electrode was pre-equilibrated in the solution pH 
prior to initiating the reaction in order to obtain a stable reading.  One unit of ADA activity was 
defined as the amount of enzyme that catalyzed the hydrolysis of 1 μmol of substrate per min at 
pH 7.5 at the specified conditions. 
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The effect of fluoride on ADA activity was determined by adding sodium fluoride (0 – 
200 mM final concentration) to the reaction solution.  The order of addition of sodium fluoride 
and enzyme in the assay was such that the enzyme was not pre-incubated with fluoride.  
5.3.2.7 Measurement of Nerve Agent Conversion and pH in Dynamic pH Controlled 
Reactions 
Reactions in which urease-catalyzed hydrolysis of urea was employed to buffer the 
degradation of paraoxon by OPH were initiated by the addition of urease and OPH to a solution 
(40 mL) containing sodium chloride (50 mM), cobalt chloride (0.15 mM) and substrate (1 mM 
paraoxon, 10 mM urea).  The reaction vessel was purged with nitrogen and subsequently sealed 
with rubber stoppers to prevent the absorption or evaporation of carbon dioxide to or from the 
reaction, which would alter the reaction pH.  Paraoxon conversion was monitored by periodically 
assaying the amount of p-nitrophenol formed spectrophotometrically at 412 nm while the 
reaction pH was followed continuously using a pH electrode, which was pre-equilibrated in the 
salt solution with substrates for 30 min prior to the addition of enzyme.  A range of urease-to-
OPH ratios (0.3 – 31 urease units/OPH units) were employed in the detoxification reactions.    
The simultaneous biocatalytic hydrolysis of DFP (0.5 mM initial concentration) and urea 
(10 mM initial concentration) was carried out in a similar reaction setup.  DFP conversion was 
monitored by assaying residual butyrylcholinesterase (BChE) inhibition using the method 
described by Ellman et al. (1961).  Complete conversion of DFP would result in 0 % relative 
BChE inhibition.  To measure residual BChE inhibition, samples from the reaction solution were 
removed periodically and diluted 33-fold in ice cold deionized water.  The diluted samples were 
subsequently diluted an additional 33-fold in buffer (1 mL; 50 mM sodium phosphate, pH 7.5) 
containing equine serum BChE (0.19 U/mL) and DTNB (5,5’-dithiobis(2-nitrobenzoic acid); 0.1 
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mM).  The solution was incubated at room temperature for 3 mins after which the 
acetylthiocholine (0.5 mM) was added.  BChE activity was subsequently followed 
spectrophotometrically at 412 nm for 30 sec. 
A similar setup was also used for the carrying out reactions involving the simultaneous 
biocatalytic hydrolysis of adenosine and DFP.  ADA (0.2 units/mL) and OPH (0.4 units/mL) 
were added to the reaction solution, which contained adenosine (25 mM) and DFP (5 mM).  DFP 
conversion was monitored in the reaction by measuring the release of fluoride, a product of DFP 
hydrolysis, using a Hach (Loveland, CO) fluoride-ion sensitive electrode.  Briefly, samples were 
periodically withdrawn from the reaction and diluted 40-fold in buffer (50 mM Bis-Tris propane, 
pH 8).  The concentration of fluoride in the diluted samples was subsequently measured by using 
the electrode. 
5.4 RESULTS AND DISCUSSION 
5.4.1 Characterization of pH Buffering in OPH-Urease System and Experimental 
Validation of Predictive Model 
Initially, the pH-dependence on urease (jack bean) activity (Figure 15A) and the kinetic 
parameters kcat and KM for the OPH-catalyzed hydrolysis of paraoxon were measured (Figure 
15B).  Because the optimum pH of urease activity was lower than that of OPH, the enzymes fit 
the general model depicted in Figure 13.  This data was employed in developing the predictive 
model for describing the system pH and extent of paraoxon conversion. 
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The impact of the addition of urease and urea on pH in the hydrolysis of paraoxon was 
subsequently determined.  With a ratio of urease-to-OPH activities of 31, the solution pH 
equilibrated to 8.1 within minutes (Figure 16A).  The simulated pH and paraoxon conversion 
profiles generated by the model closely matched the experimentally measured values over the 
entire time course of the reaction.  Given that the conversion of paraoxon and pH are intimately 
related in the model theory, significant differences between the simulated and experimental pH 
would cause the predicted conversion to deviate from its actual course.  Since this was clearly 
not the case, a strong argument can be made for the high accuracy of the model.  Control 
experiments showed that the solution pH rapidly decreases in the absence of the urease, resulting 
in the inactivation of OPH.   
 
0
5
10
15
20
6 6.5 7 7.5 8 8.5 9
pH
V
i (
μM
/m
in
)
0
500
1000
1500
2000
2500
6 6.5 7 7.5 8 8.5 9
pH
kc
at
 (s
-1
)
0
0.02
0.04
0.06
0.08
0.1
K
M
 (m
M
)
(A) (B)
V
i (
μM
/m
in
)
k c
at
 (s
-1
)
K
M
 (m
M
)
V
i (
μM
/m
in
)
k c
at
 (s
-1
)
K
M
 (m
M
)
 
Figure 15.  pH-Dependence of (A) urease (jack bean) activity and (B) the kinetic parameters kcat 
(?) and KM (?) for paraoxon hydrolysis by OPH.  Error bars are representative of standard 
deviations from the mean.   
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The complete degradation of paraoxon was achieved by increasing the concentrations of 
each enzyme 6-fold (Figure 16B).  As one would expect, since the ratio of urease-to-OPH 
activities was not changed, the pH equilibrium point was the same.  A gradual increase in the 
solution pH to 8.4 was observed as the conversion of paraoxon exceeded 60 %.  The apparent pH 
shift is a response to the decrease in the rate of acid formation, which can be attributed to the 
consumption of substrate.  As the conversion of paraoxon approaches 100 %, OPH activity 
becomes substrate concentration dependent, causing the rate at which OPH catalyzes the 
hydrolysis of paraoxon to decelerate.  Urease activity becomes negligible at this pH and thus 
there was no further increase in the solution pH.  Product inhibition, which was not accounted for 
in the predictive model, may also affect OPH activity beyond the initial rate period.  
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Figure 16.  Dynamic pH buffer created by the simultaneous biocatalytic hydrolysis of paraoxon 
and urea.  The solid line and closed circles represent the measured pH and paraoxon conversion 
profile respectively in the presence of urease (jack bean) and urea.  The dotted and dash-dotted 
lines correspond to the model predicted pH and paraoxon conversion profile also in the presence 
of urease and urea.  The dashed line and closed diamonds refer to the measured pH and paraoxon 
conversion profile in the absence of urease.  The pH set-point remained constant as long as the 
ratio of activities of the enzymes was unchanged (A) [urease] = 0.081 units/mL and [OPH] = 
0.0026 units/mL ([urease]/[OPH] = 31) (B) [urease] = 0.49 units/mL and [OPH] = 0.016 
units/mL ([urease]/[OPH] = 31). 
 
 Further model validation was performed by comparing experimental and simulated 
results with different urease-to-OPH activity ratios.  At a ratio of 0.54, the solution pH should 
equilibrate to a lower set-point than in the previously described experiments due to the greater 
relative activity of OPH.  As anticipated, a pH equilibrium was established at 7.2 (Figure 17).  
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The model accurately predicted the change in the pH set-point of the reaction solution and the 
new paraoxon conversion profile.  Additional experiments confirmed the predictability of the pH 
set-point and paraoxon conversion in the combined enzyme system at even lower urease-to-OPH 
activity ratios (Figure 18).  In the present system, the range of achievable pH’s is limited only by 
the difference in pH optima of the two enzymes (Figure 19).  In all experiments, initiation of the 
enzyme reactions over on pH unit away from the set-point did not affect the equilibrium pH of 
the solution.     
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Figure 17.  pH Buffering of paraoxon hydrolysis by OPH employing a ratio of jack bean urease-
to-OPH activities of 0.54.  The actual activities of urease and OPH were 0.0025 U/mL and 
0.0047 U/mL respectively, resulting in a pH set-point of 7.20.  The solid line and closed circles 
represent the measured pH and paraoxon conversion profile respectively in the presence of 
urease and urea.   
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Figure 18.  pH Buffering of paraoxon hydrolysis by OPH employing a ratio of jack bean urease-
to-OPH activities of 0.30.  The actual activities of urease and OPH were 0.0014 U/mL and 
0.0048 U/mL respectively, resulting in a pH set-point of 6.71.  The solid line and closed circles 
represent the measured pH and paraoxon conversion profile respectively in the presence of 
urease and urea. 
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Figure 19.  The impact of the ratio of jack bean urease-to-OPH activities on the pH set-point in 
the combined enzyme system.   
 
5.4.2 Effect of Fluoride on Urease Activity 
Inhibition of one or more of the enzyme reactions that constitute a biocatalytic buffer will 
alter the pH equilibrium created by the opposing reactions.  The effects of inhibition in 
biocatalytic buffering were explored within the context of the OPH-urease system by considering 
the hydrolysis of diisopropylfluorophosphate (DFP), which is a surrogate for the G-type nerve 
agents sarin and soman (Figure 20).  OPH as well as the other OP hydrolyzing enzymes 
diisopropylfluorophosphatase and organophosphorous acid anhydrolase catalyze the hydrolysis 
of the P-F bond in DFP.131  The hydrolysis reaction results in the release of fluoride, which has 
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been shown to strongly inhibit most ureases.132-135  Consequently, the key question thus becomes 
to what extent does the buildup of fluoride cause the pH equilibrium of the OPH-urease system 
to shift. 
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Figure 20.  Chemical structures of organophosphate compounds that are degraded by hydrolysis 
of a P-F bond.  
 
The mechanism of fluoride inhibition of ureases was elucidated by Todd and 
Hausinger.133  A detailed kinetic analysis showed that fluoride inhibition of ureases follows an 
apparent uncompeptitive, slow-binding mechanism (Figure 21).  Central to the mechanism of 
inhibition is a water molecule that bridges the two nickels in the enzyme’s active site.  This 
critical water molecule functions as a nucelophile in catalysis, attacking the carbonyl carbon of 
urea.  Upon binding of urea, the water molecule is released, thereby enabling fluoride to bind 
reversibly to the active site nickels.  Although the water molecule may release spontaneously 
with the enzyme in a resting state, the equilibrium between the native and structurally modified 
forms of the enzyme strongly favors the native state.  The enzyme-inhibitor complex may further 
bind substrate, thus forming a ternary complex that is characteristic of classical uncompetitive 
inhibition.  This ternary complex differs, however, from that in classical uncompetitive inhibition 
by the sequence in which it is formed.  Specifically, in classical uncompetitive inhibition, the 
enzyme must initially bind substrate before binding the inhibitor.     
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The degree to which urease is inhibited by fluoride is greatly affected by the 
concentration of urea and pH.132, 133  Because urea stabilizes the two forms of the enzyme-
substrate complex (i.e. E-S and E*-S), fluoride binding is inhibited by increasing urea 
concentration.  Additionally, by stabilizing the enzyme-inhibitor-substrate complex, urea also 
traps the enzyme in an inactive state.  Changes in pH alter the rate of dissociation of fluoride 
from the enzyme, which increases linearly over the pH range 6.5 to 8.5.  The observed sensitivity 
of fluoride dissociation to pH is presumably due to the ionization of an amino acid side chain 
group that is involved in fluoride binding.  Further complicating the kinetics of inhibition, the 
dependence of the dissociation of fluoride on pH increases significantly in the presence of urea.  
This suggests that urea binding may alter the pKa of group or groups that are interact with 
fluoride.  
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Figure 21.  Mechanism of fluoride inhibition of urease.  E and E* represent enzyme and a form 
of the enzyme that is missing a critical active site water molecule.  Only E* can bind fluoride. 
 
 The impact of fluoride on jack bean urease, a commercially available enzyme that was 
used in the initial demonstration of biocatalytic buffering, was determined by monitoring the 
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production of ammonia in the presence of various amounts of the inhibitor.  The rate of ammonia 
production was constant in the absence of fluoride (Figure 22A).  Addition of fluoride to the 
enzyme assay did not affect the initial burst (vo) of urease activity.  However, in the presence of 
fluoride, the rate at which ammonia was liberated steadily decreased as the reaction progressed 
until attaining a final steady-state rate (vf).  Despite fluoride concentration having no effect on vo, 
vf and the rate at which vo reached vf were significantly impacted by the fluoride level in the 
reaction.  An increase in fluoride concentration resulted in a decrease in vf, which is 
characteristic of uncompetitive inhibition, and a marked increase in the rate at which vo reached 
vf.  This data fits the apparent uncompetetive, slow-binding inhibition of K. aerogenes urease by 
fluoride observed by Todd and Hausinger.133  The propensity of fluoride inhibition implies that 
in a combined reaction system, the hydrolysis of just micromolar levels of an 
organofluorphosphate substrate would inactive urease and in turn disable the buffer. 
 86 
Time (min)
0 5 10 15 20 25 30 35
[N
H
4+
] (
m
M
)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0mM
0.2mM
0.4mM
0.6mM
1mM
2mM
5mM
Time (min)
0 5 10 15 20 25 30 35
[N
H
4+
] (
m
M
)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0mM
0.2mM
0.4mM
0.6mM 1mM
2mM
Time (min)
0 5 10 15 20 25 30 35
[N
H
4+
] (
m
M
)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0mM
0.1mM
0.4mM
1mM
Time (min)
0 5 10 15 20 25 30 35
[N
H
4+
] (
m
M
)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0mM 0.1mM
0.2mM
0.4mM
0.6mM
(A) (B)
(C) (D)
[N
H
4+
] (
m
M
)
[N
H
4+
] (
m
M
)
[N
H
4+
] (
m
M
)
[N
H
4+
] (
m
M
)
 
Figure 22.  Fluoride inhibition of (A) jack bean urease, (B) H. pylori urease, (C) Roche liquid 
stable, industrial jack bean urease, and (D) K. aerogenes 9-1 mutant urease.  The activity of the 
ureases in the presence of various concentrations of fluoride (denoted by the numbers in 
millimolar) was monitored by progress curves. 
 
 Several other ureases were subsequently screened for fluoride-resistant activity, which 
could be used in place of or as a supplement to jack bean urease to sustain the pH buffering 
effect in such reaction systems.  The urease from H. pylori, a pathogenic bacterium that resides 
in the gastric mucosa in humans136-140, was also inhibited by fluoride, although to a somewhat 
lesser degree (Figure 22B).  In the presence of 0.6 mM fluoride, the bacterial urease liberated 
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approximately 5-fold more ammonia than jack bean urease after 15 mins.  The reduced 
sensitivity of the H. pylori urease to fluoride is likely related to the acid-resistance of the 
enzyme, which stems from its unique supramolecular structure.  The α and β subunits of the 
enzyme are tightly associated in such a way that shields the enzyme’s active sites from the acidic 
environment.138, 139  Nonetheless, with just 2 mM fluoride, H. pylori urease lost greater than 98 
% of its initial activity in only 20 mins.  A liquid stable urease, also from jack bean that is 
employed in industrial processes, and a mutant urease from K. aerogenes, which was engineered 
to have increased fluoride resistance by directed evolution, were even more strongly inhibited by 
fluoride than the jack bean and H. pylori enzymes (Figure 22C and D).  The conserved 
sensitivity to fluoride may be attributed to the high degree of active site sequence homology 
among ureases.141  Interestingly, inhibition of the liquid stable urease did not appear consistent 
with the slow-binding model.  The progress curves show that the kinetics of the fluoride binding 
was significantly more rapid than in the case of the other ureases, with much of the loss of 
activity occurring in the initial 1 – 3 mins of the assay.  The observed differences in the kinetics 
of inhibition may be attributed to the active site water molecule having an increased solvent 
accessibility. 
5.4.3 Solution to the Fluoride Problem 
To solve the fluoride problem presented by the hydrolysis of DFP, three different 
strategic approaches were explored.  The first approach that was explored involved increasing 
the total activity of urease in the reaction system.  The second strategy that was investigated 
entailed the use of cationic fluoride scavengers, which, in theory, would sequester the ions as 
they are generated.  Lastly, alternative base-producing biocatalytic reactions that are resistant to 
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fluoride inactivation were considered for use as a supplment to or possible replacement for 
urease-catalyzed urea hydrolysis. 
5.4.3.1 Impact of Urease Activity on Fluoride Inactivation of OPH-Urease Buffer  
As expected, fluoride generated during the simultaneous biocatalytic hydrolysis of DFP 
and urea had a profound impact on buffering capacity of the OPH-urease system.  In a reaction 
where the amounts of urease (K. aerogenes urease 9-1 mutant) and OPH present were 0.15 
units/mL and 0.1 μg/mL respectively, the pH equilibrium was not stable over the time course of 
the reaction (Figure 23A).  The solution pH dropped gradually, despite the total conversion of 
DFP being only 9 % at the end of the reaction.  This result is consistent with the anticipated 
effect caused by the progressive inactivation of urease by fluoride.  DFP conversion was 
determined by measuring the activity of the enzyme BChE upon its inhibition with residual DFP 
in the reaction solution.  The inactivation of BChE and other cholinesterases, which regulate the 
transmission of nerve impulses, is the basis for the toxicity of OP substrates.116, 120 
The observed effects of fluoride could be mitigated by increasing the activity of urease at 
the onset of the reaction.  When the amount of urease activity was increased 3.33-fold, the 
solution pH was maintained at 7.25 for several minutes before rising (Figure 23B).  The 
observed increase in pH is to be expected when the rate of DFP hydrolysis becomes substrate 
concentration dependent.  Most importantly, DFP was degraded to completion (i.e. 0 % relative 
BChE inhibition) in the later reaction within the same time scale. 
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Figure 23.  Simultaneous biocatalytic hydrolysis of DFP (0.5 mM) and urea by OPH and urease 
(K. aerogenes urease 9-1 mutant).  The actual activities of urease and OPH were (A) [urease] = 
0.15 units/mL and [OPH] = 0.1 μg/mL and (B) [urease] = 0.5 units/mL and [OPH] = 0.1 μg/mL.  
The solid line and closed circles represent the measured pH and conversion of DFP as a function 
of relative butyrlcholinesterase inhibition respectively. 
 
By increasing the activity of urease, the added enzyme molecules presumably impact the 
reaction pH and subsequently the conversion of DFP by sequestering fluoride.  In this way, the 
enzyme molecules likely protect the fraction of urease whose activity is critical to the buffering 
of the reaction solution.  The stoichiometry of fluoride binding to ureases varies depending on 
the structure of the urease that is used.  In the case of K. aerogenes urease, which has an (αβγ)3 
quaternary structure containing two nickels per subunit, each molecule of enzyme can bind three 
fluoride ions.126  Jack bean urease, which has an (α)6 quaternary structure also with two nickels 
per subunit, can sequester six fluoride ions per enzyme molecule.142, 143  Although this method 
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was proved to be effective in overcoming the effects of fluoride, it may be impractical in cases 
where large amounts of decontamination materials are needed.   
5.4.3.2 Cationic Fluoride Scavengers 
Rather than sequestering the fluoride produced by DFP hydrolysis with excess urease, 
cationic fluoride scavengers may be added to reduce the concentration of fluoride to non-
inhibitory levels.  Cationic fluoride scavangers including calcium, magnesium, and lanthanum 
are routinely employed for removing fluoride from wastewater as well as for the treatment of 
acute fluoride poisoning.144-149  Such scavangers are able to bind to fluoride resulting in the 
formation of an insoluble salt, although the extent of precipitation of the salt is dependent upon 
its solubility product constant (Ksp).  The Ksp for several fluoride salts including calcium fluoride, 
magnesium fluoride, and lanthanum fluoride at ambient temperatures are 5.3 x 10-9, 5.16 x 10-11, 
and 7.0 x 10-17 respectively.150  The use of cationic scavengers to protect urease from ion-
induced inactivation is a novel concept. 
The capacity of calcium, lanthanum, and nickel was determined by assaying urease 
activity in the presence of fluoride and the respective scavenger.  Calcium and nickel are both 
divalent cations and thus can complex two fluoride ions per molecule of cation whereas 
lanthanum, which is trivalent, can bind three fluoride ions per cation molecule.  To mimic the 
case in which the cation scavengers and urease would compete for fluoride as it is released by 
the hydrolysis of DFP, the cations in the form of inorganic salts were added to the fluoride-
containing substrate solution immediately prior to the addition of enzyme.  Progress curve 
analysis of urea hydrolysis indicates that fluoride inactivation of urease can be partially 
prevented by calcium when added in a large stoichiometric excess (Figure 24A).  In the presence 
of calcium, the apparent rate of fluoride binding to the enzyme was markedly reduced, as is 
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evident by the increase in linearlity of the progress curves.  Although progress curves in the 
presence with lanthanum were nearly linear over the time course of the assay, urease was 
considerably inhibited by the cationic scavenger (Figure 24B).  The rate of conversion of urea 
decreased with increasing concentrations of lanthanum nitrate.  To confirm that lanthanum and 
not the nitrate anion was inhibiting urease, control experiments were carried out with lanthanum 
chloride.  Results of the control experiments showed that urease was also strongly inhibited 
lanthanum chloride.  Similarly, the addition of nickel, which did not have any protective effect 
on the inactivation of urease by fluoride,  significantly inhibited urease activity (Figure 24C). 
Based on results of the urease protection assays, calcium ions appeared to be ideal 
fluoride scavengers for the OPH-urease system.  Moreover, when assayed in the presence of 
calcium at concentrations as high as 0.5 M, the activities of urease and OPH were largely 
unaffected.  The loss of activity at higher calcium concentrations is likely due to the associated 
change in ionic strength of the reaction solution.  In the presence of 0.5 M calcium ions, DFP 
was degraded to completion in the combined OPH-urease system.  Greater than 99.9 % 
conversion of the toxin was achieved in 24 mins.  However, the same effect could be produced 
by using a sufficiently high enough urease concentration.  Still, calcium ions may be of 
considerable utility in scavenging the initial burst of fluoride released such that significantly less 
urease may be needed for full decontamination.  It is also conceivable that calcium ions may be 
effective in protecting urease in sensing applications, where it would be desireable for urease to 
remain active over long periods of time with potential exposure to low levels of fluoride. 
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Figure 24.  Protection of K. aerogenes urease mutant (9-1) from fluoride inactivation by the 
addition of (A) calcium chloride, (B) lanthanum nitrate, and (C) nickel chloride.  Urease activity 
was monitored by progress curves in the presence of various concentrations of the cationic 
fluoride scavengers.  For each assay, the concentrations of fluoride and cationic scavenger are 
inidicated as the top and bottom concentrations respectively. 
 
5.4.3.3 Alternative Base-Producing Biocatalytic Reaction 
The fluoride problem may also be solved through the use of alternative base-producing 
biocatalytic reactions that are insensitive to fluoride.  Such reactions could potentially be used 
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either in place of or in addition to biocatlaytic urea hydrolysis in the OPH-urease combined 
enzyme system.  One reaction that was identified as a possible candidate to mediate the impact 
of fluoride in dynamic pH buffering was the biocatalytic hydrolysis of adenosine.  The zinc-
containing enzyme ADA, which has been isolated from a wide range of organisims including 
bacteria, plants, vertebrates, invertebrates, mammals, and humans, catalyzes the hydrolysis of 
adenosine into inosine and ammonia (Figure 25).151, 152  Although its exact physiological role 
has yet to be elucidated, loss of ADA activity has been implicated in the onset of severe combine 
immunodeficiency disease.  Moreover, ADA activity has reportedly been linked to embryonic 
and fetal development as well as to a number of other pathologies such as, for example, 
tuberculosis, bacterial meningitis, multiple sclerosis, Down’s syndrome, and Parkinson’s 
disease.151  
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Figure 25.  ADA-catalyzed hydrolysis of adenosine. 
 
To determine the utility of ADA in dynamic pH control, the pH-dependence and fluoride 
sensitivity of ADA activity were measured.  The apparent pH-activity profile of ADA was 
strikingly similar to that of urease (Figure 26A).  The initial rate of adenosine hydrolysis, like 
the hydrolysis of urea by urease, was greatest at pH 7.0.  Given this similarity, it is logical to 
expect that, in an unbuffered solution, the simultaneous biocatalytic hydrolysis of adenosine and 
DFP, or paraoxon, by ADA and OPH respectively will form a dynamic pH equilibrium 
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comparable to that observed in the OPH-urease system.  Most significantly, ADA was largely 
uninhibited by fluoride compared to the different forms of ureases used in this study (Figure 
26B).  ADA retained considerable activity even when assayed in the presence of as much as 200 
mM fluoride.  Based on this, the biocatalytic hydrolysis of adenosine can presumably provide the 
necessary buffering means to enzymatically degrade near molar concentrations of 
organofluorophosphates.  
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Figure 26.  (A) pH-Dependence of ADA activity.  (B) The effect of fluoride ions on ADA 
activity. 
 
The fluoride resistant and pH-dependent properties of ADA make the biocatalytic 
hydrolysis of adenosine an attractive buffering agent for organofluorophosphate hydrolysis.  
Model decontamination reactions were subsequently carried out to verify if ADA-catalyzed 
adenosine hydrolysis could control pH over the course of DFP hydrolysis in an unbuffered 
solution.  Using only the biocatalytic hydrolysis of adenosine as a buffering agent, solutions of 
DFP were fully decontaminated (Figure 27).  The solution pH was dynamically controlled by 
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the rates of adenosine and DFP hydrolysis in a manner that closely resembled that in the OPH-
urease combined enzyme system.  A steady increase in the solution pH was observed as the 
conversion of DFP approached 100 %.  Due to the pH-induced inactivation of ADA, the solution 
pH ultimately stopped increasing at 8.7.  Additionally, there were no apparent effects of partial 
ADA inactivation on the pH or DFP conversion profiles over the course of the reaction. 
Dynamic pH control involving the biocatalytic hydrolysis of adenosine, while effective in 
overcoming fluoride inactivation, has several drawbacks.  One significant drawback is that the 
buffering capacity of adenosine on a per weight basis is lower than that of urea.  Specifically, 
whereas between one and two moles of base are produced per mole of urea hydrolyzed at near 
neutral pH, the hydrolysis of a single mole of adenosine produces at most one mole of base.  
Thus, considerably more adenosine may be required to buffer a given amount of acid.  The 
molecular mass of adenosine is also greater than 4-fold that of urea.  This mass difference, 
combined with the need for more buffering agent, can potentially make the tactical transport of 
decontamination materials exceedingly difficult.  Moreover, activity assays suggest that 
adenosine may partially inhibit OPH activity.  Although this inhibition did not significantly 
impact DFP hydrolysis in model reactions in this study, it may introduce constraints in systems 
involving larger quantities of OP agents.  To fully understand how this inhibition impacts the 
buffering capactivity of adenosine, the degree to which OPH is inhibited by adenosine must be 
fully characterized.  
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Figure 27.  Simultaneous biocatalytic hydrolysis of DFP (5mM) and adenosine by OPH and 
ADA.  The actual activities of adenosine deaminase and OPH were 0.2 units/mL and 0.4 
units/mL respectively.  The solid line and closed circles represent the measured pH and DFP 
conversion profile respectively.     
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5.5 CONCLUSIONS 
In conclusion, the concept of biocatalytic pH control was demonstrated in solution by 
combining the biocatalytic hydrolysis of paraoxon and urea.  The solution pH in the combined 
enzyme system, which remained constant over significant ranges of paraoxon conversion, was 
predictable.  Furthermore, by altering the ratio of OPH-to-urease activities, it was possible to 
rationally control the dynamic pH equilibrium formed by the opposing acid and base generating 
reactions.   
The use of DFP in place of paraoxon as the substrate for OPH offered a model reaction 
system for studying the impact of product inhibition on biocatalytic pH control.  Fluoride 
released by the hydrolysis of fluorophosphates group of DFP was found to inactivate ureases 
from jack bean, H. pylori, and K. aerogenes at micromolar concentrations by an apparent 
uncompetitive, slow-binding mechanism.  Fluoride inactivation of urease during the hydrolysis 
of DFP was mediated by increasing urease activity in the reaction system, enabling DFP to be 
degraded to completion.  The use of cationic fluoride scavengers to improve the resistance of 
biocatalytic pH control in the OPH-urease system to fluoride inactivation was only partially 
successful.  Addition of the scavangers prevented the loss of urease activity due to fluoride in 
kinetic assays.  However, no significant enhancement in the rate of DFP hydrolysis was observed 
in biocatalytic pH control experiments containing the scavengers.  The impact of fluoride in 
dynamic enzymatic buffers can also be overcome through the use of alternative enzymes for the 
biocatalytic formation of base.  ADA, which is significantly less sensitive to fluoride relative to 
urease, was used to buffer the pH of the conversion of DFP by catalyzing the simultaneous 
hydrolysis of adenosine.  Such use of different enzymes ultimately highlights the potential 
broader utility of this remarkable new approach to pH control. 
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6.0  REDUCING SCARRING IN LACERATED SKELETAL MUSCLE USING 
MATRIX METALLOPROTEINASE-1 
6.1 INTRODUCTION 
Formation of collagen (i.e. scar tissue), which is the result of the body’s natural wound 
healing process, is a critical barrier in the regeneration of injured skeletal muscle.153-155  Fibrotic 
tissue, which consists of predominately type III collagen in early stages of healing and type I 
collagen in later stages, is produced by fibroblasts that differentiate in response to injury.156, 157  
This phase of healing is referred to as the fibrosis phase and occurs after the initial clearing of 
damaged tissue and the onset of muscle phase.158, 159  The collagen matrix blocks progenitor cells 
from infiltrating the site of injury where they can differentiate into new muscle tissue.  
Incomplete muscle regeneration due to scarring ultimately compromises the structural integrity 
of the tissue, prevents full recovery of function, and increases the likelihood of re-injury, thus 
having long-lasting effects.154, 159, 160 
 Several approaches aimed at improving muscle regeneration and functional recovery 
have been investigated.  The growth factors insulin-like growth factor-1, basic fibroblast growth 
factor, and nerve growth factor improve regeneration when delivered to injured muscle by 
promoting myoblast proliferation and fusion.161  Leukemia inhibitory factor, which induces the 
proliferation and subsequent differentiation of progenitor muscle cells, has also been shown to 
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enhance muscle healing in an animal model of Duchenne muscular dystrophy (a genetic disorder 
that causes myocyte death in conjunction with the progressive formation of fibrotic tissue in 
skeletal muscle).162, 163  Moreover, drugs that inhibit or down-regulate expression of key fibrosis 
activators, such as transforming growth factor-β1, can enhance muscle regeneration.  Suramin, 
decorin, and γ-interferon have been reported to reduce the extent of fibrosis in injured skeletal 
muscle in vivo, thus leading to improved regeneration.164-167  Although these approaches have 
met with clinical success, related treatments are only effective if administered prior to scar 
formation.168   
Because muscle injuries are often left untreated prior to scarring, a therapy that degrades 
scar tissue during or after completion of the normal healing process would be beneficial.  The 
key to developing such a therapy may be an enzyme that targets and digests the fibrous scar 
tissue.  Delivery of the exogenous enzyme to injured tissue could potentially degrade pre-
existing scar, thereby mimicking natural tissue remodeling processes. 
 Tissue remodeling is driven by matrix metalloproteinases, a family of zinc and calcium-
dependent endopeptidases that catalyze the hydrolysis of native and denatured extracellular 
matrix proteins.169-172  The first member of this family, matrix metalloproteinase-1 (MMP-1), 
otherwise known as interstitial collagenase, was discovered in amphibian tissues, where its 
activity factilitates tissue resorption during metamorphosis.173  Later, the same enzyme was 
found to be intimately involved in the remodeling of human tissues.174  MMP-1 is expressed as a 
zymogen (proMMP-1), containing an N-terminal propeptide that must be cleaved for the enzyme 
to be catalytically active.  Naturally, because of its specificity towards type I collagen, a major 
component of mature scar, MMP-1 may be effective in resolving scarring in injured muscle 
tissue. 
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The potential utility of MMP-1 in the treatment of fibrotic conditions was established by 
Iimuro and co-workers175, who employed recombinant adenovirus expressing proMMP-1 to treat 
liver fibrosis in a rat model.  More recently, we showed that direct injection of proMMP-1 into 
fibrotic skeletal muscle in mice resulted in the reduction of collagen content without adversely 
affecting the basal lamina of uninjured muscle.176  However, by using the pro-form of MMP-1, it 
is difficult to determine the amount of enzyme that is activated in the scarred tissue prior to it 
being enzymatically degraded or diffusion of the enzyme from the tissue.  A more efficient 
approach to using MMP-1 may be to deliver the pre-activated enzyme, which would allow for 
direct control over the activity of MMP-1 administered.  Moreover, the required treatment time 
may be reduced using active MMP-1 since the enzyme would begin to work immediately. 
In this study, we have compared the efficacy of three different forms of recombinant 
human MMP-1 in resolving muscle fibrosis in a laceration model in mice including proMMP-1 
and active MMP-1 (rhMMP-1).  The active form of the enzyme (43 kDa) was produced by 
expressing cDNA that encodes for residues 101 – 469 of the full-length enzyme.  Additionally, a 
poly(ethylene glycol)-modified form of the rhMMP-1 (PEG-rhMMP-1), which was prepared by 
reacting the enzyme with an amine-reactive PEG (PEG-SPA; 5000 Mw), was also employed in 
the in vivo model.  The covalent attachment of PEG may improve the enzyme’s in vivo stability 
and thus effectiveness in degrading interfibrillar collagen at the site of laceration. 
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6.2 MATERIALS AND METHODS 
6.2.1 Materials 
Recombinant MMP-1 was produced and purified by Aldevron, LLC (Fargo, ND) using 
cDNA from human fibroblasts from American Type Culture Collection (Manassas, VA).  Latent 
full-length human MMP-1 was purchased from Sigma (St. Louis, MO).  Trypsin employed in 
peptide fingerprinting analysis of native and PEGylated rhMMP-1 was purchased from Promega 
(mass spectrometry grade, Madison, WI).  The enzymes were used without further purification.  
PEG-succinimidyl propionate (PEG-SPA) was purchased from Nektar Therapeutics (San Carlos, 
CA).  Electrophoresis reagents were purchased from Bio-Rad (Hercules, CA) and Pierce 
Biotechnology (Rockford, IL).  The MMP-1 colorimetic substrate Acetyl-Pro-Leu-Gly-[2-
mercapto-4-methyl-pentanoyl]-Leu-Gly-OC2H5 was obtained from Biomol International 
(Plymouth Meeting, PA).  Type I acid soluble, lyophilized collagen from calf skin was purchased 
from Elastin Products (Owensville, MO).  All other reagents were purchased from Sigma (St. 
Louis, MO) and were of the highest purity available.   
6.2.2 Methods 
6.2.2.1 PEGylation of rhMMP-1 
Native rhMMP-1 was diluted to a concentration of 1.5 mg/mL in buffer (50 mM HEPES, 
5 mM calcium chloride, pH 7.5).  PEG-SPA was added in excess to the enzyme solution at a 
PEG-to-protein molar ratio of 1000:1 and the reaction solution was vigorously mixed at room 
temperature for 1 hr.  Residual free PEG was removed using a centrifugal filtration device 
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(Millipore, Billerica, MA) with a nominal molecular weight limit of 10,000 Da.  The protein 
concentration of PEGylated rhMMP-1 was quantified via measuring the absorbance of the 
sample at 280 nm (ε = 66,810 M-1cm-1). 
6.2.2.2 Muscle Laceration Model 
A lacerated muscle model was created in NOD.CB17-Prkdcscid/J mice from Jackson 
Laboratories (Bar Harbor, ME) as described previously by Menetrey and co-workers.177  The 
mice were cared for and used in accordance with protocols approved by the University of 
Pittsburgh Institutional Animal Care and Use Committee (IACUC #25-03).   
Initially, the mice were anesthetized via isofluorane inhalation.  A posterior longitudinal 
incision was made in the skin to expose the right and left gastrocnemius muscle (GM) in the hind 
limbs of the mice.  The GMs were subsequently lacerated bilaterally such that the injury spanned 
50 % of the width and 100 % of the thickness of the muscle.  Following the laceration, the skin at 
the wound site was sutured closed and the mice were allowed to recover while housed in cages 
with unrestricted movement.   
To determine the effectiveness of proMMP-1, rhMMP-1, and PEG-rhMMP-1, an initial 
study was carried out using 30 female mice, which had an average age of 9 weeks at the time of 
laceration.  A suture was inserted in muscle adjacent to the site of laceration in order to mark the 
wound site.  At 33 days post-laceration, 0.4 mU or 0.8 mU of proMMP-1, rhMMP-1, or PEG-
rhMMP-1 was injected (10 μL volume) at the site of injury using the suture as a point of 
reference.  Both injured muscles in each animal received the same treatment.  The amount of 
proMMP-1 required to deliver the specified dose was determined based on the specific activity 
of the enzyme when fully activated by trypsin (Figure 28).  An equal volume of buffer (50 mM 
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HEPES, 5 mM calcium chloride, pH 7.5) was injected in the lacerated GM of control mice.  The 
animals were sacrificed 14 days post-treatment after which tissue from the laceration site was 
collected and subsequently fixed in 10 % neutral buffered formalin. 
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Figure 28.  Specific activity of proMMP-1 upon activation of the full-length enzyme with 
varying mass ratios of trypsin-to-enzyme.  When fully activated, proMMP-1 had a specific 
activity of 0.0047 units/μg-enzyme when assayed with a thioester substrate. 
 
A follow-up study, which was carried out to confirm the in vivo results, involved a total 
of 17 mice, also female, that were, on average, 10 weeks of age.  To more accurately mark the 
site of injury, blue tissue marking dye (Thermo Electron Corporation, Pittsburgh, PA) was 
applied across the wound site in place of the suture marker.  Native or PEGylated rhMMP-1 was 
injected (10 μL volume) at a single dose of 0.8 mU at the site of injury in the right leg of the 
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mice at 23 days post-laceration.  Concomitantly, the left legs of all mice were treated with an 
equal volume of buffer.  Green fluorescent microspheres (0.5 μm; Molecular Probes, Eugene, 
OR) were co-injected at a concentration of 2 x 104 microspheres/μL with the enzyme or buffer to 
confirm delivery of treatment to the scarred muscle.  At 11 days-post injection, the mice were 
sacrificed and rear legs were removed by cutting across the tibia at the proximal metaphysic and 
across the distal joint.  The legs were immediately fixed in toto in 10 % neutral buffered formalin 
upon removal. 
6.2.2.3 Histological Analysis 
Fixed specimens from the initial study were embedded in paraffin blocks from which 5 
μm sections were cut.  The extent of fibrosis in muscle tissue adjacent to the laceration site was 
quantified in brightfield images of picrosirius red-stained sections at low power by measuring the 
distance between regenerating myofibers in selected 400 x 400 pixel areas (5.08 x 105 μm2).  
Images were captured using a 4x objective on a Nikon TE2000 inverted phas-fluorescence 
microscope with a 12 bit 1600 x 1200 pixel CCD detector (Spot; Diagnostic Instruments, 
Sterling Heights, MI, USA) and a color wheel for color imaging.  Digital analysis was performed 
using Adobe Photoshop 7.0 (Adobe Systems, San Jose, CA, USA). 
In the follow-up study, the fixed tissue was cut to the bone, longitudinally across the 
incision site, orthogonally to the bone, using the blue tissue marking dye as a guide, separating 
the medial 1/4 of the tissue from the lateral 3/4.  The medial 1/4 section was embedded in 
paraffin for sectioning, with the cut surface up, to demonstrate the relationship between the 
laceration and skin to the deep tissues and to show the labeling of the healed laceration site.  The 
lateral 3/4 section was cut across the laceration and 2 mm proximal and distal to the incision.  
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These sections were also embedded in paraffin, with the incision sites up, to provide cross-
sections of muscle proximal to the healed laceration for the quantification of muscle fibrosis in 
tissue adjacent to the injured muscle fibers.  Ten-6 μm sections were then cut in paraffin ribbons 
with three unstained sections on one slide and three sections on a second slide stained with 
Masson’s trichrome to label collagen blue and muscle red.   
The healed laceration site was identified using the blue tissue marking dye in unstained 
sections.  Fluorescent images were acquired at an excitation wavelength in the rage of 450 – 490 
nm, a 510 dichroic mirror, and a 520 barrier filter in order to determine the distribution of 
microspheres, and thus enzyme or buffer, at the site of injury.   
Cross-sections of muscle at the laceration site were imaged using a 10x plan 
apochromatic objective on the same inverted phase-fluorescence microscope and camera 
employed in the initial in vivo study.  Selected areas of muscle, approximately 200 μm away 
from the blue tissue marking dye and fluorescent microspheres, were selected from the main 
images using Adobe Photoshop 7.0 for digital analysis of muscle and collagen content. 
Transmitted light photographs, using the color wheel to record in separate channels, blue, 
green and red images, were used for image analysis of the selected areas.  Specifically, blue and 
red filters, with 10 % cutoffs of approximately 390 – 520 nm and 620 – 680 nm and essentially 
no overlap between these channels were used for digital quantification of collagen content.  The 
red image was digitally subtracted from the blue image, using each image expressed as a 
grayscale 8-bit file.  Following this, the collagen signal (dark area) was separated from the 
background (light area) with a threshold levels filter (Fovea Pro 1.0, Reindeer Graphics, 
Asheville, NC, USA), yielding 2-bit images in which collagen appeared black and all other tissue 
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white.  The relative area of collagen is reported as the percent area of the image that was black 
after setting threshold levels.  Threshold levels were set by a blind observer. 
Statistical analysis comparing the amount of muscle fibrosis between treatment groups in 
both the initial and follow-up studies was performed using the Student’s t-test. 
6.2.2.4 MMP-1 Activity Assay Using Thioester Substrate 
The rate of MMP-1 catalyzed hydrolysis of the thioester substrate Acetyl-Pro-Leu-Gly-
[2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OC2H5 was assayed spectrophotometrically using a 
Molecular Devices (Sunnyvale, CA, USA) SpectraMax 340PC384 microplate spectrophotometer 
by continuously monitoring the release of free thiols in the presence of excess 5,5’-dithiobis(2-
nitrobenzoic acid) (DTNB) at 412 nm at 37 °C over 5 mins.  Briefly, native or PEG-modified 
rhMMP-1 (0 – 0.55 μg) was added to buffer (50 mM HEPES, 5 mM calcium chloride, pH 7.5) 
and DTNB (1 mM) in a 96-well polystyrene microplate.  The solution was pre-incubated at 37 
°C for 3 mins after which the reaction was initiated by the addition of substrate (100 μM final 
concentration).  The total reaction volume was 100 μL.  One unit of MMP-1 activity was defined 
as the amount of enzyme required to catalyze substrate hydrolysis at a rate of 1 OD per sec.     
To assay the activity of proMMP-1, the enzyme was first activated proteolytically by 
incubation with trypsin (0 – 200 ng-trypsin/ng-proMMP-1) in assay buffer in a 37 °C water bath.  
After 1 hr, trypsin was fully inactivated by the addition of soybean trypsin inhibitor at a mass 
ratio of inhibitor-to-trypsin of 4:1 or greater and subsequent incubation of the reaction solution at 
room temperature for 10 mins. 
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6.2.2.5 Collagen Degradation Assay 
Type I collagen scaffolds were incubated in buffer (10.3 mL, 50 mM HEPES, 5 mM 
calcium chloride, pH 7.5) containing native or PEG-modified rhMMP-1 (3 mg/mL) in 15-ml 
conical tubes in a constant temperature shaker set at 37 °C and 250 rpm.  The dry weight of the 
collagen-containing tubes was recorded prior to the addition of buffer and enzyme.  The tubes 
were periodically removed from the shaker and the remaining collagen scaffolds were washed 
repeatedly with water.  Without being removed from the tube, the scaffolds were subsequently 
dried by lyophilization.  The final weight of the collagen-containing tubes was measured to 
determine the relative mass of collagen remaining. 
6.2.2.6 Stability of Native and PEG-Modified rhMMP-1 
Enzyme was incubated in buffer (50 mM HEPES, 5 mM calcium chloride, pH 7.5) at a 
concentration of 0.1 mg/mL at 65 °C.  Thermoinactivation was followed by removing aliquots 
periodically and assaying residual enzyme activity using the thioester substrate assay.   
The thermostability of native and PEG-modified rhMMP-1 at 37 °C and 50 °C was also 
measured in the presence of varying amounts of trypsin (0 – 1 mg/mL) and substilisn (0.0 – 0.1 
mg/mL) respectively.  In these experiments, trypsin or subtilisin was fully inactivated prior 
assaying MMP-1 activity by incubating the enzyme samples with soybean trypsin inhibitor or 
phenylmethylsulfonyl fluoride respectively. 
6.2.2.7 Computation of Solvent Accessibilities of Lysines 
The solvent accessible surfaces of lysines in rhMMP-1 were determined using the Swiss-
Pdb viewer (http://expasy.org/spdbv).178  The size of the probe used to determine the solvent 
accessibility of each residue was equal in size to that of a water molecule, which has radius of 
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1.4 Å.  Solvent accessibility is reported as a percentage of the accessible surface of the residue 
relative to the accessible surface of the residue in the extended conformation of a standard 
peptide (GGXGG).  A residue that is fully exposed has a solvent accessibility of 100 % whereas 
a residue that is completely buried has a solvent accessibility of 0 %.  The crystal structure of the 
active form of MMP-1 employed for the calculations, which was solved for by Iyer et al.179, was 
acquired from the Protein Data Bank (PDB accession code: 2CLT). 
6.2.2.8 Computation of Lysine pKa Values 
The theoretical pKa values of all lysines in rhMMP-1 were predicted using the H++ 
server (http://biophysics.cs.vt.edu/H++/index.php), which employs a standard continuum 
electrostatics methodology.180      
6.2.2.9 SDS-PAGE of Native and PEG-Modified rhMMP-1 
Native and PEG-modified rhMMP-1 samples were separated on 10 % linear or 4 – 20 % 
gradient polyacrylamide gels with tris-glycine-SDS running buffer.  The enzymes were 
subsequently stained for using the SilverSNAP Stain Kit II from Pierce (Rockford, IL).  A 
staining time of 3.5 mins was used in order to enhance the intensity of protein bands 
corresponding to PEG-rhMMP-1.   
6.2.2.10 Matrix Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) 
Mass Spectrometry 
MALDI-TOF analysis of proMMP-1 in addition to native and PEG-modified rhMMP-1 
was carried out using an Applied Biosystems PerSeptive STR Mass Spectrometer (Foster City, 
CA).  Enzyme samples were mixed at a 1:1 v/v ratio with a saturated solution of sinapinic acid 
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(0.5 mL water, 0.5 mL acetonitrile, 1 μL of 1 % v/v trifluoracetic acid) and subsequently spotted 
on the sample plate where the enzyme was co-crystallized with the matrix solution at room 
temperature.  After complete evaporation of the matrix solution, MALDI-TOF spectra were 
recorded in positive-ion linear mode. 
The peptide fingerprint of trypsin-digested native and PEG-modified rhMMP-1 was also 
analyzed by MALDI-TOF.  Briefly, the enzymes were initially resolved by SDS-PAGE using a 
10 % polyacrylamide gel, which was subsequently stained with silver.  The enzyme bands were 
carefully excised, transferred to 1.5-mL microcentrifuge tubes, and destained in sodium 
thiosulphate (50 mM) and potassium ferricyanide (15 mM) for 20 mins at room temperature.  
This was followed by repeated washings of the gel pieces in ammonium bicarbonate buffer and 
acetonitrile at 37 °C, reduction and alkylation of the enzyme in the presence of dithiothreitol (10 
mM) and iodoacetamide (55 mM) respectively, and tryptic digestion.  The digestion step was 
carried out by incubating the gel pieces with typsin (25 ng/μL) in buffer (25 mM ammonium 
bicarbonate) overnight at 37 °C.  Peptide fragments were subsequently extracted by washing the 
gel pieces three times with a solution of formic acid (5 % v/v) and acetonitrile (50 % v/v) at 37 
°C for 15 mins with constant shaking.  The rinse from each wash was collected and the peptide 
fragments were concentrated by vacuum centrifugation.  The peptide fragments were then 
desalted using Millipore C18 Ziptips (Bedford, MA) and eluted into a solution of acetonitrile (50 
% v/v) and α-cyano-4-hydroxycinnamic acid and trifluoroacetic acid (0.1 % v/v), which was 
spotted on the MALDI-TOF sample plate.  Low mass peptides (≤ 10 kDa) were analyzed in 
positive reflector mode whereas high mass peptides (10 - 30 kDa) were analyzed in positive-ion 
linear mode. 
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6.2.2.11 Analytical Ultracentrifugation Analysis of Native and PEG-Modified 
rhMMP-1 
The sedimentation behavior of native or PEG-modified rhMMP-1 was determined via 
analytical ultracentrifugation using a Beckman-Coulter (Fullerton, CA) XL-A ultracentrifuge.  
Sedimentation velocity analysis was determined at 18,000 rpm at a fixed temperature of 20 °C 
using enzyme solutions that were prepared in buffer (50 mM HEPES, 5 mM calcium chloride, 
pH 7.5).  Optical scans were generated by recording the absorption of the enzyme samples at 280 
nm.     
6.3 RESULTS AND DISCUSSION 
6.3.1 Rapid Assessment of Potential Therapuetic Efficacy of proMMP-1, rhMMP-1, and 
PEG-rhMMP-1 in Laceration Model 
Morphometric analysis showed a statistically significant (p < 0.05) reduction in 
interfibrillar collagen in the lacerated GMs of mice treated with proMMP-1, rhMMP-1, and 
PEG-rhMMP-1 relative to those treated with buffer (Figures 29A and B).  This reduction was 
greatest in lacerated GMs treated with 0.8 mU rhMMP-1 (51 %) and slightly less so in lacerated 
GMs treated with 0.4 mU proMMP-1 (40 %) and with 0.4 mU (41 %) and 0.8 mU PEG-rhMMP-
1 (30 %).  However, the effects of the enzyme treatments were not dose-dependent in the range 
of enzyme concentrations studied.  This suggests that the efficacy of muscle remodeling does not 
increase linearly with the rate of collagen degradation.  Rather, there is likely a critical point at 
which the rate of remodeling becomes limiting and any subsequent increase in the rate of 
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collagen degradation has a negligible impact on muscle regeneration.  It is thus conceivable that 
the efficacy of remodeling in the lacerated muscle was maximal upon delivery of 0.4 mU of 
collagenase activity.  Additionally, it is noteworthy that SDS-PAGE indicated a significant 
fraction of the proMMP-1 preparation had undergone autolytic activation and thus any effect 
caused by the injection of proMMP-1 may be partially attributed to this faction of the enzyme. 
Excessive fibrosis in many pathologies is linked to changes in relative levels of matrix 
metalloproteinases to tissue inhibitors of matrix metalloproteinases (TIMPs).170, 175, 181, 182  
Delivery of MMP-1 to pre-existing scar in skeletal muscle may shift the balance of MMP-1-to-
TIMP activity to facilitate collagen degradation.  Assuming this to be the case, small molecules 
that inhibit TIMPs and thus alter the balance of endogenous collagenase-to-TIMP activity could 
also potentially be used to treat muscle fibrosis. 
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Figure 29.  Histological analysis of muscle adjacent to the laceration site 14 d after treatment.  
(A) Images of tissue stained with picrosirius red acquired with a 4x objective.  (B) Comparison 
of interfibrillar collagen in control and treatment groups (∗ p < 0.05).  The boxed areas represent 
the fields in which the amount of connective collagen was quantified.  Error bars represent the 
standard deviation from the mean for each treatment group. 
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6.3.2 Quantitative Comparison of Efficacies of Native and PEG-Modified rhMMP-1 in 
Reducing Muscle Scarring in Laceration Model 
In attempt to improve the in vivo stability of rhMMP-1, and thus its efficacy as a scar 
reducing agent, we covalently modified the enzyme with PEG-SPA.  PEG-modification, 
commonly referred to as PEGylation, is an often effective strategy for reducing the clearance of 
therapeutic proteins.51-53  The attachment of PEG can render a protein less immunogenic and 
prevent proteolysis and autolysis, when the target protein is itself a protease, through steric 
effects and by altering residue charge.   
A follow-up in vivo study was carried out to quantifiably compare the effects of native 
and PEG-modified rhMMP-1 on muscle fibrosis in the laceration model.  To accurately identify 
the laceration site in tissue sections, blue tissue marking dye was applied to the wound site after 
injury.  Additionally, green fluorescent microspheres were co-injected with the enzymes or 
buffer to label the injection site in relation to the site of injury.  Fluorescent images showed the 
co-localization of the microspheres with the tissue marking dye at the laceration site, thereby 
verifying delivery of the enzymes or buffer to the fibrotic tissue (Figure 30).  Hemosiderin 
deposits were also observed in muscle at the laceration site, which are the result of hematoma 
formation in the muscle tissue. 
Compared to in lacerated GMs treated with buffer, the GMs of mice injected with a 
single dose of rhMMP-1 (0.8 mU) contained 30 % less interfibrillar collagen (Figure 31).  While 
the effect of rhMMP-1 was statistically significant (p < 0.05), GMs treated with the active 
enzyme still contained on average 5-fold more interfibrillar collagen than normal (i.e. uninjured) 
GMs.  Direct injection of PEG-modified rhMMP-1 did not, however, yield a significant effect on 
the interfibrillar collagen in the lacerated GMs of mice.  The key question thus becomes why is 
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the activity of PEG-modified rhMMP-1 in the laceration model significantly lower than that of 
the native enzyme. 
 
 
Figure 30.  (A) Brightfield image of blue tissue marking dye at laceration site acquired with 
100x objective.  The arrows indicate the presence of hemosiderin, the brown pigment, at the site 
of injury.  (B) Fluorescent image of the equivalent field showing co-localization of green 
fluorescent microspheres with the tissue marking dye at the laceration site.  The arrows point to 
examples of individual microspheres in the captured field.  (C) Control image showing the size 
of the green fluorescent microspheres prepared on a blank glass slide at the same magnification. 
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Figure 31.  Results of histological analysis from follow-up in vivo study at 11 d post-treatment 
of lacerated GMs with rhMMP-1 (0.8 mU) or PEG-rhMMP-1 (0.8 mU).  (A) Images of 
unstained sections showing tissue marking dye at site of laceration and matching area in 
Masson’s trichrome stained specimens (10x objective).  (B) Selected fields from Masson’s 
trichrome stained specimens used for quantification of interfibrillar collagen and below, 
corresponding thresholded areas.  (C)  Comparison of interfibrillar collagen in the left and right 
GMs of mice within the same treatment group (∗ p < 0.05).  The level of fibrosis in the GMs of 
mice treated with buffer only and in the GM of uninjured mice are also shown.  Error bars 
represent the standard deviation from the mean for each treatment group. 
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6.3.3 Effect of PEGylation on rhMMP-1 In Vitro Activity and Stability 
To determine if PEG-attachment effected the activity of rhMMP-1, the kinetic parameters 
(kcat and KM) of native and PEG-modified rhMMP-1 were determined using a thioester peptide 
substrate (Table 4).  Differences in kcat, KM, and kcat/KM of rhMMP-1 versus PEG-rhMMP-1 
were minimal, suggesting that PEG-attachment does not drastically affect the catalytic efficiency 
of rhMMP-1.  The intrinsic activity and specificity of the recombinant human active MMP-1 
may have been subtly affected by the presence of a hexahistidine tag and differences in 
glycosylation levels of proMMP-1 and rhMMP-1.   
 
Table 4.  Kinetic parameters for native and PEG-modified rhMMP-1 catalyzed degradation of 
thioester peptide substrate.   
Enzyme  
kcat 
(s-1) 
KM 
(mM) 
kcat/KM 
(s-1mM-1) 
    
rhMMP-1  7.3 ± 0.4 0.87 ± 0.14 8.4 ± 1.8 
    
PEG-rhMMP-1  5.9 ± 0.1 0.98 ± 0.05 6.0 ± 0.4 
    
 
The error associated with the catalytic efficiency (kcat/KM) was calculated as follows: 
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The impact of PEGylation on the activity of rhMMP-1 towards type I collagen, the 
natural substrate of MMP-1 in scar, was also investigated via assaying the rate of enzymatic 
hydrolysis of collagen scaffolds (Figure 32).  Collagen is a much larger substrate molecule than 
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the thioester peptide, although since the substrates share a common target cleavage site, the 
mechanism of catalysis of collagen and thioester peptide is presumably similar.  Incubation of 
collagen scaffolds with native rhMMP-1 over the course of 14 days resulted in an approximate 
29 % reduction scaffold mass.  Conversely, the rate of hydrolysis of collagen scaffolds in the 
presence of equivalent amounts of PEG-rhMMP-1 was comparable to that of the scaffold in 
buffer.  A plausible explanation for this is the modification of a residue that is critical to the 
catalytic mechanism of the enzyme.  The rather large error in the assay results is intrinsic in the 
measurement of scaffold weights.   
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Figure 32.  Degradation of lyophilized type I collagen scaffolds by native rhMMP-1 (▲), PEG-
rhMMP-1 (?), and buffer (?).  Error bars represent the standard deviation from the mean for 
three separate experiments. 
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 To determine if PEG-attachment enhanced the overall stability of rhMMP-1, the stability 
of native and PEG-modified rhMMP-1 at elevated temperature and in the presence of proteolytic 
enzymes was assayed.  Enzyme inactivation in these studies was determined by measuring 
residual activity over time using the thioester peptide substrate.  Modification of rhMMP-1 with 
PEG resulted in a marked thermostability enhancement (a 60-fold increase in half-life) at 65 °C 
(Figure 33).  The thermostability of rhMMP-1 when incubated at the same temperature in the 
presence of 10 % (w/v) free PEG (5000 Mw) was greater than that of the native enzyme alone, 
but significantly less than that of the modified enzyme.  When incubated with trypsin or 
subtilisin, native and PEG-modified rhMMP-1 were inactivated at comparable rates, independent 
of the concentration of the added protease (Figure 34).  These results suggest that PEGylation 
does not mask the susceptibility of rhMMP-1 to proteolytic digestion.  Hence, the attachment of 
PEG would presumably have little effect on the in vivo half-life of rhMMP-1 in the laceration 
model. 
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Figure 33.  Thermostability of native (●) and PEGylated rhMMP-1 (?) at 65 °C.  The stability 
of rhMMP-1 in the presence of 10 % (w/v) fully hydrolyzed PEG-SPA (Mw 5000) was also 
measured (○).  Error bars represent the standard deviation from the mean for two separate 
experiments. 
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Figure 34.  (A) Stability of native and PEGylated rhMMP-1 in the presence of trypsin at 50 °C.  
Native rhMMP-1 (closed symbols) and PEG-rhMMP-1 (open symbols) were incubated with 
varying amounts of trypsin (0.0 mg/mL (squares), 0.1 mg/mL (diamonds), 0.5 mg/mL 
(triangles), 1.0 mg/mL (circles)).  (B) Stability of native and PEGylated rhMMP-1 in the 
presence of subtilisin Carlsberg at 37 °C.  Native rhMMP-1 (closed symbols) and PEG-rhMMP-
1 (open symbols) were incubated with varying amounts of substilisin (0.0 mg/mL (squares), 
0.001 mg/mL (diamonds), 0.1 mg/mL (circles)). 
 
6.3.4 Prediction of Reactivity of Modification Sites in rhMMP-1 
Modification with PEG resulted in the inactivation of rhMMP-1 towards collagen and 
was ineffective in enhancing the enzyme’s stability under near physiological conditions.  As a 
result, with the ultimate aim of determining the structural basis for the apparent deactivation of 
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rhMMP-1, we predicted the most likely sites of PEG-attachment by means of computational 
analysis. 
Given the reactivity of PEG-SPA towards primary amines, the principal sites for rhMMP-
1 modification are the ε-amino groups of lysines and the N-terminal α-amino group (Figure 35).  
The relative reactivity of these sites can be modeled by computing their respective pKa values 
and solvent accessibilities, enabling the most probable sites of PEG-attachment to be predicted.  
Generally, the most reactive sites are those that are on the enzyme’s surface, and thus solvent 
accessible.  These sites also typically have low pKa values, which are characteristic of strong 
nucelophiles.73, 183-185  Potential modification sites that are largely inaccessible, such as those in 
the active cleft of an enzyme, for example, may still be highly reactive if their pKa values are 
unusually low.  Therefore, the pKa value of a potential modification site can have a larger 
influence on reactivity than solvent accessibility when it is buried in the core of an enzyme.183  
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Figure 35.  Schematic of rhMMP-1 PEGylation with PEG-SPA. 
 
The pKa and solvent accessibility values of the lysines in rhMMP-1 and of the N-
terminal α-amino group, which were calculated from the crystal structure of the enzyme using 
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H++ server and Swiss-PdB Viewer respectively, are summarized in Table 5  Out of the possible 
modification sites, Lys459 is presumably the most reactive since it has the lowest pKa (9.54) and 
moderately high accessibility (31.14 %).  Another probable site for PEG-attachment is Lys432 
since it too has a comparatively low pKa (10.19), although it is largely inaccessible to solvent 
(9.89 %).  Among the other sites in rhMMP-1 that may potentially be modified based on pKa 
and solvent accessibility include Lys362, 281, and 347. 
Interestingly, Lys459, 432, 362, 281, and 347 are all in the C-terminal hemopexin domain 
of the enzyme (Figure 36).  This 183 residue segment, which is tethered to the catalytic domain 
of MMP-1 by a short hinge, plays a critical role in the enzyme’s ability to bind collagen as 
demonstrated by mutation deletion studies 186-189.  Modification of a lysine in the hemopexin 
domain or other proximal lysines would be expected to impact collagen binding.  Moreover, 
modification at these sites may not fully shield the catalytic domain from attack of proteases.  It 
may be possible to prevent deactivation of rhMMP-1 and protect the enzyme from proteolytic 
degradation through site-specific modifications.  A reversible inhibitor or substrate may also be 
used to shield critical residues in the enzyme during modification to prevent deactivation. 
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Table 5.  Theoretical pKa and solvent accessibility values of the N-terminal α-amino group and 
lysines in rhMMP-1.  The residue number corresponds to that of the residue in the sequence of 
full-length proMMP-1.   
Residue pKa Solvent accessibility (%) 
   
F81(α-NH2) 11.87 33.68 
K136 10.67 19.41 
K151 11.23 27.84 
K276 11.31 44.69 
K281 10.36 47.99 
K298 13.55 16.85 
K344 11.95 18.32 
K347 10.37 34.80 
K362 10.20 25.27 
K375 10.52 55.68 
K388 15.62 13.19 
K396 10.66 29.30 
K404 10.79 46.89 
K413 10.87 26.37 
K425 14.35 29.67 
K432 10.19 9.89 
K446 10.75 14.65 
K450 10.88 64.10 
K452 11.72 38.46 
K459 9.54 31.14 
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Figure 36.  Ribbon diagram of rhMMP-1 showing the most likely sites of PEG-attachment (red).  
The active site residues H218ALGHSLGLSH (purple) and the enzyme-associated zinc (green) 
and calcium (black) ions are also highlighted. 
  
In attempt to experimentally determined the number and sites of modification, PEG-
rhMMP-1 was further characterized using a variety of analytical and biophysical techniques.  
When separated by SDS-PAGE, PEG-rhMMP-1, prepared using a 1000:1 molar ratio of PEG -
to-protein, resolved into several species (Figure 37).  These species, ranging in molecular weight 
from 43 kDa to greater than 250 kDa, are presumably representative of rhMMP-1 modified with 
increasing number of PEGs, including a small fraction of residual unmodified enzyme.  The 
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average number of attached PEGs per enzyme molecule could not be determined, however, since 
the migration of PEG-modified proteins is not consistent with that of native proteins of 
equilivalent mass. Such differences in the migration of native and PEGylated proteinas are likely 
due to entanglement of the PEG chains and may reflect differences in SDS binding.190, 191  
Autolytic peptide fragments, which were apparent in native rhMMP-1, were presumably also 
modified, thereby complicating the analysis of PEG-rhMMP-1. 
 Analytical ultracentrifugation was also employed to quantitatively determine the extent of 
PEG-attachment to rhMMP-1.  In analytical ultracentrifugation analysis, the absolute molecular 
weight and conformation of proteins can be ascertained based on their sedimentation behavior.192  
Native rhMMP-1 sedimented as a single species in sedimentation velocity analysis whereas 
multiple sedimenting species were observed in the analysis of PEG-rhMMP-1.  This serves as 
additional evidence that PEG-rhMMP-1 was indeed modified with multiple PEGs and that the 
distribution in number of attached PEGs varied.  However, due to error associated with obtaining 
a stable baseline signal, the average molecular weight, and thus number of attached PEGs per 
enzyme molecule, of the modified enzyme could also not be determined using this method.  Such 
error, which may be due to autolytis of the modified enzyme over the course of analysis, may 
potentially be prevented in future studies by the addition of MMP-1 inhibitior or zinc chelating 
agents. 
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Figure 37.  SDS-PAGE of native and PEGylated rhMMP-1.  Lanes: (1) protein molecular 
weight markers, (2) native rhMMP-1 (0.5 μg), (3) PEG-rhMMP-1 (Mw 5000; 1 μg), and (4) 
PEG-rhMMP-1 (Mw 5000; 2 μg). 
 
A peptide mapping approach was used to pinpoint the modified sites and thus confirm 
modification of a critical lysine in the hemopexin domain.  PEG-rhMMP-1 was initially 
subjected to in-gel tryptic digestion after which the mass of the resulting peptide fragments were 
analyzed by MALDI-TOF.  A lysine that is modified with PEG will, in theory, be shielded from 
tyrpsin, thereby resulting in a shift in the expected mass of the peptide fragment containing this 
lysine.  However, the peptide fingerprint of PEG-rhMMP-1 was not detectable by MALDI-TOF, 
thereby preventing the successful identification of the modified sites in the enzyme.  The method 
settings used for MALDI-TOF analysis including the laser intensity, accelerating voltage, grid 
voltage, guide wire voltage and delay time were varied and different matricies were used in 
attempt to improve the signal of the peptide fragments.  Similarly, intact native and PEGylated 
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rhMMP-1 were also not amenable to MALDI-TOF analysis, suggesting that the enzymes and 
tryptic peptide fragments are not readily ionizable. 
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6.4 CONCLUSIONS 
In our earlier work, we have demonstrated the feasibility of using proMMP-1 to reduce 
the extent of interfibrillar collagen in lacerated skeletal muscle.  The objective of this study was 
to examine the impact of pre-activation and PEG-modification on the therapeutic efficacy of 
MMP-1 in the treatment of scarred muscle.  A rapid assessment of the efficacy of proMMP-1, 
rhMMP-1, and PEG-rhMMP-1 in an in vivo murine model of lacerated muscle found the pre-
activated enzyme to be most effective in resolving fibrotic tissue.  However, the enzyme 
treatments did not show a dose-dependent effect, suggesting the rate of muscle remodeling was 
limiting relative to that of collagen degradation.  A quantitative comparison of scar degrading 
activities of rhMMP-1 and PEG-rhMMP-1 in the laceration model confirmed that the modified 
form of the enzyme was significantly less effective than rhMMP-1 in digesting pre-existing scar.  
It was found that PEG-modification resulted in the loss of collagenase activity in in vitro activity 
assays, thereby presumably explaining the inability of PEG-rhMMP-1 to effectively degrade 
fibrotic tissue in the laceration model.  Stability studies also indicate that the covalent attachment 
of PEG did not increase the half-life of rhMMP-1 when incubated in the presence of trypsin or 
subtilisin.  Computational modeling of the reactivity of potential modification sites in rhMMP-1 
suggest that one or more critical lysines in the hemopexin domain of the enzyme are covalently 
modified, which would likely block collagen docking.  Accordingly, the impact of PEGylation 
on the activity and stability of rhMMP-1 may be dramatically improved through site-specific 
modifications. 
Overall, these results provide valuable insight into the development of a novel strategy 
for treating fibrotic pathologies based on the use of MMP-1.  Further studies are required to 
characterize the effect of MMP-1 treatment on the physiological function of fibrotic muscle.  
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These along with additional studies that examine the impact of multiple MMP-1 injections and 
different dosing regimens will be reported in a subsequent communication. 
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APPENDIX 
SOURCECODE 
MATLAB Model of pH and Paraoxon Conversion in OPH-Urease System 
Main Program: 
%Clear workspace 
clear; 
 
%Define enzyme concentrations: 
urease = (5.1/1000)*22.45;     %in U/mL 
oph_units = (0.001/1000)*2624.898;    %in U/mL 
 
%Define unit definitions of enzymes: 
%1 unit of jack bean urease activity = 1 micromole of urea hydrolyzed per min (micromol/min) 
%at pH 6.5, T=25C, and [urea]=10mM in 50mM NaCl, 0.15mM CoCl2 
%Activity determined using pH-stat method 
% 
%1 unit of Pseudomonas diminuta OPH activity = 1 micromole of paraoxon hydrolyzed per min 
(micromol/min) 
%at pH 8, T=25C, and [paraoxon]=1mM in 50mM bis-tris propane, 0.15mM CoCl2   
%Activity determined spectroscopically by monitoring p-nitrophenol generation at 412nm 
 
%Convert concentration of OPH from activity units to molar basis using Michaelis-Menten rate 
%equation and empirical kinetic parameters (kcat and KM) at pH 8: 
kmunit = 0.031;      %in mM 
kcatunit = 1740;      %in s-1 
oph =(oph_units)*1000*(10^(-6))*((kmunit/1000)+(1/1000))/((kcatunit)*60*1/1000); %in M  
 
 
%Define initial conditions for ode solver: 
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%y0(1) = Initial paraoxon concentration (M) 
%y0(2) = Initial system pH 
y0=[0.001; 6]; 
 
%Define time step: 
tspan = [0; 100];               
refine = 500; 
 
%Call ode solver:  
%ode15s is required due to stiffness of problem 
%solver calls on function “stifffun” 
options = odeset('BDF','on','Refine', refine); 
[t,y] = ode15s(@stifffun, tspan, y0, options, urease, oph); 
 
%Generate plot of pH and paraoxon conversion as a function of time: 
plot(t,y(:,2),'b'); 
 
%Write time, pH, and paraoxon conversion to data.txt (data file): 
fid = fopen('data.txt','w+'); 
[size1, size2]=size(y); 
for i=1:size1 
    paraoxon_conversion=(y(1,1)-y(i,1))./y(1,1)*100; 
    ret2 = fprintf(fid, '%f %2.5f %f\n', t(i), y(i,2), paraoxon_conversion); 
end 
status = fclose(fid); 
 
 
 
 
Function “stifffun”: 
function [dydt]=stifffun(t, y, urease, oph); 
dydt = zeros(2,1);     
 
%Calculate pH-dependent kinetic constants for OPH against paraoxon: 
km = (0.001)*(-0.01*((y(2))^2) + 0.155*(y(2)) - 0.568); %in M  
kcat = -6720*((y(2))^2) + 141600*(y(2)) - 597780;  %in min-1 
 
%Calculate rate of paraoxon hydrolysis: 
Voph = (kcat)*(oph)*(y(1))/(km+(y(1)));   %in M/min 
 
%Define acid/base dissociation constants: 
pkaPNP = 7.1;                 %p-nitrophenol 
kaNH4 = 5.6E-10;              %ammonium 
pkaH2CO3 = 6.352;          %carbonic acid 
pkaHCO3 = 10.329;            %bicarbonate 
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%Compute proportionality factors as a function of pH: 
%Generation of protons per mol of p-nitrophenol as a function of pH: 
alpha = 1 + 1/(1 + 10^(pkaPNP-(y(2)))); 
 
%Generation of hydroxide ions per mol of bicarbonate as a function of pH: 
factorA = 10^(pkaH2CO3-(y(2))); 
factorB = 10^((y(2))- pkaHCO3); 
beta = 2/(1+(kaNH4/(10^(-(y(2))))))-((1/(1+factorA))-(factorB/(1+factorA))*(1/(1+factorB)))-
2*((factorB/(1+factorA))*(1/(1+factorB)));  
 
%Conversion of d[H+]/dt to dpH/dt: 
gamma = 1/(-2.302585*(10^(-(y(2))))); 
 
%Calculate rate of urea hydrolysis 
Vurease = (10^(-6))*((-15.047*((y(2))^2) + 208.016*(y(2)) - 700.421))*(urease/0.01585);  %in 
M/min 
 
%Michaelis-Menten rate equation (dydt(1)) for monitoring rate of change of paraoxon 
%concentration:  
dydt(1) = -(kcat)*(oph)*(y(1))/((km)+(y(1)));     %in M/min 
 
%Differential equation for monitoring rate of change of system pH (dydt(2)): 
dydt(2) = (gamma)*(alpha*(Voph) - beta*(Vurease)); 
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